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1.1 Introduction 
For many years polymer chemists have been developing new synthetic routes for the 
preparation of better defined polymers. Although considerable progress has been made, 
especially with the development of controlled polymerization techniques[1], the level of control 
present in biological polymers remains unsurpassed. In nature, macromolecules, like nucleic 
acids and proteins fulfill a large variety of functions, including information storage and transfer, 
catalysis and tissue support. The fidelity of the synthesis of these macromolecules is therefore 
of utmost importance and receives special attention of the cellular machinery. From a polymer 
chemistry point of view three aspects of biological macromolecules are remarkable: Firstly, 
they are monodisperse, i.e. they are of a specific molecular weight in contrast to synthetic 
polymers, which have a molecular weight distribution. Secondly, biological polymers are 
synthesized with absolute control over monomer sequence. Thirdly, natural polymers can attain 
well-defined three-dimensional structures via multiple levels of organization as a result of the 
interplay of a variety of non-covalent interactions, like steric, hydrophobic, electrostatic and 
hydrogen bonding interactions. 
The importance of sequence information and non-covalent interactions is evident for 
proteins, where a multitude of structurally and functionally different types of proteins are made 
with a set of 20 amino acid building blocks. Some proteins evolved as enzymes catalyzing a 
wide variety of reactions, whereas others acquired regulatory or structural functions. The amino 
acid sequence affects the possible spatial arrangement of the polypeptide chain and can result in 
the regular hydrogen bond stabilized α-helical and β-sheet secondary structures. In the next 
level of organization, the three-dimensional arrangement of the secondary structural elements, 
stabilization primarily occurs via hydrophobic and electrostatic interactions. Furthermore, 
proteins can associate into macromolecular assemblies. 
These organizational principles have been an inspiration source for materials scientists 
interested in designing precise nano- and mesoscopic structures using chemically synthesized 
compounds. In this area of research, termed “supramolecular chemistry”[2] components are 
organized into patterns or structures with the use of multiple non-covalent interactions. This 
process where components organize without human intervention is often termed “self-
assembly”. The interest in self-assembly arises among other reasons from the wish to make 
materials with ever-smaller feature sizes for use in nanotechnology. 
The interest of material scientists in proteinaceous materials results from the wish to 
understand how assembly at different scales contributes to the macroscopic, mechanical 
properties of materials. In this respect, fibrous structural proteins, such as collagens, silks and 
elastins have drawn much attention. Although composed of the same amino acid building 
blocks, their distinct organization gives these materials a variety of properties, like rigidity, 
toughness or elasticity. Better understanding of how their organization translates into final 
material properties may lead to the development of new kinds of high performance materials. 
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The synthesis of high molecular weight polypeptides with control over amino acid 
sequence via chemical routes is still a troublesome procedure (see Chapter 2). A valuable 
alternative for their synthesis is therefore the use of the biosynthetic pathway of               
(micro-)organisms. This approach has been followed for many years for the production or 
modification of globular proteins, resulting in the development of a whole range of techniques 
for gene construction, protein expression and purification. However, only since the last decade, 
protein engineering has been used extensively as a tool for the preparation of structural proteins. 
One type of structural protein that has received much attention is silk. Since this material is the 
source of inspiration of the research described in this thesis, the characteristics of this class of 
structural proteins, as well as their application in materials science will be discussed in more 
detail in the next paragraphs. 
 
1.2 Silk worm cocoon silk and spider dragline silk 
Silks are fibrous structural proteins that are produced by more than 30.000 known species of 
spiders and by over 100.000 known species of insects.[3] Of all those silks, two types of silk 
have been studied most extensively, namely the cocoon silk of the domesticated silk worm 
Bombyx mori and spider dragline silk from the golden orb weaver Nephila clavipes and the 
garden cross spider Araneus diadematus. The interest in silk worm silk is, of course, the result 
of its large-scale production for use as high-quality textile fiber. Dragline silk, produced in the 
major ampullate  gland and forming the web frame, has attracted attention because it is stronger 
than other biomaterials and tougher (energy to break) than engineered materials, like Kevlar and 
high-tensile steel.[4] 
Silkworm silk has been best characterized of all silks. The fiber consists of a heavy (H) 
and a light (L) chain polypeptide (molecular weights of ~ 390 kDa and 26 kDa, respectively) 
which are linked via their C-terminus by a disulfide bridge.[5-8] In addition, another 25 kDa 
polypeptide associates with the H-L complex primarily by hydrophobic interactions.[5] The 
structurally important H-chain has been shown to consist of a repetitive motif of alternating 
amorphous and crystalline domains.[9-13] Only recently, a complete amino acid sequence was 
reported as deduced from genomic DNA.[14, 15] However, some variability in molecular weight 
and composition of the H-chain exists between Bombyx mori stocks.[11, 12] The 12 crystalline 
domains contain multiple repeats of the hexapeptide GAGAGS (G = glycine, A = alanine and S 
= serine), separated by a more variable repeating motif. The strict G-X alternation (X = A in 
65%, S in 23% and Y (tyrosine) in 9%) is occasionally interrupted by the GAAS tetrapeptide 
sequence. A typical sequence of a crystalline domain is depicted in Figure 1.1a. The number of 
tandem repeats (n) within these domains is variable. The crystalline domains are connected by 
11 conserved, non-repetitive linker sequences of approximately 30 residues, containing a 
proline, a tryptophan, and charged residues (these residues are completely absent from the 
crystalline domains). 
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Figure 1.1 Amino acid sequence motifs for (a) a crystalline domain of Bombyx mori heavy chain 
fibroin and (b) Nephila clavipes dragline silk fibroins (G = glycine, A = alanine, S = serine, Y = 
tyrosine, R = arginine, L = leucine, Q = glutamine and P = proline). 
 
The crystallinity of silk was already known in 1913[16] via X-ray diffraction and has later been 
assigned to the regular G-X repeats in the fibroin.[17, 18] The diffraction pattern is characteristic 
of an antiparallel pleated β-sheet structure.[19-21] Silkworm silk can thus be considered as a 
semicrystalline material made of amorphous flexible chains reinforced by strong and stiff β-
sheet crystals (Figure 1.2). The β-sheet crystals (with a size of 6 × 2 × 21 nm) can be considered 
as non-covalent crosslinks and are oriented with the polypeptide chains lying parallel to the 
fiber axis.[22] 
 
Figure 1.2 Schematic representation of the silk structure. The crystalline β-sheet domains are 
embedded in an amorphous matrix, which allows the crystalline domains to orient themselves under 
strain, and makes the fibers flexible. 
 
In comparison to silkworm silk, limited information on the composition of spider dragline silk 
is available. Dragline silks are considered to be composed of two major proteins.[23] Lewis et al. 
reported the presence of two proteins, termed major ampullate spidroin 1 and 2 (MaSp-1 and 
MaSp-2), in the dragline silk from Nephila clavipes.[24, 25] Based on cloned cDNA sequences 
containing the C-terminal part of these silk fibroins their repetitive character became apparent. 
However, no complete sequence data are available due to the repetitiveness and high molecular 
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masses of these fibroins. Apparent molecular masses between 180 and 720 kDa have been 
reported depending on the applied analytical technique.[26-28] Repeating sequence motifs of 
approximately 34 and 45 amino acid residues are found for MaSp-1 and MaSp-2, respectively. 
Within these repeat motifs, short poly(alanine) blocks of 7-10 residues in length are present 
(Figure 1.1b). These poly(alanine) stretches have been found to form crystalline β-sheet stacks, 
giving the material its strength.[29-33] The β-sheet crystals (2 × 5 × 6 nm) are dispersed in a less 
well-defined glycine-rich matrix, which provides elasticity to the fiber.[34] Two motifs can be 
recognized in the glycine-rich sequence, namely GPGXX in MaSp-2 (with X often representing 
glutamine (Q)) and GGX in MaSp-1. The first motif has been suggested to form a β-turn spiral, 
and most likely provides elasticity, based on the predominance of this motif in the more elastic, 
flagelliform silk and the presence of comparable proline-containing motifs in other elastic 
proteins, such as elastin and gluten.[35-38] The GGX motif has been proposed to form a 31-
helix.[39] Similar repetitive motifs were found in major ampullate fibroins of Araneus 
diadematus and other spiders.[23, 40] Furthermore, the conserved, non-repetitive carboxyl-
terminal sequence[40] contains a cysteine residue that may participate in interfibroin disulfide 
cross-linking.[28] 
 
1.3 Recombinant synthesis of silk proteins 
The production of silk by genetically modified organisms has been focused on spider dragline 
silk, which is tougher than the brittle cocoon silk of Bombyx mori. The isolation of large 
amounts of spider silk from natural sources is not feasible, due to the territorial nature of 
spiders. Spinning of spider silk occurs at ambient temperatures and pressures using water as 
solvent and yields a biodegradable fiber. Therefore it is considered as a “green” alternative to 
traditional synthetic fibers.[41] Furthermore, recombinant fibroin synthesis allows variation of 
silk primary sequences and thus enables the production of fibers with a wide range of 
properties.[42] An anticipated application of silk fibers is, for example, as fine monofilament 
sutures in microsurgery.[43] 
Factors that complicate the recombinant production of spider silk fibroins are the length 
and repetitiveness of the genes and their high gc-content. Only partial cDNA clones of dragline 
silk genes have been obtained and have been used for the production of recombinant silk in a 
number of host organisms. Arcidiacono et al. reported the low level expression (4 mg L-1) in E. 
coli of a partial cDNA clone from the 3’-end of the Nephila clavipes spidroin 1 gene resulting 
in a 43 kDa recombinant silk protein.[44] More recently, mammalian cells (bovine and 
hamster)[43], and insect cell lines (derived from the fall armyworm Spodoptera frugiperda) using 
the baculovirus expression system[45], were used for the production of recombinant silk fibroins. 
The company Nexia Biotechnologies even investigated the use of transgenic goats that secrete 
silk protein in their milk.[46] 
Synthetic genes have been engineered to optimize codon usage for the applied 
expression host and to minimize repetitiveness of the silk genes. Building up genes from small 
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oligonucleotide repeats allows control over gene and protein sequence and the final protein size. 
Synthetic genes have been used mainly in E. coli[47-52], but also in the yeast Pichia pastoris[53] 
and plants like tobacco and potato[54, 55] and silk fibroins with a molecular weight of up to 150 
kDa have been produced. Fahnestock and coworkers were the first to express synthetic 
analogues of both Nephila clavipes dragline silk fibroins in E. coli.[47] To minimize 
repetitiveness they used long DNA monomers (303 bp), encoding four variant repeats of the 
natural protein. The genes consisting of 8 or 16 monomer repeats were quite stable (less than a 
few percent of deletion observed after 400 doublings) and expressed well (300 mg L-1). 
However, truncated protein products were formed predominantly due to premature termination 
of translation. The fraction of full length protein was determined to be approximately 50% for 
the 8-mer gene and decreased to 9% for the 16-mer gene. This limitation was overcome by 
using the methylotrophic yeast Pichia pastoris as a production host. By expressing the genes 
under control of the methanol-inducible AOX1 promoter, yields of 1g L-1 were obtained and 
longer products up to 2000 amino acid residues could be synthesized without evidence of 
truncated synthesis.[53] 
 
1.4 Silk assembly 
The production of recombinant silk proteins similar to the natural counterparts is, by itself, not 
sufficient to produce fibers with good mechanical properties. Another critical factor is the 
artificial spinning of these silks. Several physiological and mechanical parameters play an 
important role in natural silk spinning. For example, the spinneret involved in the production of 
dragline silk fibers by Nephila clavipes has been well studied.[56] The silk fibroins are stored at 
high concentrations (up to 50% w/v) in the silk gland without apparent aggregation.[57] This 
“spinning dope” is liquid crystalline, meaning that neighbouring molecules are aligned 
approximately parallel to one another. This allows extrusion of the fiber using minimal 
forces.[58] Thread assembly occurs during passage of the silk dope through the spinning duct and 
is accompanied by extraction of water, sodium and chloride ions from the lumen.[59, 60] At the 
same time potassium ions and protons are secreted into the lumen which results in lowering of 
the pH from 6.9 to 6.3. It is thought that this triggers partial unfolding of the proteins and the 
transition of the polyalanine stretches from an α-helical to a β-sheet conformation. This results 
in interchain hydrogen bonds, and thus in physical cross-linking.[61-63] The presence of these 
cross-linked domains results in the remarkable mechanical properties of spider dragline silk. 
Mechanical tests show that it is among the strongest biomaterials known and is tougher (energy 
absorption before breakage) than engineering materials, like Kevlar (Figure 1.3). 
Recombinant spider silk proteins have been spun from the strongly denaturing solvent 
hexafluoroisopropanol or from dilute solutions in concentrated formic acid using methanol as 
coagulant [64-66], but the properties of the natural silks have not been reproduced. A procedure 
more similar to the natural spinning process is the one described by Lazaris and coworkers.[43] 
Silk fibroin from Araneus diadematus expressed in mammalian cells was spun into fibers from 
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an aqueous spinning dope (>23% w/v of protein) by coagulation in 70-80% methanol. The 
fibers were subjected to postspinning draw, where higher draw ratios resulted in higher 
strength, toughness and stiffness values. However, the strength values were typically 5-fold 
lower than for dragline silk, but similar to those measured for fibers spun from regenerated 
spider silk.[67] The toughness and stiffness values were comparable to native dragline silk. 
 
 
Figure 1.3 Schematic stress-strain curves for major ampullate gland (MA) silk and Kevlar 49 
showing the characteristic parameters for tensile tests. Some values for biological and synthetic 
materials are given. The stress is the normalized force (force divided by cross-sectional fiber area) 
and the strain is the normalized deformation (change in fibril length divided by initial length). The 
toughness represents the area under the stress-strain curve. The values are from reference [4]. 
 
1.5 Artificial protein polymers 
The resemblance of structural proteins to segmented multiblock copolymers has instigated 
researchers to combine blocks from different structural proteins to design new materials, and 
furthermore get insight in the individual contributions of the blocks on the final material 
properties. Designed repetitive block copolypeptides which combine motifs like β-sheets in 
silk, β-spirals in elastin, animal cell adhesion sequences in fibronectin, and leucine zipper 
motifs in DNA-binding proteins, have been reported.[68-72] 
Alternatively, low-complexity sequences were designed to control polypeptide assembly. 
An example is the repeating sequence “(EAEAKAK)n”, which forms extended β-strand 
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structures as a result of the alternating polar and non-polar residues.[73] These polypeptides self-
assemble into fibrils and form self-sustaining gels. Tirrell and coworkers have explored the 
possibility to control the solid-state structure and in particular the crystal structure of artificial 
polypeptides.[74] They reported the biosynthetic production of a series of polypeptides, with the 
generic sequence -[(AG)xEG]n- (x = 3, 4, 5, and 6), with the aim to have control over 
polypeptide folding after crystallization. For conventional polymers, including the aliphatic 
polyamides (the nylons), a commonly occurring crystalline element is the adjacent re-entry 
chain-folded lamella (Figure 1.4a). Keller and others showed already in the 1950s for 
polyethylene single crystals that the polymers must bend back on themselves forming a 
regularly folded configuration.[75, 76] It is a generally accepted configuration for linear polymers 
that are sufficiently flexible to form hairpin-like folds.  
 
 
 
Figure 1.4 (a) A single polymeric crystal in the form of a folded-chain lamella. The polymer chains 
fold regularly and sharply with a uniform fold-period: the adjacent-reentry model. (b) Lamella 
formation for poly-[(AG)xEG] (x = 3). The alanylglycine (AG) repeats form antiparallel β-strands 
in the lamellar interior, whereas the glutamic acid (E) residues are located at the lamellar surface. 
The number of AG-repeats (x) determines the lamellar thickness, d. 
 
By introducing sequence information in polypeptide-based materials the objective was to obtain 
control over lamellar crystals with respect to (1) chain conformation (2) lamellar thickness and 
(3) lamellar surface structure. The design of the –[(AG)xEG]n- sequence was based on the 
observation that poly(alanylglycine) (AG) and AG-rich polypeptides, including Bombyx mori 
silk fibroin have an antiparallel β-sheet arrangement in the solid state.[77, 78] Secondly, glutamic 
acid (E) is a poor β-sheet former and its size and polarity makes inclusion in the lamellar 
interior sterically unfavorable.[79] Indeed, crystallization of these polypeptides from formic acid 
produced antiparallel β-sheet structures with the glutamic acid residues at the lamellar surface 
(Figure 1.4b). This crystal structure was supported by X-ray diffraction, vibrational 
spectroscopy and cross-polarization magic angle spinning 13C nuclear magnetic resonance.[80-82] 
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In particular, the diffraction results showed that the lamellar thickness, d, is dependent on the 
number of AG-repeats, ranging from 3.6 nm for -[(AG)3EG]- to 5.5 – 6.2 nm for                  
-[(AG)5EG]-.[74] In addition, artificial polypeptides with other amino acids at the turn positions 
were reported. The crystallization of periodic polypeptides into β-sheet crystals was reported 
for the sequences –[(AG)3XG], where X is serine (S), asparagine (N), valine (V), phenylalanine 
(F), tyrosine (Y) and alternating glutamic acid (E) and lysine (K).[83] The β-sheet stacking 
periodicity was shown to increase with an increasing bulkiness of the amino acid at the turn 
position. These examples show that protein engineering is a powerful tool for the synthesis of 
artificial polypeptides which have a higher level of organization than traditional polymers. 
 
1.6 Aim and outline of this thesis 
In this thesis, the preparation of “hybrid” block copolymers, consisting of artificial β-sheet 
polypeptide blocks and synthetic, non-peptidic blocks is described. The polypeptide blocks are 
based on the β-sheet sequence of Bombyx mori silkworm silk and have the generic sequence -
[(AG)3XG]- (where X = glutamic acid or lysine). They adopt a regular antiparallel β-sheet 
structure in the solid state (see Section 1.5). The aim of this thesis is to combine these β-sheet 
elements with synthetic polymers. The resulting silk-like model structures could give insight in 
the relationship between the structure of silk and its unique physical properties. The amorphous 
synthetic polymer part should be beneficial for the processability of the final composite 
material. In addition, the presence of glutamic acid or lysine residues at the surface of 
crystallized poly-[AG)3XG] could be used for functionalization with e.g. mesogenic groups, 
resulting in new liquid crystalline materials. A literature review on the various synthetic 
methods for the preparation of “hybrid” block copolymers is given in Chapter 2. 
Chapter 3 describes the construction of artificial genes coding for the repetitive sequence 
-[(AG)3EG]n-. The design considerations and the expression of this sequence in E. coli is 
discussed. Furthermore, the expression of a variant with lysine residues at the turn position,       
-[(AG)3KG]n-, is described. 
Chapter 4 deals with the conjugation of synthetic polymer blocks to recombinantly 
produced poly-[(AG)3EG]. This polypeptide was equipped with telechelic cysteine residues, 
which could be used for the selective attachment of maleimide-functionalized polymers. The 
emphasis is on triblock copolymers, consisting of a central poly-[(AG)3ΕG] β-sheet block and 
poly(ethylene glycol) end blocks. Furthermore, conjugation with a more hydrophobic synthetic 
polymer, poly(methyl methacrylate), is described. 
Chapter 5 describes the secondary structure characterization of these triblock 
copolymers using infra-red and circular dichroism spectroscopy. Furthermore, the effect of the 
attachment of poly(ethylene glycol) on the assembly of the β-sheet block has been investigated 
by transmission electron microscopy and atomic force microscopy. 
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Chapter 6 deals with the design and synthesis of artificial α-helical polypeptides. These 
polypeptides could be useful for the preparation of monodisperse glycopolymers, where spacing 
between carbohydrate epitopes can be controlled. Multivalent glycopolymers can be potent 
inhibitors of cell surface carbohydrate-binding receptors and are considered as attractive drug 
candidates for certain disease states, such as chronic and acute inflammation. An initial 
polypeptide design with the repetitive sequence [(MAKA)2MAA]n is presented. In this design 
lysine and methionine residues are located on opposing sides of the helix, and could be useful 
for the attachment of carbohydrate epitopes at regular intervals along the helical axis. This 
could give more insight in multivalent interactions between glycopolymers and carbohydrate 
receptors. 
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Abstract 
The progress in both peptide and polymer chemistry has led to the preparation of hybrid 
molecular architectures with properties not achievable with the separate components. The 
current synthetic methodologies for the preparation of peptide-containing block copolymers, 
either being completely peptidic or as hybrids with synthetic polymer blocks, are described. For 
the hybrid block copolymers two categories are distinguished, i.e. block copolymers with the 
peptide segments either in the main chain or in the side chain. The different techniques to 
prepare these polymers are ordered by level of control over peptide sequence and hence their 
molecular structure. 
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2.1 Introduction 
The development of synthetic approaches for the preparation of well-defined polypeptide-based 
materials has attracted increasing attention in the polymer chemistry field. The many levels of 
supramolecular organization present in proteinaceous materials in nature show that only a 
limited number of monomer building blocks is sufficient for the construction of complex 
structures, with a wide range of properties. The chemical information stored in the amino acid 
side chains does not only result in the folding of the peptide main-chain into a specific 
secondary structure, but is also responsible for tertiary folding as a result of the delicate 
interplay of a variety of non-covalent interactions, like hydrophobic, hydrogen-bonding and 
ionic interactions. Despite the large variety of monomers that can be polymerized chemically 
and the increasing level of control over polymer size distribution using controlled 
polymerization techniques[1], a fundamental limitation is the lack of absolute control over 
monomer sequence. 
In many cases, only small peptide sequences are already sufficient to introduce specific 
functionality such as folding, recognition, biodegradability and mechanical properties into 
molecular structures. This realization has led to an increased use in polymer science of 
polypeptide preparation methods of organic synthetic and biosynthetic origin. Especially, the 
combination of amino acid sequences and synthetic, non-peptidic polymers has drawn much 
attention. The synthetic polymer part can either act simply as a carrier or contribute to the 
overall molecular features with its specific solubility or mechanical properties. These block 
copolymer systems are expected to be useful for compatibilization of synthetic and biological 
systems. 
In this chapter the current (bio)synthetic methodologies are described for the preparation 
of peptide-containing block copolymers, which can be either completely peptidic or hybrids 
with synthetic polymer blocks. The different techniques are ordered by level of control over 
peptide sequence and molecular structure. Furthermore, both main and side chain peptide 
containing polymers will be discussed. 
 
2.2 Homopolypeptide block copolymers 
The most frequently used synthetic methodology for the preparation of  block copolymers 
containing homopolypeptides is the ring-opening polymerization of protected α-amino acid-N-
carboxyanhydrides (α-NCAs) initiated by a primary amino-end functional polymer (Figure 
2.1). This technique allows multigram-scale synthesis, but has long been plagued by chain-
breaking transfer and termination reactions, resulting in products with a wide range of 
molecular weights (polydispersity index, PDI > 1.4).[2] Furthermore, an often observed 
phenomenon of NCA-polymerizations is precipitation of the growing polypeptide chain at a 
certain molecular weight and/or the formation of secondary structure, which may result in 
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physical termination. Fractionation has therefore commonly been applied before physical 
characterization of these polymers. 
 
 
 
Figure 2.1 Preparation of a polypeptide containing block copolymer by ring-opening 
polymerization of α-amino acid N-carboxyanhydrides initiated by an amino-functional polymer. 
 
A large number of different block copolymers have been prepared using ω-amino or α,ω-
diamino end-functionalized synthetic polymer blocks as initiator. This subject has been  
reviewed by Gallot[3], Klok et al.[4] and Schlaad et al.[5] Commonly used NCAs are γ-benzyl L-
glutamate and N-ε-benzyloxycarbonyl L-lysine, since their polymerization is known to be the 
best controlled.[2] The synthetic polymer blocks have been varied extensively from hydrophobic 
blocks, like polystyrene and polybutadiene  to hydrophilic blocks like poly(ethylene glycol) and 
poly(vinyl alcohol).[3] Polypeptide blocks based on poly(glutamic acid) or poly(lysine) are 
known to form α-helical secondary structures in the solid-state and in solution, resulting in rod-
like molecules which behave as mesogens. By combining them with coil-like synthetic 
polymers these rod-coil block copolymers show a strong preference in the solid state for the 
formation of a lamellar structure of alternating polyvinyl and polypeptide sheets. In addition to 
these lamellae, the α-helical polypeptides are arranged in a hexagonal array and for longer 
polypeptides the chain backfolds. The final result is a hexagonal-in-lamellar morphology as 
depicted in Figure 2.2.[5]  
 
 
 
Figure 2.2 Schematic model of the hexagonal-in-lamellar morphology of polyvinyl-polypeptide 
block copolymers (α-helical polypeptides are represented as cylinders).[5] 
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Oligomeric rod-coil block copolymers have been described by Klok et al. who studied the 
supramolecular organization of diblock copolymers with an α-helical oligopeptide rod based on 
either γ-benzyl-L-glutamate (10 – 80 units) or ε-benzyloxycarbonyl-L-lysine (20 – 80 units) and 
a short oligostyrene block (10 units).[6, 7] The supramolecular organization of these block 
copolymers was shown to be sensitive to temperature. Depending on the amino acid and the 
polypeptide length, a partial transition from an α-helical to a β-sheet secondary structure was 
observed upon increasing the temperature. A small fraction of peptide segments with a β-sheet 
conformation was found to be sufficient to prevent the regular organization of the α-helical 
blocks, resulting in a change in observed supramolecular organization from a hexagonal to a 
lamellar β-sheet morphology. 
An interesting example of structure formation in dilute solution is the work on 
polybutadiene-block-poly(L-glutamate) (PB-b-PGA). Kukula et al. reported on the formation of 
spherical micelles and large vesicles (“peptosomes”, diameter ~ 150 nm) in aqueous solution, 
depending on the chemical composition of the copolymer.[8] Chécot et al. described the 
formation of vesicular aggregates by PB40-b-PGA100. The secondary structure of the polypeptide 
block changed from α-helix at pH 4.5 to random coil at a higher pH.[9] This conformational 
transition was reflected in the hydrodynamic radius of the vesicles, which increased from 
approximately 100 nm at pH 4.5 to 150 nm above pH 7. The proposed model for the build-up of 
these vesicles is depicted in Figure 2.3. The 1,2-vinyl bonds of the polybutadiene block could 
be used for UV-induced cross-linking and resulted in stable vesicles which might be suitable for 
drug encapsulation or sensor nanodevices.[10] 
 
 
 
Figure 2.3 Proposed model for the self-assembly of polybutadiene-block-poly(L-glutamate) (PB40-
b-PGA100) into vesicular aggregates.[9] 
 
The synthesis of well-defined block copolypeptides by NCA polymerization has become 
accessible since the use of transition metal-amine initiator complexes like bipyNi(COD) (bipy = 
2,2’-bipyridyl, COD = 1,5-cyclooctadiene) instead of primary amine initiators. Block 
copolypeptides could be prepared via this method with better control over chain length and with 
Chapter 2 
 -26- 
low polydispersity (PDI < 1.2).[11, 12] Recently described alternatives for this “coordination” 
polymerization process include the use of hydrochloride salts of primary amines as initiator and 
the use of high vacuum techniques.[13, 14] However, only for the block copolypeptides prepared 
via “coordination” polymerization, physical characterization has been reported. For example, 
amphiphilic diblock copolymers have been synthesized with a poly(L-lysine bromide salt) or 
poly(L-glutamate sodium salt) hydrophilic block and a poly(L-leucine) or poly(L-valine) 
hydrophobic block. These diblock amphiphiles were found to form rigid hydrogels (instead of 
micelles as would be expected) that retained their mechanical strength up to temperatures of 
about 90 °C and recovered rapidly after stress.[15-17] The gelation properties of these copolymers 
were not solely dependent on the amphiphilic nature of the polypeptide, instead it appeared that 
gelation was tied to the conformations of the hydrophobic domains, where α-helical segments 
formed by the poly(L-leucine) blocks were slightly better gelators than β-strands formed by 
poly(L-valine). 
Another block copolypeptide, consisting of L-cysteine and L-lysine, acted as a 
morphology-directing component in the formation of ordered silica structures.[18] This block 
copolymer, which mimics the protein silicatein, self-assembles as a result of its amphiphilic 
character, whereas the L-cysteine residues enable hydrolysis of the tetraethoxysilane precursor 
at neutral pH. These examples show that although NCA polymerization does not provide 
absolute sequence control, the assembly properties of these materials can make them useful as 
tissue engineering scaffolds, drug carriers or templates for bio-mimetic composite formation.[17, 
19-25] 
 
2.3 Solution phase synthesis of peptide-containing block copolymers  
Solution phase synthesis of peptides is useful for the preparation of short sequences of up to 10 
residues in length. Difficulties that limit this technique are non-quantitative coupling reactions 
and the often problematic solubility of oligopeptides. Only few examples have been reported in 
which small peptidic elements have been used in the preparation of “hybrid” multiblock 
copolymers. An interesting example in which the peptide segment was used to contribute to the 
mechanical properties of the final material is the work of Sogah et al.[26-28] They prepared 
Bombyx mori silk worm silk and Nephila clavipes spider dragline silk mimetic block 
copolymers. Silk worm silk is of interest because of its use in textile fibers, whereas spider 
dragline silk is one of the types of spider silk known to have a remarkable combination of 
strength and toughness.[29] Both silks contain repetitive amino acid sequences which form 
crystalline and amorphous domains in the silk fiber. The crystalline domains give the material 
strength, whereas the amorphous protein matrix allows the crystalline domains to orient under 
strain to increase the strength of the material and introduces flexibility to increase the energy to 
break. The crystalline β-sheet sequences are poly(alanylglycine) in silkworm silk and 
poly(alanine) in dragline silk. Sogah et al. used either the tetrapeptide GlyAlaGlyAla (Gly = 
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glycine; Ala = alanine) or poly(Ala) and replaced the amorphous silk sequences with 
poly(ethylene glycol). Multiblock copolymers were prepared via polycondensation using two 
approaches. The first one made use of an aromatic hairpin residue to force formation of parallel 
β-sheets as is schematically depicted in Figure 2.4a. A second approach is depicted in Figure 
2.4b and is a fully linear system in which the β-sheet segments were free to form intra- and 
intermolecular parallel or antiparallel β-sheets. 
 
 
 
Figure 2.4 Schematic drawing of multiblock copolymers consisting of a poly(ethylene glycol) 
“soft” block and a tetrapeptide GlyAlaGlyAla, crystalline “hard” block in two variants: (a) 
Templated system in which an aromatic hairpin turn is used to force parallel β-sheet formation. (b) 
Non-templated system in which peptide segments are free to form parallel and/or antiparallel β-
sheets. Adapted from ref. [26]. 
 
For both designs a microphase separated morphology was observed with 20 – 50 nm peptide 
domains dispersed in a continuous poly(ethylene glycol) phase. Furthermore, a 100 – 150 nm 
superstructure was observed in cast films which were explained to result from the 
polydispersity and multiblock character of the polymers. The mechanical properties of fibers 
and films made from these block copolymers could be modulated by manipulating the length 
and nature of the constituent blocks. Similar work was reported by Shao et al.[30] 
In an alternative approach atom transfer radical polymerization (ATRP) was used for the 
introduction of the tetrapeptide AlaGlyAlaGly  in the side chain of a polymer.[31] For this 
purpose the peptide sequence was functionalized at the C-terminus with a methacrylate moiety, 
which was polymerized in a controlled fashion. This side chain polymer was subsequently used 
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as a macroinitiator for ATRP of methyl methacrylate to yield the corresponding amorphous 
poly (methyl methacrylate). Infra-red spectroscopy clearly showed that the resulting well-
defined triblock copolymer possessed a β-sheet secondary structure. The same ATRP 
methodology has also been applied for the construction of side chain polymers containing 
pentapeptide repeats commonly found in tropoelastin (ValProGlyValGly).[32] In this case the 
pentapeptide was synthesized either by solution or solid phase peptide chemistry. The N-
terminus was modified with a methacrylate handle.  Subsequent ATRP from a bifunctional 
poly(ethylene glycol) macroinitiator resulted in a triblock copolymer with a narrow molecular 
weight distribution (PDI = 1.2). This block copolymer showed a temperature and pH dependent 
aggregation behavior which was similar to elastin. 
A unique way of introducing small peptides in the side chain of polymers has been 
reported by Cornelissen et al.[33] They prepared amphiphilic block copolymers containing a 
polystyrene tail and a charged poly(isocyanide) headgroup derived from isocyano-L-alanine-L-
alanine and isocyano-L-alanine-histidine. This type of rod-coil block copolymer formed 
micelles, vesicles and bilayer aggregates in aqueous solution as is depicted in Figure 2.5. 
Furthermore, the chirality of the poly(isocyanodipeptide) block was shown to be dependent on 
the dipeptide used. Moreover, helical superstructures were of opposite chirality to that of the 
constituent block copolymer. 
 
 
 
Figure 2.5 TEM micrographs of the morphologies formed by polystyrene-block-
poly(isocyanodipeptide)s in aqueous solution: (a) vesicles (b) bilayer filaments (c) left-handed 
superhelix, (d) schematic representation and (e) right-handed helical aggregate.[33] 
 
2.4 Solid phase synthesis of peptide-containing block copolymers 
For the synthesis of small to medium-sized peptides solid phase peptide synthesis is the method 
of choice. This technique involves the stepwise addition of N-protected amino acids to a peptide 
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chain anchored with its C-terminus to a polymeric support.[34] With this method a peptide is 
constructed via sequential coupling and deprotection steps and thus sequence-specific peptides 
can be prepared. The immobilization of the peptide allows the use of excess of coupling and 
deprotection reagents, resulting in high yields per step. The immobilization of the desired 
product obviates the need to purify intermediates. Deletions and truncations are however 
unavoidable, making this method less trivial for the preparation of larger peptides (> 50 
residues). 
Several studies of “hybrids” prepared by a fully solid phase based synthetic procedure 
have been reported. An interesting example was reported by Burkoth et al.[35-37], who 
investigated fibril formation of β-amyloid peptide, the primary component of amyloid plaques 
in Alzheimer’s disease. They derivatised the C-terminus of the central domain of β-amyloid 
peptide (Aβ(10-35)) with poly(ethylene glycol)-3000 using standard Fmoc solid phase peptide 
synthesis. Although some models for β-amyloid structure (with the C-terminal hydrophobic 
domain in the fibril interior) suggested the attachment of PEG would disturb fibril formation, 
the conjugate did self-associate into fibrils. The fibril formation was, unlike the native peptide, 
completely reversible and the solubility of the formed fibrils was greatly improved. The lateral 
association of the fibrils into bundles was prevented, as can be seen in the electron micrographs 
of Figure 2.6. 
 
 
 
Figure 2.6 Electron microscopy images of fibrils formed by (a) β-amyloid peptide (Aβ (10-35)) and 
(b) poly(ethylene glycol)-3000 conjugate of Aβ (10-35). Scale 200 nm. Adapted from ref. [35]. 
 
Using the same synthetic procedure, Rosler et al. investigated the solid state and melt structures 
of poly(ethylene glycol) di- and triblock copolymers, containing amphiphilic β-strand peptide 
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sequences.[38] These hybrids formed superstructures consisting of alternating PEG layers and 
peptide domains in an antiparallel β-sheet conformation. 
 
 
Figure 2.7 (a) Triblock copolymer consisting of a central amphiphilic β-strand peptide and 
flanking poly(ethylene glycol) blocks. (b) Model for the nanoscale organization of the block 
copolymer. The plane of amino acid side-chain interactions is shown (Coulombic interaction 
between lysines (Lys) and glutamic acids (Glu)/aspartic acids (Asp), hydrophobic interaction 
between leucines (Leu) and hydrogen bonding between glutamines (Gln)). Hydrogen bonding takes 
place perpendicular to the plane of the paper.[38] 
 
A report that emphasizes the synthetic procedure for the preparation of a hybrid triblock 
copolymer in the solid phase was reported by Reynhout et al.[39] The triblock copolymer 
consisted of a central β-turn peptide (from the circumsporozoite (CS) protein of the malaria 
parasite Plasmodium falciparum) and polystyrene end blocks. In this approach amine-
functionalized polystyrene was coupled to an aldehyde modified resin by reductive amination 
(Figure 2.8). The resulting secondary amine was then used for the build-up of the peptide 
segment, followed by coupling of a carboxylic acid functionalized polystyrene at the N-
terminus. Non-quantitative coupling of the first amino acid to the secondary amine and the 
second polymer to the N-terminus of the peptide resulted in a mixture of polystyrene, PS-b-
peptide and PS-b-peptide-b-PS. The triblock copolymer could however be purified by column 
chromatography resulting in a final yield of 15% based on initial loading. Alternative total solid 
phase based strategies for the preparation of polymer-peptide block copolymers were based on 
the controlled polymerization of the synthetic polymer block from the supported peptide 
segment using either nitroxide-mediated radical polymerization (NMRP) or ATRP (Figure 
2.9).[40, 41] 
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Figure 2.8 Solid phase synthetic route towards triblock copolymer consisting of a β-turn peptide 
middle block and polystyrene end blocks.[39] 
 
Figure 2.9 Two solid phase strategies towards peptide containing block copolymers by 
polymerization from the supported peptide via (a) nitroxide-mediated radical polymerization and 
(b) atom transfer radical polymerization. Adapted from ref. [40, 41]. 
Chapter 2 
 -32- 
For NMRP a small peptide, containing a peptide transduction domain (PTD) sequence was 
prepared via standard Fmoc solid phase synthesis. The N-terminus was subsequently 
functionalized with a fluorine-labeled alkoxyamine initiator. This could be used for the 
sequential solvent-free polymerization of tert-butyl acrylate and methyl acrylate, resulting in an 
ABC triblock copolymer. Traditional characterization of this triblock copolymer by gel 
permeation chromatography and MALDI-TOF mass spectroscopy was however complicated 
partly due to solubility problems. Therefore characterization of this block copolymer was 
limited to 1H and 19F NMR and no conclusive evidence on molecular weight distribution and 
homopolymer contaminants was obtained. The same principle was shown for ATRP of 
hydroxyethyl methacrylate from a resin-supported fibronectin-based RGD peptide sequence. 
Polymerization was carried out in methyl ethyl ketone/propanol (7:3) and resulted in a bio-
hybrid with a polydispersity of 1.5. 
Attachment of a polymerisable handle to peptides synthesized by solid phase peptide 
synthesis has been used for generating high molecular weight polymers with peptide moieties 
pending from the backbone. These side chain peptide polymers are especially of interest in the 
development of synthetic vaccines. The preparation of defined, chemically synthesized peptide-
antigens could exclude the use of infectious material and thus result in safer vaccines. However, 
short peptides generally do not elicit good immune responses, therefore several synthetic 
approaches have been used to generate higher molecular weight polymers from them.[42] One 
approach is the so called “multiple antigen peptide” (MAP) system.[43]  These molecules consist 
of a branched core resulting from the use of both amino groups of lysine (N-α and N-ε, Figure 
2.10). Antigenic peptides are either chemically synthesized onto this core or coupled after 
synthesis. An alternative approach has been described using acryloyl modified peptides which 
are polymerized by free radical polymerization, allowing the production of copolymers of 
different epitopes.[44] 
 
 
Figure 2.10 Example of a branched “multiple antigen peptide” consisting of a lysine-b-alanine 
core. Adapted from ref. [43]. 
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The limitations of solid phase peptide synthesis with respect to length can be overcome by 
“chemoselective ligation” of smaller unprotected peptide fragments. This strategy has become 
especially attractive with the introduction of “native chemical ligation” , in which the coupling 
results in the formation of the native, amide bond (in contrast to earlier chemical ligation 
strategies which resulted in e.g. thioester, thioether or oxime bonds).[45] Native chemical 
ligation is based on the reaction of a peptide-α-thioester with another peptide segment 
containing an amino-terminal cysteine residue (Figure 2.11a). The thioester-linked intermediate 
that is formed spontaneously rearranges, resulting in the formation of an amide bond and the 
regeneration of the free sulfhydryl group. An interesting practical extension of this concept is 
the fully solid-phase based chemical ligation which allowed the build-up of longer peptides (up 
to 118 amino acids) in either the N→C or the C→N direction.[46] Furthermore, the development 
of the 1-phenyl-2-sulfanylethyl auxiliary group has allowed the ligation of peptides without the 
requirement of a cysteine group (Figure 2.11b).[47] 
 
 
Figure 2.11 (a) The principle of native chemical ligation. Peptide 1, containing a C-terminal 
thioester, undergoes a nucleophilic attack by the cysteine residue at the N-terminus of peptide 2. 
The intermediate rearranges spontaneously to form the native peptide bond. (b) Native chemical 
ligation without the requirement of a cysteine residue using the 1-phenyl-2-sulfanylethyl auxiliary 
group. Adapted from ref. [45, 47]. 
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This cleavable thiol-containing auxiliary is added to the alpha-amino group of one peptide 
segment to facilitate amide bond-forming ligation. The amine-linked 1-phenyl-2-mercaptoethyl 
moiety is stable under the conditions used to cleave and deprotect peptides after solid-phase 
peptide synthesis. However, after ligation the auxiliary group can be removed by treatment with 
anhydrous hydrogen fluoride or trifluoroacetic acid. This methodology has been demonstrated 
in the synthesis of cytochrome b562.[48] Furthermore, also the Staudinger ligation has been 
proposed as a peptide ligation method which does not depend on the amino acids present at the 
junction site. The potential of this reaction for the ligation of unprotected peptide segments is, 
however, still not established.[49] An extensive review on the chemical synthesis of proteins by 
ligation has been reported by Borgia et al.[50] 
Elegant work in which the chemical ligation methodology was used for the preparation 
of a polymer-modified protein was reported by Kochendoerfer et al.[51] They prepared a 
monodisperse, polymer-modified, synthetic erythropoiesis protein (SEP) (Figure 2.12). SEP 
was designed to be analogous to human erythropoietin (Epo), a glycoprotein hormone that 
regulates the proliferation, differentiation and maturation of erythroid cells. SEP was assembled 
by native chemical ligation of four individual peptide segments (from 27 to 55 amino acids) 
resulting in a 166-amino acids polypeptide chain. 
 
 
 
Figure 2.12 Molecular structure of synthetic erythropoietin protein (SEP). (a) Primary amino acid 
sequence with three ligation sites circled in red. (b) Structure of the branched, negatively charged 
poly(ethylene glycol) based polymer. (c) Scheme for the synthesis of SEP by chemical ligation. 
Branched polymers were first attached to the individual peptide segments by oxime-forming 
ligation followed by native chemical ligation.[51] 
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Before this ligation, two of the peptide segments were functionalized via oxime forming 
ligation[52] with a monodisperse, negatively charged and branched poly(ethylene glycol) 
derivative. These polymer moieties were attached to sites corresponding to two glycosylation 
sites of Epo and their negative charge enabled prolonged duration of action in vivo. This 
synthetic methodology resulted in a precisely defined 51 kDa protein-polymer conjugate that 
was produced in quantities over 100 mg, which is a considerable synthetic improvement in 
comparison to common protein-polymer conjugates that are often heterogeneous with respect to 
the polymers attached and the attachment sites. 
 
2.5 Preparation of artificial polypeptides by protein engineering 
The term “protein engineering” encompasses a whole range of techniques, which are focused on 
altering the expression or properties of proteins in a specific manner. It is applied in a variety of 
areas such as biochemistry, microbiology, molecular biology and genetics and is used for 
example to change the cellular localization of enzymes or to modify the properties of enzymes 
with respect to catalysis and stability. The cloning and expression of genes has become a 
standard tool in biochemistry and molecular biology[53] and has been recognized only since the 
last decade as a useful synthetic tool for the preparation of polypeptide-based materials. This 
technique allows the preparation of monodisperse, high molecular weight polypeptides with 
complete sequence control. Protein engineering has been successfully used for the preparation 
of recombinant, structural proteins, such as silks, collagen and elastin.[54, 55] The common 
feature of these fibrous protein polymers is the presence of repetitive sequence motifs which 
form defined secondary structures. 
The repetitive amino acid sequences present in structural proteins offer the possibility to 
construct artificial genes by multimerization of small synthetic oligonucleotide sequences and 
thus build up high molecular weight proteins. The constructed artificial genes can be 
incorporated into an expression plasmid, which can subsequently be transferred to a bacterial 
host for production of the desired polypeptide (Figure 2.13). The most commonly used host is 
E. coli. 
The resemblance of structural proteins to segmented multiblock copolymers has 
instigated researchers to combine blocks from different structural proteins to design new 
materials, and furthermore get insight in the individual contributions of the blocks on the final 
material properties. Some examples are given on designed repetitive block copolypeptides 
which combine motifs like β-sheets in silk, β-spirals in elastin, leucine zipper motifs in DNA-
binding proteins and animal cell adhesion sequences in fibronectin. 
Multiblock copolymers consisting of silk-like β-sheet blocks and elastin-like blocks 
were reported by Capello and Ferrari.[56] The silk-like blocks consisted primarily of GAGAGS, 
derived from silkworm silk fibroin and the elastin-like blocks had the general amino acid 
sequence VPGVG, derived from mammalian elastin. By varying the ratio of crystallizing        
β-sheet blocks and solubilizing elastin blocks, the rate of irreversible hydrogel formation, 
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bioresorption and the release of solutes from these gels could be influenced. These 
characteristics make these block copolymers interesting for controlled drug delivery.[57] 
 
 
Figure 2.13 Protein biosynthesis by bacterial expression of artificial genes. Based on the desired 
amino acid sequence an artificial gene is built up from chemically synthesized oligonucleotides and 
introduced via a plasmid in the microbial host, which in turn can produce the desired protein 
polymer. 
 
Conticello et al. and Chilkoti et al. investigated the self-assembly of elastin-like block 
copolymers.[58-60] The temperature at which aggregation of elastin-like polypeptides occurs, i.e. 
the lower critical solution temperature (LCST), can be tuned by variation of the fourth amino 
acid residue of the consensus pentapeptide repeat VPGVG. With an increasing polarity of the 
amino acid residue at this position, the LCST is increased.[61] Thermoreversible micelles and 
hydrogels could be prepared using AB diblock copolypeptides and BAB triblock 
copolypeptides, respectively. In these block copolypeptides the B block is more hydrophobic 
and aggregates selectively, whereas the more hydrophilic A block stays solvated. The 
possibility for entrapment of hydrophobic drugs in the micellar core and the triggered 
disassembly of the micelles, suggests their potential application in targeted drug delivery. 
Block copolypeptides with envisioned applications in tissue engineering were reported 
by several groups. These polypeptides combined structural domains from silk or elastin with 
cell-binding domains from the natural extracellular matrix protein fibronectin. Cappello and 
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coworkers prepared block copolypeptides consisting of the silkworm silk β-sheet sequences and 
the tripeptide sequence arginine-glycine-aspartic acid (RGD), which is the cell adhesion motif 
of fibronectin.[56] The crystalline β-sheet blocks have been described to adsorb to hydrophobic 
plastic surfaces, while exposing the cell adhesion sequences. Urry et al. and Panitch et al. used 
elastin-like sequences which they combined with RGD or an alternative fibronectin sequence 
REDV.[62, 63] These materials had mechanical properties similar to those of the arterial wall and 
supported the adhesion of vascular endothelial cells. 
Coiled-coil motifs are present in a large variety of proteins, like DNA binding proteins, 
keratins and muscle proteins. An interesting example in which a coiled-coil motif has been used 
to prepare pH dependent reversible hydrogels, is the work on triblock copolymers comprising a 
central random coil, polyelectrolyte domain [(AG)3PEG]10 flanked by leucine zipper domains 
based on the Jun oncogene product (Figure 2.14).[64] 
 
 
Figure 2.14 (a) Triblock protein polymer consisting of a polyelectrolyte middle block with the 
repetitive sequence [(AG)3PEG]10 and two leucine zipper end blocks (helix). (b) Physical gelation 
of this triblock copolymer is the result of leucine zipper dimerization and can be modulated by pH 
and temperature.[64] 
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The leucine zipper motif is characterized by a consensus heptad repeat (abcdefg), with a and d 
the hydrophobic amino acids, whereas e and g are usually charged. The hydrophobic amino 
acids are located on one side of the helix and cause the formation of a dimeric coiled-coil 
structure. The charged amino acids modulate the stability of the dimer. The result is a 
switchable hydrogel: At low pH and low temperature the material formed elastic gels, while 
gelation was lost upon increase in pH or temperature. 
 
2.6 Conclusion 
The improvement of synthetic methodologies has allowed the synthesis of increasingly better 
defined “hybrid” block copolymers. The elucidation of the new structural organizations found 
in these block copolymer systems and the design of materials with multiple levels of structural 
hierarchy will be a challenge for material scientists. Direct applications of these materials will 
most likely be in the biomedical area, where peptide elements can serve as recognition elements 
in targeted drug delivery. Furthermore, the development of truly chemoselective ligation 
reactions, like the “Staudinger ligation”[49] and “click chemistry”[65], together with the ability to 
incorporate non-natural amino acids as functional handles in proteins in vivo, will allow the  
preparation of bioconjugates in a complex biological environment. 
This review has shown that the preparation of peptide-containing block copolymers is 
mostly performed via chemical synthetic methodologies in which the polypeptide blocks are 
often limited in length or sequence information. The complexity of the materials that can be 
made is therefore also limited. The preparation of polypeptide blocks by protein engineering 
allows the build-up of more complex polypeptide sequences. Combining these polypeptides 
with traditional synthetic polymers is still a relatively unexplored research area. 
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Abstract 
The construction of artificial genes coding for the β-sheet polypeptides with the repetitive 
sequence [(AG)3EG]n (n = 10 – 50; A = alanine, G = glycine and E = glutamic acid) and their 
expression in E. coli is described. 
Whereas expression of poly-[(AG)3EG] with a minimal number of additional amino 
acids was unsuccessful, the polypeptides were effectively produced as a fusion with glutathione-
S-transferase (GST, 26 kDa). The shake flask expression of the fusion protein GST-[(AG)3EG]20 
resulted in a yield of approximately 80 mg per liter of culture after GST affinity purification. 
After proteolytic cleavage of the fusion protein with thrombin, the polypeptide [(AG)3EG]20 was 
separated from GST by reversed phase chromatography, resulting in a final yield of 
approximately 20 mg per liter of culture. In an alternative approach [(AG)3EG]20 was produced 
with a small (11 amino acids) N-terminal “T7-tag”, which gave a yield of approximately 20 mg 
per liter of culture after Ni-NTA chromatography. Expression of this construct resulted in the 
formation of truncated polypeptide, which could be removed by reversed phase 
chromatography. 
In addition, the expression of a polypeptide with the repetitive sequence [(AG)3KG]24 (K 
= lysine) is described. The production of this polypeptide was, however, complicated by the 
sensitivity of this sequence to proteolysis. The polypeptide had to be purified directly after 
expression by Ni-NTA chromatography. Polypeptides with the complete repetitive part were 
separated from the truncated polypeptides by gel filtration chromatography, resulting in a final 
yield of approximately 2 mg per liter of culture. 
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3.1 Introduction 
The design and synthesis of artificial, repetitive polypeptides is an area of research which is 
important for materials science. In nature, structural proteins such as silks, elastin and collagen 
consist largely of highly repetitive sequences. Recombinant DNA technology and bacterial 
protein expression have been used for the biosynthesis of repetitive polypeptides based on 
sequences found in these structural proteins[1-7] as well as for the production of artificial 
polypeptides without a direct parallel in nature.[8-18] 
However, the first large, repetitive polypeptides that were produced in E. coli, were not 
intended for application in materials. Doel et al. constructed a synthetic gene coding for 
multiple repeats of the dipeptide L-aspartyl-L-phenylalanine, which is the basis of an artificial 
sweetener.[19] The dipeptide could be released by proteolytic digestion. A number of other, 
larger peptides have been produced as tandem repeats in E. coli with the aim to release the 
monomeric form afterwards by chemical or proteolytic cleavage.[20-23] For example, tandemly 
linked proinsulin could be produced in a stable form, whereas the monomeric form was subject 
to proteolytic degradation.[20] 
With an increased interest in the recombinant production of fibrous proteins, the number 
of reports describing the construction and expression of repetitive, synthetic genes increased. 
The natural genes for fibrous proteins derived from cDNA are long and repetitive and their 
corresponding protein products have a restricted amino acid composition. The propagation and 
expression of such genes in E. coli can present typical problems.[3, 24-26] Firstly, maintenance of 
repetitive DNA sequences on plasmid vectors can result in deletions or to a lesser degree 
elongation of the genes. The second difficulty results from premature translation termination as 
a consequence of a limiting stock of appropriate aminoacyl-tRNAs. These problems can be 
alleviated by the construction of synthetic genes with a codon usage adapted to E. coli and a 
reduced repetitiveness at the genetic level, as was, for example, demonstrated in the production 
of Nephila clavipes silk fibroins.[3, 24] 
The construction of synthetic genes has, however, not only been carried out with the 
purpose to faithfully reproduce the natural gene products. In addition, low-complexity protein 
polymers have been prepared which consist of tandem repeats of small peptide sequences found 
in structural proteins as well as “de novo” designed peptide sequences. A few examples are 
provided in Table 3.1. The construction of synthetic genes gives the opportunity to synthesize 
new protein structures or improve the functionality or processability of existing structural 
proteins beyond what is offered by the natural gene product. 
The biosynthesis of these protein polymers requires the construction of large synthetic 
genes by enzymatic multimerization of double-stranded synthetic oligonucleotide sequences. A 
variety of strategies for an efficient generation of such multimeric genes have been reported.[13, 
23, 27-30] Expression of these genes has been carried out most effectively using the “pET 
expression system”.[31] In this system the genes are placed under the control of the 
bacteriophage T7 promoter and transcription is carried out by the highly processive T7 RNA 
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polymerase.[32] High yields have been obtained for some protein polymers, such as poly(L-
alanylglycine), elastin-like polypeptides and sea mussel bioadhesive precursor protein (see 
Table 3.1), despite the incongruity of the proteins to the endogenous proteins of E. coli in terms 
of amino acid composition.  
 
Table 3.1 Some examples of protein polymers prepared via E. coli expression. 
Protein polymer type Amino acid sequence Yielda 
(mg L-1) 
Properties Ref. 
Spider dragline  
silk-like polymer 
(PGGYGPGQQG 
PGGYGPGQQG 
PSGPGSAAAAA 
AAAG)16 
 
4  β-sheet crystalline 
fibers 
[2] 
Elastin-like 
polypeptide (ELP) 
(VPGVG)251 60,  
200-800b 
Elastic chains 
assemble above phase 
transition temperature 
 
[4, 5] 
Sea mussel 
bioadhesive precursor 
protein 
 
(KAKPSYPPTY)20 300 Precursor for water-
compatible adhesive 
 
[7] 
Poly[(AG)3PEG] [(AG)xPEG]n (x = 3 -
4; n = 10 – 54) 
10 Amorphous glass 
 
 
[8, 33] 
Poly(L-alanylglycine) (AG)240 50, 1000b β-sheet silk-like 
 
 
[9] 
Poly[(AG)3XG] [(AG)xXG]n (X = E, 
F, N, S, V, Y; x = 3 – 
6; n = 13 - 59) 
10 - 40 β-sheet silk-like 
forming needle-
shaped lamellar 
crystals 
 
[10-12] 
Poly(EAK) (AEAEAKAK)18 5 Amyloid-like stable 
fibrils 
 
[13, 14] 
Alanine-rich helices [(AAAQ)x(AAAE)(A
AA)x]n (n = 2 – 6) 
5 - 10 Water-soluble helices 
for controlled 
placement of 
carbohydrate ligands 
 
[15, 16] 
Poly(L-glutamic 
acid) 
[(E)17D]n (n = 3 – 6) 5 – 10c Rod-like polymer 
with smectic ordering 
after side-chain 
benzylation 
[17, 18] 
a Typical expression yield in shake flask experiments. b Yield for high cell density fermentation.        
c Yield of fusion protein (21.5 kDa N-terminal mouse dihydrofolate reductase). 
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The expression of some protein polymers has been more troublesome. For example, the 
biosynthesis of poly(L-glutamic acid) (PLGA) was complicated by the resemblance of the 
coding sequence to the consensus Shine-Dalgarno (SD) sequence found at translation initiation 
sites in bacterial mRNA.[34] Induction of PLGA mRNA, containing multiple noninitiator SD-
like sequences, resulted in inhibition of protein synthesis by complex formation with 16S and 
23S rRNA. For the protein polymer with the sequence [(AG)4PEG]14, the formation of truncated 
products was observed and explained by the action of peptidases.[33] 
In this chapter the construction of artificial, repetitive genes coding for poly-[(AG)3EG]  
and approaches to produce this polypeptide in E. coli are described. Poly-[(AG)3EG] is known 
to crystallize into antiparallel β-sheets with glutamic acid residues located at the turn positions 
(see Chapter 1). The glutamic acid residues could be useful for functionalization with e.g. 
mesogenic groups resulting in a material with liquid crystalline properties. In addition, the 
expression of poly-[(AG)3KG] is described. Chemical modification of the lysine residues of this 
polypeptide is expected to be more efficient. 
 
3.2 Results and discussion 
3.2.1 Construction of artificial genes coding for poly-[(AG)3EG] 
The cloning strategy for the construction of repetitive genes encoding poly-[(AG)3EG] is 
depicted in Figure 3.1. A 48 basepair synthetic oligonucleotide was used which encoded two 
copies of the octapeptide repeating unit (Figure 3.1a). The sequence of this oligo was designed 
with the following considerations: (1) avoidance of codons with a low frequency of occurrence 
in E. coli[35], (2) minimization of sequence repetitiveness and (3) use of non-palindromic 
overhangs for unidirectional multimerization by T4 DNA ligase. A cloning vector was used 
containing two inversely oriented recognition sites for the restriction enzyme BspMI (Figure 
3.1b).[27] Digestion with this enzyme resulted in cleavage at a single position (indicated with the 
arrows) and overhangs were generated which were compatible with the introduction of the 
synthetic oligonucleotide. After insertion of this oligonucleotide and verification of its 
sequence, the plasmid was digested with BspMI, followed by isolation of the monomer. After 
multimerization of the monomer by T4 DNA ligase, the multimer was ligated with the 
linearized cloning vector. The same procedure was repeated until multimers of sufficient length 
were obtained (Figure 3.1c). Multimers consisting of up to 5 repeating units were visible on 
DNA gel (Figure 3.2a) after the first multimerization step. The 5-mer was extracted from gel 
and ligated with the linearized vector. After plasmid amplification and BspMI digestion, a 
larger amount of 5-mer was extracted from gel and a second multimerization was carried out. 
The linearized plasmid was added to this multimerization reaction and resulted in a series of 
plasmids, carrying synthetic genes coding for 10 to 50 repeating units of -(AG)3EG- (240 to 
1200 basepairs in size) (Figure 3.2b). These multimeric genes were transferred to the pET-3b 
expression vector using the NdeI and BamHI restriction sites. 
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Figure 3.1 Cloning strategy for the construction of repetitive genes encoding poly-[(AG)3EG]. (a) 
Multimerization of synthetic oligonucleotides coding for 2 octapeptide repeating units. (b) Cloning 
cassette for the introduction of multimeric genes. Two inversely oriented BspMI recognition sites 
are positioned to allow cleavage to occur at a single position (indicated with the arrows). NdeI and 
BamHI sites are used for transfer to the pET-3b expression vector.  (c) Ligation of multimers with 
BspMI digested cloning vector. After amplification of the resulting plasmid, the multimers can be 
isolated by BspMI digestion and a second round of multimerization can be carried out. 
Construction and expression of artificial genes encoding repetitive β-sheet polypeptides 
 -49-
 
Figure 3.2 (a) Multimerization of 48 basepair synthetic oligonucleotide analyzed on 2.5% agarose 
gel. (b) BspMI restriction analysis of plasmids carrying synthetic genes coding for 10 to 50 
repeating units of -(AG)3EG- (240 to 1200 basepairs). 
 
3.2.2 Expression and purification of His-tagged and GST-fused poly-[(AG)3EG] 
Approach 1: Poly-[(AG)3EG] with a minimal number of additional amino acids.  In this 
first approach the cloning strategy was designed with the aim to obtain a polypeptide in which 
the desired β-sheet sequence was flanked with a minimal number of amino acids (Figure 3.3). 
The constructed expression vector coded for a target polypeptide with an N-terminal 6 × 
histidine tag for purification by immobilized metal affinity chromatography. Furthermore, the 
repetitive polypeptide part was flanked on both sides by two methionine residues, which should 
enable the removal of the 6 × histidine tag and the C terminus by cyanogen bromide 
cleavage.[35] Cleavage at the carboxyl-terminal side of methionine should leave only one and 
two extra amino acids at the N- and C-terminal side of the repetitive polypeptide part, 
respectively. 
 
Figure 3.3 Target sequence of poly-[(AG)3EG] containing a minimal number of non-repetitive 
amino acids. An N-terminal 6 × histidine tag was included for purification by immobilized metal 
affinity chromatography. Methionine residues flank the β-sheet element for removal of the 6 × 
histidine tag and the residual amino acids at the C terminus by cyanogen bromide (CNBr) 
cleavage. 
 
Expression experiments were carried out in E. coli strains BL21(DE3) and BL21(DE3)pLysS 
cells and conditions were varied with respect to temperature (30 and 37 °C), inducer 
concentration (0.1 – 1 mM IPTG; IPTG = isopropyl-β-D-thiogalactopyranoside) and induction 
times (1 – 24 hours). However, no expression of target polypeptides with 10 to 50 repeats of the 
β-sheet sequence, and ranging in calculated molecular weight from 7.7 to 30.5 kDa, was 
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observed in whole cell lysates analyzed by sodium dodecylsulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) and Coomassie staining. Also after native and denaturing 
purification by nickel-nitrilotriacetate (Ni-NTA) affinity chromatography no bands 
corresponding to expressed polypeptide were detected using either Coomassie or silver staining 
(data not shown). 
 
Approach 2: Poly-[(AG)3EG] as GST-fusion protein. As a second attempt the expression of 
poly-[(AG)3EG] as a fusion with glutathione-S-transferase (GST) was undertaken. This 26 kDa 
protein can be highly expressed in E. coli[36] and is therefore a good way to assess the effect of 
fusing the poly-[(AG)3EG] sequence to this protein on the expression level. Therefore, the 
repetitive genes developed for approach 1 were transferred to the pGEX-2T expression vector 
(described in the experimental section 3.4.3), which directs the expression of poly-[(AG)3EG] 
with GST at the N terminus (Figure 3.4a). The presence of a thrombin cleavage site allowed 
removal of the GST-protein from the poly-[(AG)3EG] sequence. Furthermore, cyanogen 
bromide could be used to cleave off the 6 × His tag and the C terminus. Purification of GST-
fusion proteins was performed using a sepharose matrix functionalized with glutathione, which 
is a tripeptide with high affinity for the binding site of GST. Expression of the repetitive 
polypeptides from the pGEX-2T plasmids in E. coli strain BL21 was successful for all the poly-
[(AG)3EG] variants, from 10 to 50 repeats in length (Figure 3.4b). 
 
 
Figure 3.4 (a) Target protein consisting of poly-[(AG)3EG] fused with the amino-terminal 
glutathione-S-transferase (GST-protein). The GST-protein can be removed by cleavage with the 
site-specific protease thrombin. Cyanogen bromide (CNBr) can cleave off the residual amino acids. 
(b) SDS-PAGE analysis of expression of GST-fused poly-[(AG)3EG] in E. coli BL21 cells, before 
(0) and 3 hours (3h) after induction with IPTG. Cultures were grown at 30 °C, induced by the 
addition of IPTG to a final concentration of 0.4 mM and incubated for an additional 3 hours. 
Proteins were visualized by Coomassie staining. 
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Expressed protein bands appeared 3 hours after induction with increased molecular weights for 
longer poly-[(AG)3EG] sequences. All fusion proteins appeared at the expected molecular 
weight (for n = 10 - 50 molecular weights are 35 - 58 kDa) and the attachment of longer poly-
[(AG)3EG] sequences did not seem to have a major effect on expression yield. 
The GST-fusion proteins were purified with GST-affinity chromatography followed by 
thrombin cleavage to remove the GST protein. This is shown for GST-[(AG)3EG]20 and GST-
[(AG)3EG]40 in Figure 3.5a. After thrombin cleavage a band corresponding to GST at the 28 
kDa molecular weight marker appeared, together with an additional protein band which 
corresponded with poly-[(AG)3EG]. The expected molecular weights of poly-[(AG)3EG] for n = 
20 and 40 were 14.3 and 25.7 kDa, respectively. It is clear from Figure 3.5a, however, that these 
proteins were migrating slower on an SDS-polyacrylamide gel than would be expected from 
their molecular weights. This has been reported before for this sequence and for other highly 
acidic proteins.[8, 10] 
 
 
 
Figure 3.5 SDS-PAGE analysis of (a) purified GST-[(AG)3EG]n with n = 20 and 40 before (-) and 
after (×) thrombin cleavage and (b) reversed phase chromatography of thrombin cleaved GST-
[(AG)3EG]20. The [(AG)3EG]20 and [(AG)3EG]40 products after thrombin cleavage are indicated 
with an arrow. Proteins were visualized by Coomassie staining. 
 
Expression of GST-[(AG)3EG]20 on a 2.5 liter scale resulted in approximately 200 mg 
polypeptide after purification with glutathione-sepharose column chromatography. The β-sheet 
polypeptide was cleaved from the GST-fusion protein by proteolytic cleavage using thrombin. 
Because this cleavage was incomplete, the β-sheet polypeptide had to be purified from both 
GST as well as GST-fusion protein. This could be performed by reversed phase 
chromatography, since the β-sheet polypeptide eluted at a lower concentration acetonitrile (~ 
5%) than the GST and GST-fusion proteins (which eluted simultaneously at ~ 25% 
acetonitrile). The purification procedure resulted in approximately 50 mg of the desired 
polypeptide after freeze-drying. Amino acid compositional analysis showed peaks for the major 
amino acids alanine, glycine and glutamic acid and their ratios agreed well with the expected 
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values (calculated amino acid analysis for [(AG)3EG]20 (mol percent): Ala, 37.1; Gly, 50.9; Glu, 
12.0. Values found: Ala, 37.3; Gly, 49.4; Glu, 13.3). The chemical composition of the 
polypeptide was furthermore confirmed by 1H-NMR spectroscopy (Figure 3.6). 
 
 
 
Figure 3.6 400 MHz 1H-NMR spectrum of [(AG)3EG]20 polypeptide in TFA-d obtained after 
thrombin cleavage of the corresponding GST-fusion. 
 
Cyanogen bromide cleavage of the polypeptide was carried out in 70% formic acid. After 
cyanogen bromide cleavage, the ability to stain the polypeptide by Coomassie or silver staining 
was lost.  
The MALDI-TOF spectra of the polypeptide before and after cyanogen bromide 
cleavage are depicted in Figure 3.7a and b, respectively. Before CNBr cleavage, the major peak 
at 14.6 kDa is somewhat higher than the expected molecular mass of 14.3 kDa and could 
indicate the formation of an adduct of the polypeptide with glutathione (which was used for 
elution of the polypeptide from the GST column) via a disulfide bridge with the single cysteine 
residue. The calculated mass of this adduct is 14625 Da. Ionization of the polypeptide after 
cyanogen bromide cleavage seemed to be more difficult, but the molecular mass of the major 
peak at 11706 was slightly larger than the expected mass of 11659 Da (calculated average mass 
for H-G-[(AG)3EG]20-A-homoserine-OH). 
 
Construction and expression of artificial genes encoding repetitive β-sheet polypeptides 
 -53-
 
 
Figure 3.7 MALDI-TOF spectra of [(AG)3EG]20 polypeptide after (a) thrombin cleavage and (b) 
after cyanogen bromide cleavage. 
 
In conclusion, we can state that we successfully expressed poly(AG)3EG up to 50 repeats as a 
fusion with glutathione-S-transferase. Purification of [(AG)3EG]20 by GST affinity purification, 
thrombin cleavage and reversed phase chromatography was demonstrated. The secondary 
structure characterization of this polypeptide is described in Chapter 5. 
Although the expression of poly-[(AG)3EG] was successful as GST-fusion, the use of 
the rather expensive thrombin was not very compatible with the desire to produce this 
polypeptide in larger quantities. Omitting the thrombin cleavage step and instead directly 
cleaving the GST-fusion protein with cyanogen bromide was attempted, but purification of 
poly-[(AG)3EG] from the multiple peptide fragments was unsuccessful. Therefore it was 
decided to return to the pET-expression system and remake the construct with the smaller T7 
tag at the N terminus and additional amino acids at the C terminus. Since it was shown for 
cyanogen bromide cleaved [(AG)3EG]20 that Coomassie or silver staining was not possible, the 
additional amino acids could be beneficial for staining and the T7 tag would furthermore be 
useful for visualization of expression by Western blotting, since T7 antibodies were available. 
 
Approach 3: Poly-[(AG)3EG] with an N-terminal “T7 tag”. For the expression of poly-
[(AG)3EG] with an N-terminal T7 tag, the same pET-3b vector as in approach 1 was used, but 
the repetitive genes were introduced in an alternative way (described in experimental section 
3.4.3), which resulted in a target polypeptide with a sequence as is depicted in Figure 3.8a. The 
expression of these polypeptides was successful, as is depicted in Figure 3.8b. The theoretical 
molecular weights for [(AG)3EG]n for n is 10, 20 and 30 are 10.9, 16.6 and 22.3 kDa, 
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respectively. The apparent molecular weights on SDS-polyacrylamide gel were much higher 
and were comparable with the migration behaviour of the β-sheets which were prepared after 
thrombin cleavage of the GST-fusions (Figure 3.5), as would be expected. Purification of 
[(AG)3EG]20 was performed with Ni-NTA chromatography under denaturing conditions using 
guanidine hydrochloride. Three bands were detected in the elution fraction (Figure 3.8c).  
 
 
 
Figure 3.8 (a) Amino acid sequence of poly-[(AG)3EG] β-sheets. Cyanogen bromide (CNBr) 
cleavage allows removal of the residual amino acids introduced in the cloning process. (b) 
Expression of [(AG)3EG]n (n = 10, 20 and 30) in E. coli BL21(DE3)pLysS, before (0) and 4 hours 
(4h) after induction with IPTG. The arrows indicate the formation of the β-sheet proteins. (c) 
[(AG)3EG]20 after denaturing Ni-NTA purification (lane 1) and reversed phase chromatography 
(lane 2). 
 
MALDI-TOF mass spectrometry showed that the upper band corresponded to full-length 
polypeptide (Figure 3.9a). The observed mass of 16748 Da was somewhat higher than the 
calculated average mass of 16459 Da. This could indicate the formation of a glutathione adduct 
via the one cysteine residue (calculated average mass is 16764 Da). The polypeptide migrating 
at the height of the 20 kDa marker was removed by reversed phase chromatography. This band 
most likely corresponded to truncated polypeptide. The truncated nature of the band at 20 kDa 
was confirmed for a variant of the [(AG)3EG]20 sequence carrying N- and C-terminal cysteine 
residues and is described in Chapter 4. The final yield of the purified product was 
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approximately 20 mg per liter of cell culture. Cyanogen bromide cleavage was carried out to 
remove the non-repetitive N and C termini. MALDI-TOF analysis showed that the major 
product was completely cleaved polypeptide (calculated average mass is 11659 Da for H-G-
[(AG)3EG]20-A-homoserine-OH). However, in addition, partially cleaved product was present 
(Figure 3.9b). 
 
Figure 3.9 MALDI-TOF spectra of [(AG)3EG]20 polypeptide (a) before and (b) after cyanogen 
bromide cleavage. 
 
The difference in expression results reported for the two pET expression vectors (approach 1 
and 3) used in this research is likely to be the result of the presence of an N-terminal T7 tag in 
the successful construct. This 11 amino acids leader sequence is derived from the bacteriophage 
T7 gene 10 which codes for the highly expressed major capsid protein. It has been proposed by 
Sprengart and coworkers that in messenger RNA from genes 0.3 and 10 of bacteriophage T7, a 
specific region located downstream (+15 to +26) of the initiation codon serves as an 
independent translational signal, besides the upstream Shine-Dalgarno sequence.[37, 38] This 
region of the mRNA sequence has been termed “downstream box” and it has been shown that 
an increasing complementarity of this sequence to the penultimate stem of the 16S  ribosomal 
RNA resulted in a significant increase (10 to 20-fold) in protein accumulation.[39, 40] For the 
expression vector without the T7 tag, 6 consecutive histidine codons are positioned directly 
downstream of the initiation codon, which might result in problems with translation initiation. 
However, no experiments were performed to confirm this. Although the T7 tag is not an 
absolute necessity for expression, it has been reported that, at least, it promotes protein 
expression.[41] 
In conclusion, poly-[(AG)3EG] can be expressed as a GST-fusion as well as with the 
small T7 gene 10 leader sequence. The final yields for [(AG)3EG]20 were comparable  (20 mg 
L-1) for both systems. The expression system based on T7 RNA polymerase (approach 3) was 
considered to be more straightforward for large-scale expression and purification, since no 
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enzymatic cleavage step is necessary. A complication in this system was, however, the 
appearance of a truncated polypeptide fraction, which was not observed for the GST-fusions. 
 
3.2.3 Expression and purification of poly-[(AG)3KG] 
Repetitive polypeptides in which the alanylglycine repeats are interrupted by lysine (K) residues 
were expressed analogous to approach 3 for poly-[(AG)3EG]. An expression vector was used 
which contained 24 repeats of (AG)3KG (kindly provided by J. Thies and D. Tirrell).  The 
target sequence of this polypeptide is depicted in Figure 3.10a. SDS-PAGE analysis of the 
induction of protein expression for [(AG)3KG]24 in E. coli BL21 (DE3) cells is depicted in 
Figure 3.10b. A new band appeared after IPTG induction with an apparent molecular weight of 
26 kDa, which is higher than the calculated molecular weight of 19.0 kDa. In addition, lower 
molecular weight bands were observed on gel, which could be distinguished from E. coli 
proteins due to their specific purple color after Coomassie staining. After 2 hours of protein 
expression the amount of presumed full-length product no longer increased and the laddering at 
lower molecular weights became more apparent, suggesting that degradation already took place 
during expression. Because product degradation was observed during storage of the cell pellet 
at -20 °C, Ni-NTA purification had to be carried out directly after cell harvesting. The purity 
and extent of degradation after native Ni-NTA affinity chromatography in the presence of the 
protease inhibitor phenylmethanesulphonyl fluoride (PMSF) is shown in Figure 3.10c. 
Alternatively, denaturing purification using 6M guanidine hydrochloride was carried out (not 
shown), which however did not diminish the amount of degradation. Figure 3.10d shows that 
the majority of the truncated products could be removed by gel filtration chromatography, using 
a Superdex-75 column. The final product yield after dialysis and freeze-drying was however 
low with approximately 2 mg per liter of cell culture.  
MALDI-TOF analysis of the final product indicated two peaks at a molecular weight of 
17.7 and 17.9 kDa (Figure 3.11a), which is lower than the calculated molecular weight of 19.0 
kDa for the full-length polypeptide. Since the N terminus was present as determined by 
immunoblot analysis (data not shown), apparently part of the C terminus was not. Based on 
these findings, the observed molecular weight with MALDI-TOF seems to correspond to 
cleavage after the last lysine residue. For removal of the non-repetitive residues cyanogen 
bromide cleavage was carried out (Figure 3.10e). The presence of formic acid resulted already 
in partial cleavage of the polypeptide, which occurred presumably at the acid-sensitive aspartyl-
prolyl (DP) bond.[42] In the presence of cyanogen bromide, two bands were formed on SDS-
PAGE gel with the major product located just below the 20 kDa marker. 
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Figure 3.10 (a) Target sequence of [(AG)3KG]24. SDS-polyacrylamide analysis of (b) Expression of 
[(AG)3KG]24, before and 2, respectively 3 hours after induction with IPTG. (c) Native Ni-NTA 
purification (lys = soluble lysate, ft = column flow-through, el = column elution fraction). (d) 
Separation of full-length product and degradation products by Superdex-75 gel filtration 
chromatography. (e) Cyanogen bromide cleavage of [(AG)3KG]24. (-) and (×) correspond to 
polypeptide after incubation for 2 days in 70% formic acid without and with cyanogen bromide, 
respectively. Proteins were visualized by Coomassie staining. 
 
MALDI-TOF analysis showed a peak with a molecular mass of 15.4 kDa (Figure 3.11b), which 
is higher than the calculated mass of 13.9 kDa for completely cleaved product. The observed 
molecular mass indicates that CNBr cleavage at the C-terminal methionine residue was not 
successful. This is likely to be the result of the presence of a serine residue at the C-terminal 
side of this methionine, which is known to prevent cleavage of the peptide backbone and 
instead results in conversion of methionine to homoserine.[43] The susceptibility of poly-
[(AG)3KG] for proteolytic degradation, prohibited a large-scale purification of this polypeptide. 
This difference in comparison with poly-[(AG)3EG], combined with the regular ladder of 
cleaved products observed on SDS-PAGE gel suggests cleavage at the lysine residues. 
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Figure 3.11 MALDI-TOF spectra of [(AG)3KG]24 polypeptide (a) before and (b) after cyanogen 
bromide cleavage. 
 
A possible candidate responsible for proteolytic degradation of poly-[(AG)3KG] is 
oligopeptidase B, a cytoplasmic protease which cleaves at the C-terminal side of lysine and 
arginine residues.[44] Alternatively, degradation may be caused by energy-dependent heat shock 
proteins (with the exception of the cytoplasmic Lon protease, which is not present in the 
BL21(DE3)pLysS strain), which are responsible for 90% of the overall protein degradation in 
the cytoplasm.[45] Several approaches to decrease protein degradation may be considered, such 
as the use of protease and heat shock deficient strains[46-48] or the addition of protease inhibitors 
to the culture medium.[49] In addition, “capping” with fusion partners on both termini (“dual 
fusion strategy”) may protect against proteolytic cleavage and allow an easier purification of 
full-length product.[50] 
 
3.3 Conclusions 
The expression of artificial genes coding for poly-[(AG)3EG] was successful via two 
approaches: they could be expressed either as a fusion protein with glutathione-S-transferase 
(GST) or as a polypeptide containing the T7 gene 10 leader sequence. Expression of GST-
[(AG)3EG]20 resulted in a high yield of approximately 80 mg L-1 of cell culture. Since the part 
of interest only makes up approximately 35% of the fusion protein, the final isolated yield for 
[(AG)3EG]20 after thrombin cleavage and reversed phase chromatography was 20 mg L-1 of cell 
culture. The use of the bacteriophage T7 expression system was only successful when the T7 
gene 10 sequence was included at the N terminus. In contrast to the GST-system, truncated 
polypeptide product was produced. After removal of this truncated product by reversed phase 
chromatography an isolated yield of 20 mg L-1 of cell culture was obtained. 
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The expression of poly-[(AG)3KG] was complicated by the sensitivity of this sequence 
to proteolytic degradation. Despite direct Ni-NTA purification a substantial amount of truncated 
product was formed. Using gel filtration chromatography most of it could be removed, but the 
final isolated yield was low (2 mg L-1 of cell culture). This product contained the complete 
repetitive part, but was still truncated at the C terminus. An efficient strategy for the purification 
of this polypeptide could be the use of two different affinity tags on both termini. 
 
3.4 Experimental section 
3.4.1 Materials 
E. coli strain XL1-Blue used for cloning was obtained from Stratagene. The plasmids 
pBluescript® II SK(-) and pET-3b were from Stratagene. The plasmid pGEX-2T was obtained 
from Amersham Biosciences. Expression strains BL21, BL21(DE3) and BL21(DE3)pLysS 
were from Novagen. Synthetic oligonucleotides were purchased from Biolegio (Malden, the 
Netherlands). Restriction endonucleases (Gibco/New England Biolabs), T4 polynucleotide 
kinase (Gibco), T4 DNA ligase (Promega), calf intestine phosphatase (New England Biolabs) 
and Klenow fragment of DNA polymerase I (New England Biolabs) were used as 
recommended by the manufacturers. Plasmid midiprep kits and Qiaquick® gel extraction kits 
were from Qiagen. Lysozyme was purchased from Serva, RNAse A was from Sigma and 
DNAse I was from Boehringer Mannheim. Isopropyl-β-D-thiogalactopyranoside (IPTG) and 
phenylmethanesulphonyl fluoride (PMSF) were purchased from Sigma. Ni-NTA agarose beads 
were obtained from Qiagen. Glutathione sepharose 4B beads, reduced glutathione and thrombin 
(from bovine plasma, T3399, 95 units mg-1 protein) were obtained from Sigma. Dithiotreitol 
(DTT) was purchased from Sigma. The reversed phase column (RPC-15µm C2/C8 column 
HR16/10) and the gel filtration column (Superdex-75 Hi-LoadTM) were from Amersham 
Biosciences. Purifications were performed on a Biologic FPLC instrument from Biorad. 
Dialysis membranes were purchased from Spectra. Cyanogen bromide was purchased from 
Aldrich. 
 
3.4.2 General methods 
Cloning and expression. DNA manipulations, bacterial growth media and transformation 
conditions were carried out as described by Maniatis.[52] 
NMR spectroscopy. 1H-NMR spectra were recorded on a Varian Inova-400 instrument at 298 
K. 
MALDI-TOF mass spectrometry. Spectra were measured on a Bruker Biflex III spectrometer. 
Freeze-dried products were dissolved in 1:1 (v/v) water:acetonitrile with 0.1% trifluoroacetic 
acid to a final concentration of 10 mg mL-1 and mixed in a 1:1 ratio with a solution of 20 mg 
mL-1 of sinapinic acid (Sigma) in the same solvent and spotted on a MALDI-plate. 
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Amino acid analysis. 1 mg of polypeptide was placed in a hydrolysis tube and dissolved in 1 
mL 5.7 N HCl. After purging with nitrogen for 10 min, the solution was frozen with dry 
ice/acetone and evacuated with high vacuum. The tube was closed by melting and heated for 48 
hours at 110 °C. The solution was then evaporated and the residual solid was evaporated three 
times with water at 40 °C. The amino acids in the hydrolyzate were derivatized with 9-
fluorenylmethylchloroformate, separated by high performance liquid chromatography (Varian 
HPLC 9000 series) on a reversed phase C18 silica column (TSK-RP18) and detected at a 
wavelength of 269 nm.[51] 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). SDS-PAGE was performed using 
15% resolving gels on a mini-Protean II slab cell apparatus (BioRad) according to standard 
procedures.[35] 
Cyanogen bromide cleavage. Polypeptides were dissolved in 70% formic acid (2 mg mL-1) 
and an equal volume of CNBr (100 mg mL-1) in 70% formic acid was added, followed by 
incubation on a rotary arm for 2 days at room temperature in the dark. The samples were dried 
under vacuum in a centrifugal dryer at room temperature. The pellets were redissolved in demi-
water and dialyzed for 2 days against demi-water using a dialysis membrane (3.5 kDa 
molecular weight cut-off). 
 
3.4.3 Synthetic gene construction 
Approach 1: Poly-[(AG)3EG] with a minimal number of additional amino acids. The 
vector pSK-BspMI, which was used for creating DNA multimers encoding poly-[(AG)3EG], 
was prepared with the use of the synthetic oligonucleotide 1 (depicted below). 
  
 
 
Both single-stranded oligos were dissolved in deionized water (80 ng µL-1). 2.5 µL of each 
oligonucleotide solution was mixed with 2 µL 680 mM KCl and 1 µL water, and annealing was 
carried out by boiling for 4 min followed by cooling slowly to room temperature. 0.5 ng of 
annealed product was ligated with 25 ng EcoRI/BamHI double digested pBluescriptII® SK(-) 
using 1 unit of T4 DNA ligase. The ligation was performed in 10 µL in a buffer composed of 50 
mM Tris.HCl (pH 7.6), 10 mM MgCl2, 10 mM dithiotreitol (DTT) and 1 mM ATP. After 
ligation for 3 hours at room temperature, 5 µL was transformed to 50 µL XL1-Blue cells using 
a heat shock procedure.[52] The transformed cells were plated on LB plates containing 100 µg 
mL-1 ampicillin and grown for 16 hours at 37 °C. Positive clones were identified by restriction 
analysis and the sequence was confirmed.  
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The resulting vector (pSK-BspMI) was successively digested with BspMI, 
dephosphorylated using calf intestine phosphatase (CIP) and extracted from agarose gel.  
The two single-stranded oligonucleotides used for the construction of the gene coding for poly-
[(AG)3EG] (Figure 3.1a) were phosphorylated using 1 µg of oligonucleotide and 5 U of T4 
polynucleotide kinase for 10 min at 37 °C. After heat inactivation at 65 °C for 10 min, the 
complementary oligonucleotides were annealed as described above. Multimerization was 
carried out overnight at room temperature in ligation buffer using 1U of T4 DNA ligase. 
Multimerization products were separated on a 2.5% TAE agarose gel and a 5-mer product was 
extracted from gel. The 5-mer was ligated with the BspMI-digested and dephosphorylated 
vector pSK-BspMI. Clones containing the multimeric insert were analyzed by restriction 
analysis and the sequence was verified. After amplification of the correct plasmid and BspMI 
digestion, the 240 bp 5-mer was extracted from gel. After multimerization of this fragment for 3 
hours by T4 DNA ligase at room temperature, the BspMI-digested and dephosphorylated vector 
pSK-BspMI was added and ligation was continued overnight. Transformation of this ligation 
mixture resulted in clones containing multimers of up to 25 oligonucleotide repeats (designated 
pSK-BspMI-[(AG)3EG]n (n = 10, 20, 30, 40 and 50)). The multimeric genes were transferred to 
the pET-3b expression vector using the NdeI and BamHI restriction sites. 
 
Approach 2: Poly-[(AG)3EG] as GST-fusion protein. Expression vectors for the expression 
of GST-fused poly-[(AG)3EG] were constructed using the pGEX-2T vector. This vector was 
linearized with SmaI resulting in blunt ends and subsequently dephosphorylated by calf 
intestine phosphatase. The multimeric genes were obtained from the vectors described in 
approach 1 by digestion with EcoRI and BamHI. The 5’ overhangs of the isolated multimeric 
genes were filled in using Klenow fragment of DNA polymerase I. The blunt-end multimeric 
genes were ligated overnight by T4 DNA ligase. Plasmids carrying the multimeric genes in the 
correct orientation were used for expression experiments. 
 
Approach 3: Poly-[(AG)3EG] with an N-terminal “T7 tag”. For the expression of poly-
[(AG)3EG] with an N-terminal T7-tag, a new cloning vector, pSK-JS1, was constructed by 
ligation of the double stranded synthetic oligonucleotide 2 with EcoRI/BamHI-digested plasmid 
pBluescriptII® SK(-). 
 
 
 
This vector was comparable to pSK-BspMI (Approach 1), but the NdeI site was replaced by a 
BamHI site. The multimeric genes were obtained from approach 1 by digestion of pSK-BspMI-
[(AG)3EG]n (n = 10, 20 and 30) with BspMI, followed by gel extraction and ligation with 
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BspMI-digested and dephosphorylated pSK-JS1. The resulting vectors were digested with 
BamHI and the multimeric genes were subsequently introduced into the BamHI-digested and 
dephosphorylated expression vector pET-3b. 
 
3.4.4 Expression of poly-[(AG)3EG] using pET plasmids 
Competent cells of E. coli strain BL21(DE3) or BL21(DE3)pLysS were transformed with 100 
ng of the respective pET-3b plasmids and the transformation mixture was plated on LB agar 
plates with ampicillin (100 µg mL-1) for BL21(DE3) and a mixture of ampicillin (100 µg mL-1) 
and chloramphenicol (34 µg mL-1) for the LysS strain. The plates were incubated overnight at 
30 °C. A positive colony was selected and streaked out on a new LB-plate containing the 
appropriate antibiotic(s). A preculture of 1 × LB medium with the appropriate antibiotic(s) and 
1% glucose was inoculated with a single colony and grown overnight at 30 °C. The cells were 
harvested by centrifugation (5000 g, 5 min) and resuspended in fresh medium which was used 
to inoculate the main culture to an OD of 0.1. This culture was incubated at 30 °C or 37 °C. 
When an OD600 of 0.6 was reached, IPTG (0.1 - 1 mM) was added to the culture to initiate 
protein expression. Cells were cultured for an additional 4 to 24 hours and then harvested by 
centrifugation (5000 g, 5 min). The supernatant was decanted, and the remaining cell pellet was 
stored at –70 °C. 
 
3.4.5 Ni-NTA purification of poly-[(AG)3EG] 
Native conditions. 5 mL of lysis buffer (50 mM NaH2PO4 (pH 8.0); 300 mM NaCl; 1 mM 
PMSF; 1 mg mL-1 lysozyme) was added per gram (wet weight) of cell pellet. The pellet was 
resuspended and incubated for 30 min at 4 °C. The suspension was sonicated for 15 min on ice 
(Branson sonicator, 50% duty cycle, 5 units power). RNAse A (10 µg mL-1) en DNAse I (5 µg 
mL-1) were added, followed by incubation on ice for 15 min. The lysate was centrifuged for 30 
min at 10000 g at 4 °C. Ni-NTA agarose was added to the lysate (1 mL per liter culture) and the 
mixture was incubated for 1 hour at 4 °C. A column was loaded, which was subsequently 
washed with 5 bed volumes of lysis buffer and wash buffer (with the same composition as the 
lysis buffer, with the addition of 20 mM imidazole). Elution was performed with 5 bed volumes 
of elution buffer (as lysis buffer with the addition of 250 mM imidazole). 
 
Denaturing conditions. 5 mL of 6M guanidine hydrochloride (100 mM NaH2PO4, 10 mM 
Tris.HCl and 6 M guanidine.HCl, pH 8.0) was added per gram (wet weight) of cell pellet, 
followed by stirring for 1 hour at room temperature. After 30 min of centrifugation at 10000 g, 
Ni-NTA agarose was added to the supernatant (1 mL per liter culture) and the mixture 
incubated for 1 hour at room temperature. A column was loaded which was washed 
subsequently with 5 bed volumes of 6M guanidine.HCl with pH 8.0, 6.3 and 5.9 respectively. 
Elution was performed with 5 bed volumes of 6M guanidine.HCl (pH 4.0).  
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For the purification of [(AG)3EG]20 produced via approach 3 the elution fractions were 
subjected to reversed phase chromatography using a RPC-15µm C2/C8 column HR16/10. The 
composition of the eluents was as follows: Eluent A: water + 0.1% TFA; eluent B: 80% MeCN 
+ 0.1% TFA. A 100 mL gradient was applied from 0 to 100% eluent B with a flow of 1 mL 
min-1. Sample volumes of 5 mL were loaded. The samples were dialyzed against demi-water 
(3.5 kDa molecular weight cut-off) and freeze-dried. Isolated yield: 20 mg L-1 cell culture. 
Characterization of [(AG)3EG]20 (obtained via approach 3): MS (MALDI-TOF): m/z = 
16532 and 16748 (calcd. mass: 16459 Da). After cyanogen bromide cleavage: m/z = 11620 
(calcd. mass for H-G-[(AG)3EG]20-A-homoserine-OH: 11659 Da), 13992 (incomplete 
cleavage), 5832 (+2) and 6966 Da (+2, incomplete cleavage). 
 
3.4.6 Expression and purification of GST-fusion proteins 
50 µL of competent E. coli BL21 cells were transformed with 100 ng pGEX-2T plasmids 
carrying the multimeric genes coding for poly-[(AG)3EG], and plated on LB agar plates with 
ampicillin (100 µg mL-1). After growth overnight at 30 °C, single colonies were used to 
inoculate 100 mL LB medium, containing 100 µg mL-1 ampicillin. The cultures were incubated 
overnight at room temperature and placed at 30 °C in the morning. The culture was induced at 
an optical density (OD600) of 0.6 by adding IPTG to a final concentration of 0.4 mM, followed 
by incubation for 3 hours. The cells were sedimented by centrifugation at 6000 g for 10 min at 4 
°C and the cell pellet was stored at -70 °C. The cells were resuspended in 5 mL ice-cold 1 × 
PBS (phosphate buffered saline) and disrupted by sonication on ice (250 W Branson sonicator, 
four 45-seconds bursts with a 45 second cooling period between each burst, 50% duty cycle, 5 
units power). The lysate was centrifuged at 12000 g for 10 min at 4 °C and the supernatant was 
used for purification. Purification was performed with 0.1 g glutathione sepharose 4B beads 
which were equilibrated by swelling in 10 mL 1 × PBS overnight at 4 °C, resulting in a 1 mL 
bed volume. The cleared lysate was added to the beads, the suspension was incubated for 2 
hours at 4 °C on a rotating wheel and subsequently transferred to a disposable column. The 
flow-through was collected and the column was washed 3 times with 10 bed volumes of 1 × 
PBS. The fusion protein was eluted with glutathione elution buffer (10 mM reduced glutathione 
in 50 mM Tris.HCl, pH 8.0).  
Large-scale expression and purification of GST-[(AG)3EG]20 was carried out analogous 
as described above. To 125 mL lysate obtained from 2.5 L culture, 20% Triton X-100 was 
added to a final concentration of 1%, followed by incubation for 30 min at 4 °C. Purification 
was performed using a 20 mL glutathione sepharose 4B column. The eluted polypeptide was 
dialyzed against demi-water for 2 days (3.5 kDa molecular weight cut-off) and freeze-dried. For 
thrombin cleavage, the freeze-dried GST-fusion proteins were redissolved in 1 × PBS at a 
concentration of 5 mg mL-1. The thrombin protease used was dissolved in 1 × PBS to a 
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concentration of 1 unit per µL. Per milligram of fusion protein 5 µL of thrombin solution was 
added and the solution was incubated for 16 hours at room temperature.  
Purification of [(AG)3EG]20 from GST and GST-fusion protein was performed by 
reversed phase chromatography (RPC-15µm C2/C8 column HR16/10) at room temperature. 
The composition of the eluents was as follows: Eluent A: water + 0.1% TFA; eluent B: 80% 
MeCN + 0.1% TFA. 5 mL samples were loaded for each run and after washing with 20 mL 
eluent A, a 100 mL gradient was applied from 0 to 100% eluent B. 
1H-NMR (400 MHz, TFA-d): δ = 1.53 (d, 186H, Ala-Hβ), 2.17 and 2.53 (s, 40H, Glu-
Hβ), 2.66 (s, 40H, Glu-Hγ), 4.26 (s, 170H, Gly-Hα), 4.72 (s, 62H, Ala-Hα), 4.86 (s, 20H, Glu-
Hα). MS (MALDI-TOF): m/z = 14631 Da (calcd. mass: 14320 Da), m/z = 7288 (+2) and 28714 
Da (dimer). Amino acid analysis (mol percent): Ala, 37.3; Gly, 49.4; Glu, 13.3. Calculated 
amino acid percentages for [(AG)3EG]20 (mol percent): Ala, 37.1; Gly, 50.9; Glu, 12.0. After 
cyanogen bromide cleavage: MS (MALDI-TOF): m/z = 11706 Da (calcd. mass for H-G-
[(AG)3EG]20-A-homoserine-OH: 11659 Da), m/z = 5870 (+2) and 23402 Da (dimer). 
 
3.4.7 Expression and purification of poly-[(AG)3KG] 
E. coli BL21(DE3)pLysS strain was transformed with pET-624 (coding for 24 repeats of 
(AG)3KG), plated on LB agar plates supplemented with ampicillin (100 µg mL-1) and 
chloramphenicol (34 µg mL-1) and grown overnight at 30 °C. One colony was used to inoculate 
a 200 mL LB medium containing the appropriate antibiotics, followed by growing at 30 °C 
overnight. This preculture was used to inoculate 4 L of main culture, which was grown at 37 °C 
and induced with 0.4 mM IPTG at an OD of 0.6. After 3 hours of protein production the cells 
were centrifuged for 15 min at 6000 g at 4 °C. The pellet was immediately resuspended in 100 
mL lysisbuffer (50 mM NaH2PO4 (pH 8.0), 300 mM NaCl and 1 mM PMSF) and sonicated for 
10 min on ice (250 W Branson sonicator, 50% duty cycle, 5 units power). The lysate was 
clarified by centrifugation for 15 min at 4000 g at 4 °C. The lysate was incubated with 5 mL Ni-
NTA beads for 1 hour at 4 °C, and the beads were subsequently poured into a column. The 
column was washed with 100 mL lysis buffer, followed by a 100 mL gradient from 0 to 200 
mM imidazole (50 mM NaH2PO4 (pH 8.0), 300 mM NaCl). The elution fractions were stored at 
-20 °C. Preparative gel filtration chromatography was performed using a Superdex-75 Hi-
LoadTM 26/60 column at 4 °C.  The eluent composition was as follows: 50 mM NaH2PO4 (pH 
8.0), 150 mM NaCl, 1 mM PMSF. A flow of 2 mL min-1 was used. Sample volumes up to 10 
mL were used per run. 
Characterization of [(AG)3KG]24: MS (MALDI-TOF): m/z = 17932, 17767 (calcd. mass 
of full-length polypeptide: 18897 Da) and 8890 Da(+2). 1H-NMR (400 MHz, D2O): δ = 1.35 (d, 
231H, Ala-Hβ), 1.65 (m, 52H, Lys-Hγ), 1.85 (m, 104H, Lys-Hβ/γ/δ), 2.85 (t, 52, Lys-Hε), 3.92 
(m, 202H, Gly-Hα), 4.30 (s, 103H, Ala/Lys-Hα). After CNBr cleavage: MS (MALDI-TOF): 
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m/z = 15427 (calcd. mass for H-G-[(AG)3KG]24-A-homoserine-OH: 13918 Da) and 7726 Da 
(+2). 
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Abstract 
The synthesis of silk-like triblock copolymers consisting of a central β-sheet polypeptide block 
and poly(ethylene glycol) (PEG) end blocks is described. Polypeptides consisting of 10 and 20 
repeats of the β-sheet forming sequence -(AG)3EG- (A = alanine, G = glycine and E = glutamic 
acid), flanked by cysteine residues, were expressed in E. coli and purified by nickel-
nitrilotriacetate (Ni-NTA) chromatography. Further purification by gel filtration or reversed 
phase chromatography was necessary for both polypeptides to remove truncated product, which 
was formed during expression. The isolated yield of [(AG)3EG]10 produced in shake flask 
cultures was approximately 6 mg per liter. The polypeptide [(AG)3EG]20 was produced in high 
cell density culture, resulting in isolated yields of approximately 10 mg per liter. Unfortunately, 
high cell density fermentation was unsuccessful for the production of larger amounts of 
polypeptide, since the amount of produced polypeptide per cell decreased dramatically in 
comparison with shake flask expressions.  
The thiol functionality of the cysteine residues was subsequently used for the conjugation 
of maleimide-functionalized PEGs. The polypeptide [(AG)3EG]10 was conjugated with PEGs 
with molecular weights of 750, 2000 and 5000 g mol-1. The polypeptide [(AG)3EG]20 was 
conjugated only with PEG-750. The excess PEG which was used to obtain complete 
functionalization, could be efficiently removed by Ni-NTA chromatography. Cyanogen bromide 
cleavage was then used to remove the non-repetitive N- and C-terminal amino acids. MALDI-
TOF mass spectrometry indicated that the main products that were formed, were polypeptides 
functionalized with two PEG chains. 
In addition, the synthesis of triblock copolymers in which the central polypeptide block 
was flanked by poly(methyl methacrylate) (pMMA) end blocks was performed. PMMA was 
prepared by atom transfer radical polymerization and subsequently functionalized using ε-
maleimidocaproic acid. Although SDS-PAGE analysis indicated successful coupling, the 
chemical characterization of this conjugate proved to be troublesome. 
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4.1 Introduction 
Synthetic polymer-protein conjugates are of considerable interest because of their application 
potential in a variety of fields. The usefulness of these biological-synthetic hybrids was first 
established in the area of biomedicine in the 1970s.[1-3] The conjugation of poly(ethylene glycol) 
(PEG) to peptide- or protein-based drugs was found to have beneficial effects on the therapeutic 
properties of these drugs, in terms of reduced immunogenicity, higher stability and increased 
plasma half-life. Several protein-PEG conjugates have been commercialized.[4] More recently, 
the use of synthetic polymer-protein conjugates for bioanalytical application, bioseparations or 
for modulation of recognition properties has been investigated.[5, 6] For these applications 
thermosensitive polymers (e.g. poly(N-isopropylacrylamide) are used, whose reversible, 
temperature-induced precipitation behaviour  and solubilization is an interesting tool for 
enzyme recovery and immuno-assays. 
Relatively new is the use of hybrid block copolymers for the build-up of supramolecular 
architectures. The folding and recognition properties of peptides may allow the construction of 
more complex, hierarchically organized materials with properties unequalled by traditional 
synthetic polymers. Most research in this area has focused on the combination of small peptide 
motifs (β-strands and coiled-coils) and PEG and the majority of these conjugates were prepared 
by solid-phase synthesis. One of the first examples was reported by Meredith et al., who 
investigated the aggregation properties of a diblock copolymer of the central domain of β-
amyloid peptide (Aβ(10−35) and PEG.[7] Fibril formation by the conjugate was, unlike for the 
native peptide, completely reversible and the solubility of the formed fibrils was improved. It 
was suggested this could facilitate the characterization of the different stages of fibril formation. 
The self-assembly properties of di- and triblock copolymer based on PEG and amphiphilic β-
strand sequences have been reported more recently.[8] These hybrids formed lamellar structures 
consisting of alternating PEG layers and peptide domains in an antiparallel β-sheet 
conformation in the solid-state. 
An interesting example in which the peptide segment was used to contribute to the 
mechanical properties of the final material is the work of Sogah and coworkers.[9, 10] They 
prepared multiblock copolymers of oligopeptide β-sheet silk domains (poly(alanine) or GAGA 
sequence) and PEG via polycondensation. Another example worth mentioning is the work by 
Nolte and coworkers., who studied the self-assembly properties of a synthetic polymer-protein 
conjugate composed of a single polystyrene chain (degree of polymerization of approximately 
40) and lipase B from Candida antarctica.[11] This hybrid block copolymer can be considered as 
a giant amphiphile, consisting of a polar enzyme head group and an apolar polymer tail. Indeed, 
this conjugate formed well-defined micrometer long fibers, consisting of micellar rods and 
seemed to behave similar to its low molecular weight counterparts. 
In this chapter, the preparation of triblock copolymers, consisting of a β-sheet forming 
central poly-[(AG)3EG] sequence and flanking synthetic polymer blocks, is described. The 
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rationale behind the attachment of synthetic polymer blocks at the N and C termini was to 
restrict macroscopic crystallization and to allow translation of the β-sheet design characteristics 
of width, height and surface functionality into the self-assembled structures. With the aim to 
investigate the effect of the nature of the synthetic polymer part on the assembly behaviour of 
the β-sheet polypeptides, both hydrophilic PEG and the more hydrophobic poly(methyl 
methacrylate) were conjugated to the β-sheet polypeptides. The strategy for the preparation of 
these hybrid block copolymers is depicted in Figure 4.1. 
 
 
Figure 4.1 (a) Amino acid sequence of cysteine flanked poly-[(AG)3EG]. Cyanogen bromide 
cleavage allows removal of the residual amino acids introduced in the cloning process. (b) 
Conjugation of maleimide functionalized polymers to poly-[(AG)3EG] using selective reaction of 
maleimide functionality and thiol group of the cysteine residues. 
 
For conjugation of synthetic polymers, the poly-[(AG)3EG] sequence is outfitted with N- and C-
terminal cysteine residues. The thiol functionality of the cysteine residues can subsequently be 
used for selective alkylation with maleimide functionalized polymers. The 6 × histidine-tag can 
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be used for purification of the conjugates. The use of methionine residues allows removal of the 
residual amino acids by cyanogen bromide cleavage. This chapter describes subsequently the 
expression and purification of these polypeptides, the synthesis of the maleimide functionalized 
polymers and their subsequent conjugation and characterization. 
 
4.2 Results and discussion  
4.2.1 Expression and purification of cysteine-flanked  poly-[(AG)3EG] 
For the preparation of cysteine-flanked poly-[(AG)3EG] the multimeric genes encoding 10 and 
20 repeats of the -(AG)3EG- sequence (described in Chapter 3), were transferred to a new 
plasmid containing the genetic information for the T7-tag, the His-tag and the N- and C-
terminal cysteines. The expression of cysteine-flanked [(AG)3EG]10 (1) in E. coli BL21(DE3) 
cells was followed by immunoblot analysis using T7 tag mouse monoclonal antibodies (Figure 
4.2a), since expression was not or barely visible by Coomassie staining. Whereas already before 
induction a band at the 28 kDa marker was present, the intensity of this band increased after 
induction with IPTG. In addition, a second band appeared at the height of the 21 kDa marker. 
Both products were present in the soluble fraction after cell disruption and were purified by 
native Ni-NTA chromatography (Figure 4.2b). Gel filtration chromatography with a Superdex-
75 column was performed under reducing conditions (10 mM β-mercaptoethanol) and resulted 
in separation of both products. The band located at the 28 kDa marker was expected to 
correspond to full-length product based on the expression results for the poly-[(AG)3EG] 
variants without cysteine residues (Chapter 3, Paragraph 2.2). This was confirmed by MALDI-
TOF mass spectrometry (Figure 4.2c). The observed average mass of 11134 Da is higher than 
the calculated average mass for the reduced polypeptide (10980 Da). However, it corresponds 
well with the calculated average mass for an adduct of the polypeptide with β-mercaptoethanol 
(11132 Da). The band located at the height of the 21 kDa marker was shown to consist of a 
mixture of truncated products from 5.9 kDa to 6.9 kDa with the dominant peak at 6.2 kDa. This 
peak corresponds to a protein product from N-terminus to alanine-75, which is the first alanine 
after six octapeptide repeats. This result was confirmed by amino acid analysis by comparison 
of amino acid content for amino acids located at the N-terminus and the three amino acids 
located in the repeats. The final yield of full-length polypeptide after dialysis and freeze-drying 
was approximately 6 mg per liter of culture.  
The polypeptide [(AG)3EG]20 (2) was produced by high cell density fermentation. The 
fermentation was carried out according to a protocol described by Panitch and coworkers[12], 
who used it for the production of poly(L-alanylglycine). Medium with a chemically defined 
nutrient composition was used to obtain a high cell density.[13] Batch growth of E. coli 
BL21(DE3)pLysS cells was carried out using glucose as carbon source. After depletion of 
glucose (occurring at an OD600 of approximately 25), determined by a rise in pH and a reduced 
oxygen consumption, fed-batch growth was established using a pH-stat feeding strategy.[14] 
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Figure 4.2 (a) Expression of cysteine-flanked [(AG)3EG]10 (1) in E. coli BL21(DE3) cells analyzed 
by immunoblotting using T7-tag antibodies. Expression was induced by addition of IPTG to a final 
concentration of 1 mM at t = 0.  (b) Purification of cysteine-flanked [(AG)3EG]10 analyzed by SDS-
PAGE. The polypeptide was purified by native Ni-NTA chromatography (lys = soluble lysate, ft = 
column flow-through; el = elution). Gel filtration chromatography (Superdex-75) was used to 
separate full-length product (at the height of the 28 kDa marker) from truncated product. Proteins 
were visualized by Coomassie staining. (c) MALDI-TOF spectrum of cysteine-flanked [(AG)3EG]10. 
 
During this stage glucose was fed to the reactor through the acid pump in response to increased 
pH. The expression was induced at the end of the batch phase by the addition of IPTG to a final 
concentration of 1 mM. After 4 hours of expression an optical density of 25 – 30 was reached. 
The expression was analyzed by immunoblot analysis (Figure 4.3a). Two main protein products 
were formed. The lower band was located at the same height as the byproduct observed during 
[(AG)3EG]10 expression and corresponded to the same truncated product. The full-length 
polypeptide had an apparent molecular weight of 32 kDa and was located in the soluble fraction 
of the lysate. Since the column size used for native Ni-NTA purification was not adequately 
adapted to the amount of expressed polypeptide, still a large amount of contaminating E. coli 
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proteins were present in the elution fraction (Figure 4.3b). However, by a simple heating step 
(10 min at 70 °C), most E. coli proteins precipitated and could be removed by centrifugation. 
Finally, reversed phase chromatography was used to isolate full-length product, since the 
truncated product eluted at a lower acetonitrile concentration (15%) than the full length product 
(20% acetonitrile).  
 
 
 
Figure 4.3 (a) Expression of cysteine-flanked [(AG)3EG]20 (2) during high cell density fermentation 
of E. coli BL21(DE3)pLysS cells analyzed by immunoblotting using T7-tag antibodies. Expression 
was induced by addition of IPTG to a final concentration of 1 mM at t = 0. (b) Purification of 
cysteine-flanked [(AG)3EG]20 analyzed by SDS-PAGE. The polypeptide was purified by native Ni-
NTA chromatography (lys = soluble lysate, ft = column flow-through; el = elution). Heat treatment 
(10 min at 70 °C) was used to precipitate E. coli proteins. Results before (-) and after (+) heat 
precipitation are depicted. Reversed phase chromatography (RPC-15µm C2/C8) was used to 
separate full-length product (between the 28 and the 35 kDa marker) from truncated polypeptides. 
(c) MALDI-TOF spectrum of cysteine-flanked [(AG)3EG]20. 
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MALDI-TOF mass spectrometry gave an average molecular mass of 16811 Da, which is higher 
than the calculated average mass for the reduced polypeptide (16686 Da), and could correspond 
to an adduct of the polypeptide with β-mercaptoethanol (calculated average mass is 16836 Da) 
(Figure 4.3c). The isolated yield after freeze-drying was approximately 10 mg per liter of 
culture. Alternatively, gel filtration chromatography (Superdex-75 column) could be used for 
the separation of both polypeptides (not shown). 
The expression level of [(AG)3EG]20, in terms of produced protein per cell, was assessed 
to be approximately 5 times lower in high cell density fermentation in comparison to shake 
flask experiments (based on immunoblot analysis of whole cell lysates). However, since 
approximately 20-fold higher cell densities were reached in comparison to shake flask 
experiments, the amount of polypeptide produced per liter of culture was higher. However, this 
high cell density fermentation could not be called satisfactory, since more effort was needed in 
the purification procedure. In later high cell density fermentations, carried out for the 
production of [(AG)3EG]10, the amount of produced polypeptide per cell was more than 50-fold 
lower than in shake flask expressions, making this method with its current protocol unsuitable 
for the production of this polypeptide. 
Although high cell density fermentation of recombinant E. coli is a well-established 
technique for the large-scale production of proteins[15, 16], and also repetitive proteins such as 
poly(L-alanylglycine) (240 repeats)[12] or the sea mussel adhesive protein (75 repeats of a 
decapeptide sequence)[17] have been produced in inclusion bodies with yields of 1 to 5 gram per 
liter of culture, a successful large-scale production of poly-[(AG)3EG] has not been established, 
unfortunately.  
One of the possible causes for low expression in high cell density culture is plasmid 
instability. Because of the higher number of generations in comparison to shake flask 
experiments, the plasmid might have been lost from a large fraction of the E. coli cells. 
Incompletely repressed expression and loss of selective pressure as a consequence of ampicillin 
degradation by secreted β-lactamase or acidic conditions can cause overgrowth of the culture 
with plasmid-free cells. The latter effect may be alleviated by using the ampicillin analog 
carbenicillin, which is less susceptible for degradation.[18] Furthermore, the production of 
acetate in the presence of excess glucose has been shown to reduce recombinant protein 
synthesis and growth rate.[19-23] Overfeeding of glucose should not have taken place with a pH-
stat feeding strategy, but actual measurement of glucose and acetate concentrations in the 
fermentor during the fed-batch phase was not carried out. Feeding strategies different from pH-
stat, such as DO-stat (constant level of dissolved oxygen)[24], constant[25] or exponential 
feeding[26] were not performed, but could also have an effect on protein production.[17]  
Furthermore, the lack of certain metabolites might hinder higher levels of expression. 
Since the expressed polypeptide deviates considerably from the average E. coli protein, amino 
acid starvation might occur. The response includes the down regulation of genes involved in 
transcription, translation and amino acid biosynthesis.[27] Furthermore, enhanced proteolysis 
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might occur to release amino acids from nonessential proteins for incorporation into proteins 
essential for cell survival.[28, 29] The addition of the appropriate amino acids might alleviate this 
stress response and can result in higher levels of protein expression.[30, 31] 
Besides the difficulties with high cell density fermentation for large-scale polypeptide 
production, another complicating factor was the presence of trunctated product. Remarkably, 
the truncated products for [(AG)3EG]10 and [(AG)3EG]20 were the same, corresponding to a 
mixture of polypeptides from N-terminus to around 6 -(AG)3EG- repeats. Besides the negative 
effect on yield of full-length product (up to 50 weight percent of truncated polypeptide was 
formed for [(AG)3EG]20), it also was a complicating factor for purification. For [(AG)3EG]36 
reported by Tirrell and coworkers, also truncated product seemed to have formed, but no further 
comment on the nature of this product was given.[32] However, for the similar repetitive 
sequence [(AG)4PEG]14, the appearance of a mixture of truncated product was reported.[33] The 
fragments consisted of the complete N-terminus followed by four to six copies of the repeating 
undecapeptide sequence. It was explained by the action of exo- and endopeptidases. The 
formation of truncated products was also reported for the expression of silk fibroins in E. coli 
and was determined to be caused by premature translation termination.[34] It is not clear why 
during the expression of poly-[(AG)3EG] a relatively discrete truncated product was formed. 
This would not be expected in the case of proteolysis or premature termination of translation. 
The purified full-length polypeptides produced were used for the attachment of the 
synthetic polymer poly(ethylene glycol). 
 
4.2.2 Preparation of maleimide functionalized poly(ethylene glycols) 
For the preparation of poly(ethylene glycol) (PEG) conjugates of poly-[(AG)3EG] β-sheets, 
maleimide functionalized PEGs were prepared, which are capable of reacting with the thiol 
groups of the cysteine residues located on both sides of the poly-[(AG)3EG] segment. These 
were prepared by reaction of monoamine-functionalized PEGs with ε-maleimidocaproic acid 
using BOP (benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium hexafluorophosphate) 
as a coupling agent (Figure 4.4). This reaction was performed for PEGs with molecular weights 
of 750, 2000 and 5000 g mol-1. The reaction was carried out for 24 hours at room temperature 
using an equimolar amount of ε-maleimidocaproic acid. Gel filtration chromatography with a 
Sephadex LH-20 column was performed to remove the formed hexamethylphosphoramide 
(HMPA) and hydroxybenzotriazole (HOBt) and the isolated yield was 68 to 89%. MALDI-TOF 
analysis showed that the PEGs were completely functionalized with the maleimide group. 
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Figure 4.4 Coupling reaction of monoamine-functionalized poly(ethylene glycols) with ε-
maleimidocaproic acid using BOP (benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium 
hexafluorophosphate) as a coupling agent. 
 
4.2.3 Conjugation of maleimide functionalized poly(ethylene glycols) and poly-
[(AG)3EG] 
Initial conjugation experiments were carried out with [(AG)3EG]20 and maleimide 
functionalized poly(ethylene glycol) with a number average molecular weight of 750 g mol-1 
(PEG-750). The free thiol content after dissolution of the freeze-dried polypeptide in sodium 
phosphate buffer was determined with Ellman’s essay[35], which indicated that only 5% of the 
cysteines was in the reduced form. Therefore the oxidized cysteines were reduced with an 
excess of dithiotreitol (DTT). Initially dialysis was used for removal of DTT, but turned out to 
be impractical since only 30% of the cysteines were in the reduced form after dialysis. Non-
reducing SDS-PAGE analysis showed bands at higher molecular weights indicating 
intermolecular disulfide bridge formation (data not shown). 
A more practical alternative was to precipitate the polypeptide with the use of 
trichloroacetic acid (TCA), which is a commonly used protein precipitation method[36], and 
turned out to be suitable for the precipitation of this acidic polypeptide. Subsequent washing 
with 20% TCA and demi-water was carried out to remove DTT. The resulting pellet could be 
redissolved in sodium phosphate buffer (pH 6.8) for coupling with maleimide functionalized 
PEG-750. Determination of free thiol content showed that the number of free thiols typically 
was 1.5- to 2-fold higher than the theoretical number of cysteines, indicating the presence of 
some residual DTT. However, this procedure was chosen to avoid re-oxidation of cysteines and 
the presence of DTT could be compensated by the addition of excess of PEG-750. 
Coupling experiments were performed with increasing equivalents (0.4 - 40) of PEG 
relative to cysteine residues to determine the amount needed for complete conversion, i.e. 
bifunctionalization of [(AG)3EG]20 with PEG-750. SDS-PAGE showed that only by using 20 
equivalents of PEG-750 a complete shift of the polypeptide band to a higher molecular weight 
was realized (Figure 4.5a). 
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Figure 4.5 (a) SDS-PAGE analysis of conjugation reaction of [(AG)3EG]20 and maleimide 
functionalized PEG-750. Reactions were carried out in 100 mM NaH2PO4 buffer (pH 6.8) 
containing 150 mM NaCl at room temperature for 1 day. (b) Cyanogen bromide cleavage of (1) 
[(AG)3EG]20 and (2) [(AG)3EG]20-PEG-750 conjugate. (-) sample incubated in 70% formic acid 
without CNBr and (×) sample incubated in 70% formic acid containing CNBr. Visualization of 
bands for CNBr cleaved samples required contrast enhancement. 
 
After conjugation, the 6 × histidine tag was used to remove the excess of PEG by Ni-NTA 
chromatography. After loading the conjugation mixture, the column was washed until the 
absorbance at 214 nm no longer decreased, indicating complete removal of PEG. Subsequently 
the conjugate was eluted from the column with the use of imidazole. Then, the fractions were 
dialyzed and freeze-dried. In Figure 4.5b the CNBr cleavage of [(AG)3EG]20 and its PEG-750 
conjugate is depicted and shows a shift of both bands to a lower molecular weight. The removal 
of hydrophobic and basic residues by cyanogen bromide cleavage resulted in a product which 
was almost not stainable with the Coomassie Brilliant Blue R-250 dye, as was observed for the 
analogous proteins in Chapter 3. In this experiment the non-cleaved control was incubated in 
the presence of 70% formic acid without cyanogen bromide. Under these conditions additional 
bands are present below the full-length product. This is most likely the result of cleavage at the 
acid-labile aspartyl-prolyl bond, which is present twice in the expressed polypeptide. It has to 
be noted here that when methionine reacts with cyanogen bromide, it is converted to 
homoserine lactone, which is even under acidic conditions in equilibrium with homoserine.[37] 
However, the exact chemistry at the C-terminal side of the polypeptide has not been 
determined. 
Although MALDI-TOF mass spectrometry gave relatively weak signals the presence of 
[(AG)3EG]20 bi-functionalized with PEG-750 as the predominant product was established. 
However, also smaller peaks were present for monofunctionalized and trifunctionalized 
polypeptide. The latter is most likely the result of functionalization of the C-terminal lysines or 
the N-terminus, since the maleimide functionality eventually also reacts with amines (although 
~ 1000 times slower than with thiol groups).[38] A 1H NMR spectrum of [(AG)3EG]20-PEG-750 
conjugate dissolved in D2O is depicted in Figure 4.6. Because of the large water peak at 4.8 
ppm, only the spectrum from 0 to 4.5 ppm is shown. Comparison of the major signals from the 
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polypeptide (Ala-Hβ, 1.40 ppm) and PEG (ethylene oxide, 3.71 ppm) showed that the ethylene 
oxide signal was approximately 1.2 times the value expected for bifunctionalized product. 
Furthermore, it has to be noted that for unknown reasons the signal for glycine-Hα is too small 
relative to alanine-Hβ (only a factor 0.6 of the expected value), whereas this ratio was still as 
expected for the unfunctionalized polypeptide. 
 
 
 
Figure 4.6 400 MHz 1H NMR spectrum of conjugate of [(AG)3EG]20 and poly(ethylene glycol)-750 
in D2O (NaOH was added for solubilization, 40 mM final concentration). 
 
For [(AG)3EG]10 a series of conjugates were made using ε-maleimidocaproic acid and PEGs 
with number average molecular weights of 750, 2000 and 5000 g mol-1. The conjugation 
procedure was similar as used for the preparation of conjugates of [(AG)3EG]20 and PEG-750, 
with the only difference that in the trichloroacetic acid precipitation step the second wash of the 
pellet was performed with 1% TCA instead of demi-water, since the [(AG)3EG]10 polypeptide 
partly redissolved by washing with demi-water. After resuspension in coupling buffer the 
cysteine content was determined to be 75% of the theoretical value (based on weighed in 
product). In contrast to the conjugation experiments described for [(AG)3EG]20, one equivalent 
of maleimide functionalized PEG relative to cysteine residues was sufficient for complete 
functionalization, since SDS-PAGE analysis showed no further shift of bands on use of more 
equivalents of PEG (data not shown). However, for subsequent experiments 5 equivalents of 
maleimide functionalized PEGs were used. The SDS-PAGE analysis of these conjugation 
reactions is depicted in Figure 4.7a. Lane 1 shows the product after conjugation with ε-
maleimidocaproic acid and a slight downshift was observed in comparison to unreacted 
polypeptide (lane 5). Some unreacted polypeptide still seemed to be present. Surprisingly, also 
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the attachment of PEG-750 resulted in a slightly increased electrophoretic mobility (lane 2), 
whereas the attachment of longer PEG-chains (PEG-2000 and PEG-5000; lane 3 and 4) again 
resulted in a shift of bands to higher molecular weight. The strange migration behavior on SDS-
PAGE gel cannot be explained easily. One has to take into account, however, that the unreacted 
polypeptide already migrates anomalously slow on gel. Furthermore, particularly for the PEG-
5000 conjugate, higher molecular weight bands were detected. These bands are most likely 
physically aggregated conjugates, since SDS-PAGE was carried out under reducing conditions 
(loading buffer contained 2% β-mercaptoethanol).  
The expected molecular weights for [(AG)3EG]10 conjugated with two PEG-chains of 
PEG-750, PEG-2000 and PEG-5000 are 13.1, 15.6 and 21.7 kDa, respectively. MALDI-TOF 
mass spectrometry showed that the predominant PEG-conjugates formed were in agreement 
with these values. Some impurities could be observed corresponding to monofunctionalized and 
trifunctionalized product. Trifunctionalization is likely to be the result of reaction with lysine 
residues. Comparison of the major 1H NMR signals from the polypeptide (Ala-Hβ, 1.40 ppm) 
and PEG (ethylene oxide, 3.71 ppm) showed that the ethylene oxide signal was approximately 
1.1 times the value expected for bifunctionalized product for the PEG-750 conjugate, whereas 
this factor was 1.2 for the PEG-2000 and PEG-5000 conjugates. 
 
 
 
Figure 4.7 SDS-PAGE analysis of (a) conjugation of [(AG)3EG]10 and (1) ε-maleimidocaproic 
acid, (2) poly(ethylene glycol) -750 (PEG-750), (3) PEG-2000 and (4) PEG-5000. (5) unreacted 
[(AG)3EG]10. (b) cyanogen bromide (CNBr) cleavage of (1) [(AG)3EG]10-ε-maleimidocaproic acid, 
(2) [(AG)3EG]10-PEG-750, (3) [(AG)3EG]10-PEG-2000 and (4) [(AG)3EG]10-PEG-5000. Samples 
were loaded in the presence of 1% β-mercaptoethanol. For both the non-cleaved samples (-) and 
the CNBr-cleaved (×) 10 µg was loaded. Visualization of bands for CNBr cleaved conjugates 
required contrast enhancement. 
 
After removal of PEG by Ni-NTA chromatography and subsequent dialysis, cyanogen bromide 
cleavage was carried out. After this reaction the capability of staining the conjugates with 
Coomassie was almost completely lost (Figure 4.7b). Only after contrast enhancement, vague 
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bands could be detected at slightly lower molecular weight than the original conjugates 
(compare lanes – and ×). With contrast enhancement and at these high loadings of 10 µg the 
aggregated, high-molecular weights can be detected clearly. Furthermore, for the conjugate with 
ε-maleimidocaproic acid two bands are present before cyanogen bromide cleavage. The upper 
band was located at the height of unreacted polypeptide (visible in Figure 4.7a), but could also 
corresponds to polypeptide monofunctionalized with ε-maleimidocaproic acid.  
Although the quality of the spectra obtained by MALDI-TOF mass spectrometry was 
poor, the main signals for the conjugates of [(AG)3EG]10 with PEG-750, PEG-2000 and PEG-
5000 (Figure 4.8a, b and c, respectively) were in reasonable agreement with the calculated 
average masses (Figure 4.8d). For the [(AG)3EG]10-PEG-5000 conjugate an additional peak at 
9215 Da was present, which could only correspond to partially cleaved [(AG)3EG]10 without 
conjugated PEG. 
 
 
 
Figure 4.8 MALDI-TOF mass spectra of cyanogen bromide cleaved conjugates of [(AG)3EG]10 and 
(a) PEG-750, (b) PEG-2000, (c) PEG-5000. (d) Calculated average masses of [(AG)3EG]10 bi-
functionalized with PEG (polypeptide part: H-GTCAG-[(AG)3EG]10-AC-homoserine-OH). 
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4.2.4 Conjugation of maleimide functionalized poly(methyl methacrylate) and 
poly-[(AG)3EG] 
Besides the preparation of poly(ethylene glycol) (PEG) conjugates, the conjugation of the more 
apolar, synthetic polymer poly(methyl methacrylate) (pMMA) was attempted. The effect of the 
synthetic polymer block on the aggregation behaviour of the β-sheet polypeptide can thus be 
investigated. Atom transfer radical polymerization (ATRP) was used to prepare pMMA of 
which one end could be functionalized with a maleimide group (Figure 4.9). An amine-
functional α-bromoester, of which the amine moiety was protected with a tert-butyloxycarbonyl 
(Boc) group, was used to initiate polymerization of MMA using Cu(I)Cl as a catalyst. The 
polymerization was carried out in deuterated DMSO, which enabled determination of 
polymerization kinetics. A polymer was obtained with a number average molecular weight (Mn) 
of 3.4 kg mol-1 and a polydispersity (PDI) of 1.22 (10a). After polymerization, the Boc-group 
was deprotected and the resulting free amine group was used for reaction with ε-
maleimidocaproic acid, using a similar procedure as was described for the functionalization of 
PEG (Paragraph 4.2.3). This polymer (10b) was used for coupling to [(AG)3EG]20. 
 
 
 
Figure 4.9 Preparation of maleimide functionalized poly(methyl methacrylate) by atom transfer 
radical polymerization. 
 
For conjugation to [(AG)3EG]10, pMMA was used with a Mn of 3.9 kg mol-1 (11; kindly 
provided by Joost Opsteen). Before conjugation the cystine disulfide bridges of the 
polypeptides were reduced with dithiothreitol (DTT) using the same procedure as described in 
Paragraph 4.2.3. Maleimide functionalized pMMA was dissolved in tetrahydrofuran (THF) and 
slowly added to the reduced polypeptide, which was dissolved in sodium phosphate buffer (pH 
6.8) (final ratio THF-buffer 3:2). 
For [(AG)3EG]10 the effect of conjugation of pMMA-maleimide was analyzed by SDS-
PAGE (Figure 4.10a). Whereas for Boc-protected pMMA (lane 1) no band shift was observed, 
the use of increasing equivalents of pMMA-maleimide (lane 3 – 6), resulted finally for 20 
equivalents of pMMA-maleimide in a shift of the polypeptide band to lower molecular weight. 
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A shift to lower apparent molecular weight was observed earlier after the conjugation of PEG-
750 (Figure 4.7). Because of the anomalous migration behaviour of the polypeptide alone, the 
effect of conjugation on electrophoretic mobility seems to be difficult to predict. For unclear 
reasons, with the use of less equivalents of pMMA a band at high molecular weight was also 
present. 
 
 
 
Figure 4.10 SDS-PAGE analysis of (a) conjugation of [(AG)3EG]10 and pMMA (Mn = 3.9 kg mol-1). 
Lane 1: without polymer (only THF); lane 2: 5 eq. of Boc-protected (unreactive) pMMA; ; lane 3 – 
6: 0.5, 1, 5 and 20 eq. (relative to cysteine residues) of maleimide functionalized pMMA. 
Electrophoresis was carried out under reducing conditions, using 2% β-mercaptoethanol in the 
loading buffer. (b) conjugation of [(AG)3EG]20 and pMMA (Mn = 3.4 kg mol-1). Lane 1: 20 eq. 
pMMA-maleimide; lane 2: Boc-protected (unreactive) pMMA; lane 3: no polymer (only THF), 
respectively. Electrophoresis was carried out under reducing conditions. (c) like b, using non-
reducing SDS-PAGE. 
 
For [(AG)3EG]20, the conjugation of pMMA was analyzed by SDS-PAGE under both reducing 
(Figure 4.10b) and non-reducing conditions (Figure 4.10c). Also for this polypeptide 
conjugation with pMMA resulted in a shift of the polypeptide band to lower molecular weight 
under reducing conditions (compare lane 1 and 2). For Boc-protected (unreactive) pMMA (lane 
3) no shift was observed. The product formed after reaction with pMMA-maleimide was not 
able to form disulfide bridges as was observed by SDS-PAGE under non-reducing conditions 
(Figure 4.10c). The incubation in the presence of Boc-protected pMMA in THF (lane 2) and 
THF without polymer (lane 3) resulted in disulfide bridge formation. The band below the 32 
kDa marker is likely the result of intramolecular disulfide bridge formation. Furthermore, for 
incubation with THF (lane 3) multimers were visualized as a result of the formation of 
intermolecular disulfide bridges. The extent of intramolecular disulfide bridge formation 
seemed to be more extensive after incubation with Boc-protected pMMA (lane 2), since no 
laddering was observed and presumably most of the product was insoluble and remained in the 
wells. 
Attempts were made to isolate the conjugates from the excess of pMMA used. Thereto, 
the solvents were evaporated, followed by extraction with water. Although SDS-PAGE analysis 
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seemed to indicate that the product could be extracted, 1H-NMR of the product in DMSO only 
showed signals corresponding to the polypeptide. Also MALDI-TOF analysis was unsuccessful. 
No final proof for conjugation of pMMA was obtained, since no chemical characterization of 
the conjugates was realized. 
 
4.3 Conclusions 
The expression and purification of poly-[(AG)3EG] sequences with flanking cysteine residues 
has been successfully carried out, although the production was complicated by low yields and 
the formation of truncated polypeptide product. The feasibility of the preparation of block 
copolymers of recombinantly prepared polypeptide sequences and synthetic polymer blocks has 
been demonstrated. Triblock copolymers consisting of a central poly-[(AG)3EG] block and two 
PEG end blocks could be prepared by using the selective reaction between the sulfhydryl group 
of cysteines flanking the poly-[(AG)3EG] sequence and the maleimide functionality of PEG. 
The structural characterization of these block copolymers is described in Chapter 5.  
The preparation of block copolymers of poly[(AG)3EG] and poly(methyl methacrylate) 
was more complicated. Although the successful coupling was indicated by SDS-PAGE, 
chemical characterization of these conjugates was not accomplished. 
 
4.4 Experimental section 
4.4.1 General methods 
Protein purification. Ni-NTA, gel filtration and reversed phase chromatography were 
performed using a Biologic FPLC instrument (BioRad). 
NMR spectroscopy. 1H-NMR spectra were recorded on a Varian Inova-400 instrument at 298 
K. Chemical shifts are reported in ppm relative to tetramethylsilane (δ = 0.00 ppm) or the 
appropriate solvent signal. 13C-NMR spectra were recorded on a Bruker AC-300 instrument at 
298 K.  
MALDI-TOF mass spectrometry. Spectra were measured on a Bruker Biflex III spectrometer. 
Freeze-dried products were dissolved in 1:1 (v/v) water:acetonitrile with 0.1% trifluoroacetic 
acid to a final concentration of 10 mg mL-1 and mixed in a 1:1 ratio with a solution of 20 mg 
mL-1 of sinapinic acid (Sigma) in the same solvent and spotted on a MALDI-plate. 
Amino acid analysis. 1 mg of polypeptide was placed in a hydrolysis tube and dissolved in 1 
mL 5.7 N HCl. After purging with nitrogen for 10 min, the solution was frozen with dry 
ice/acetone and evacuated with high vacuum. The tube was closed by melting and heated for 48 
hours at 110 °C. The solution was then evaporated and the residual solid was evaporated three 
times with water at 40 °C. The amino acids in the hydrolyzate were derivatized with 9-
fluorenylmethylchloroformate, separated by high performance liquid chromatography (Varian 
HPLC 9000 series) on a reverse phase C18 silica column (TSK-RP18) and detected at a 
wavelength of 269 nm.[39] 
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Gel permeation chromatography. Molecular weight distributions were measured using GPC, 
on a Shimadzu system equipped with a guard column and a PL gel 5 µm mixed D column 
(Polymer Laboratories) with differential refractive index and UV (254 nm) detection, using 
THF as an eluent at 1 mL min-1 at 35 °C. Poly(styrene) standards were used to calibrate the 
SEC with THF as an eluent. 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analysis. SDS-
PAGE was performed using 15% resolving gels on a mini-Protean II slab cell apparatus 
(BioRad) according to standard procedures.[40] For immunoblot analysis the separated whole 
cell lysate samples were transferred to nitrocellulose membranes (Protran, Schleicher & Schuell 
BioScience) using the Mini Trans-Blot cell (BioRad). The composition of the used transfer 
buffer was as follows: 25 mM Tris.HCl, 192 mM glycine (pH 8.3), 20% methanol. 
Subsequently the blots were incubated in TBST (10 mM Tris.HCl (pH 8.0), 150 mM NaCl, 
0.1% Tween 20) containing 5% milk powder for 1 hour at room temperature, followed by 
incubation with T7 tag mouse monoclonal antibody (Novagen; 1 : 10000) in 5% milk powder in 
TBST overnight at 4 ºC. The blots were washed 3 times for 10 min with TBST and then 
incubated with rabbit-anti-mouse peroxidase (Dako Diagnostics; 1 : 2000) for 1 hour at room 
temperature. After washing 3 times for 5 min with TBST at room temperature and drying with 
Whatmann paper, the blots were developed using the ECLTM Chemiluminescent Detection 
Reagents (Amersham Biosciences). The detection solution was prepared by mixing equal 
volumes of solution 1 and 2 on a glass plate and the blots were placed with the protein-
containing side down on top of this solution for 30 seconds. After drying with Whatmann paper 
the blots were enclosed in plastic wrap and exposed to film (KODAK® chemiluminescence 
film) for 30 seconds before development. 
Ellman’s assay for free thiol determination.[35] To 50 µl of polypeptide solution of suitable 
concentration 950 µl of 100 mM NaH2PO4 buffer (pH 6.8) containing 150 mM NaCl and 1mM 
EDTA was added. To this solution 50 µl of 3 mM 5,5’-dithio-bis-2-nitrobenzoic acid (DTNB; 
Sigma, dissolved in the same buffer) was added. The absorbance difference between the 
polypeptide sample and a reference without protein was measured at 412 nm (ε412 = 10900 M-1 
cm-1). 
Cyanogen bromide cleavage.[40] Conjugates were dissolved in 70% formic acid (2 mg mL-1), 
and an equal volume of CNBr (100 mg mL-1) (Sigma) in 70% formic acid (Merck) was added 
followed by incubation on a rotary arm for 2 days at room temperature in the dark. The samples 
were dried under vacuum. The pellets were redissolved in demi-water and dialyzed for 2 days 
against demi-water using a dialysis membrane (Spectra Por dialysis tubing, 3.5 kDa molecular 
weight cut-off). 
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4.4.2 Construction of expression vectors for cysteine flanked poly-[(AG)3EG] 
For the expression of poly-[(AG)3EG] with flanking cysteine residues, a new cloning vector, 
pSK-JS2, was constructed by ligation of the double stranded synthetic oligonucleotide 1 (Sigma 
Genosys) with EcoRI/BamHI-digested pBluescriptII®SK(-). 
 
 
 
The multimeric genes coding for [(AG)3EG]10 and [(AG)3EG]20, prepared as described in 
Chapter 3, were cloned into BspMI-digested pSK-JS2. The resulting vector was digested with 
BamHI and the multimeric gene fragment was cloned into the BamHI digested pET-3b 
expression vector. 
 
4.4.3 Expression and purification of cysteine-flanked [(AG)3EG]10 (1) 
Expression. The pET-3b expression vectors carrying the artificial genes coding for 10 repeats 
of the octapeptide sequence -(AG)3EG- were transformed to E. coli BL21(DE3) cells 
(Novagen) and grown overnight at 30 °C. A single colony was used to inoculate 250 mL 2 × 
YT medium containing 100 µg mL-1 ampicillin, 34 µg mL-1 chloramphenicol and 1% glucose. 
After growth overnight at 30 °C this preculture was used to inoculate 4.5 L of 2 × YT medium 
to OD = 0.1 and cells were grown at 37 °C. Protein expression was induced during logarithmic 
growth by addition of IPTG to a final concentration of 1 mM. 
 
Purification by Ni-NTA and gel filtration chromatography. Cells were harvested after 4 
hours of expression by centrifugation at 6000 g for 15 min at 4 °C. Cells were resuspended in 
50 mL lysis buffer (50 mM NaH2PO4 (pH 8.0), 300 mM NaCl, 10 mM imidazole, 10 mM β-
mercaptoethanol and 1 mM PMSF) and disrupted by sonication on ice for 5 min using a 250 W 
Branson sonicator (50% duty cycle, 5 units power). RNase A (10 µg mL-1) and DNase I (5 µg 
mL-1) were added, followed by incubation on ice for 15 min. The lysate was centrifuged at 
10000 g for 30 min to pellet the cellular debris. The supernatant was incubated with 5 mL Ni-
NTA agarose beads for 1 hour at 4 °C. The suspension was then loaded onto the column 
followed by washing with 40 mL wash buffer (as lysis buffer, except with the addition of 20 
mM imidazole). The protein was eluted with 10 mL elution buffer (as lysis buffer, but 200 mM 
imidazole). The elution fractions were further purified by gel filtration chromatography using a 
Superdex-75 Hi-LoadTM 26/60 column (Amersham Biosciences) operated at room temperature.  
The eluent composition was as follows: 50 mM NaH2PO4 (pH 8.0), 150 mM NaCl, 10 mM β-
mercaptoethanol. A flow of 2 mL min-1 was used. Typically 10 mL of sample was loaded on the 
column. The isolated yield after dialysis for 2 days against demi-water (Spectra Por dialysis 
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tubing, 3.5 kDa molecular weight cut-off) and freeze-drying was 6 mg per liter of culture. Full-
length [(AG)3EG]10 (1): MS (MALDI-TOF): m/z = 11134 Da (calcd. mass: 10980 Da). 
 
4.4.4 Expression and purification of cysteine-flanked [(AG)3EG]20 (2) 
High cell density fermentation. Competent cells of E. coli strain BL21(DE3)pLysS were 
transformed with the pET-3b vector carrying the artificial gene coding for cysteine-flanked 
[(AG)3EG]20. The transformation mixture was plated on LB agar medium under ampicillin (200 
µg mL-1) and chloramphenicol (34 µg mL-1) selection for 16 h at 30 °C. A single colony of a 
positive transformant was used to inoculate 200 mL of 2 × YT medium, supplemented with 1% 
glucose, ampicillin (200 µg mL-1) and chloramphenicol (34 µg mL-1). This preculture was 
incubated at 30 °C for 16 h. The cells were isolated by centrifugation at 4000 g and 4 °C for 15 
min and resuspended in 100 mL minimal medium. The 5 L fermentor (Bioflo 110, New 
Brunswick Scientific Co.), containing 4 L of minimal medium was inoculated to an optical 
density of 0.1. The minimal medium was made according to a recipe described by Panitch and 
coworkers.[12] MgSO4, thiamine hydrochloride and glucose were separately filter sterilized in ¼ 
of the final medium volume. The other medium components were autoclaved in the fermentor 
in ¾ of the final medium volume. Before start of the fermentation, the filter sterilized 
components were added to the fermentor and the pH was adjusted to 6.8 with 4N NH4OH. 
Antifoam (Antifoam A concentrate, Sigma), ampicillin (200 µg mL-1) and chloramphenicol (34 
µg mL-1) were added just before inoculation. The culture was grown at 37 °C. During the 
fermentation the pH was kept constant (6.8) by the addition of 4 N NH4OH (also used as 
nitrogen source). The dissolved oxygen was set at 20% air saturation. The agitation speed was 
500 rpm and the aeration rate was 2 L min-1. Dissolved oxygen was kept constant by cascading 
to pure O2. The doubling time of the cells was approximately 1 hour under these conditions.  
The depletion of glucose (after approximately 10 hours and an optical density of approximately 
20) was observed by an increase of the dissolved oxygen concentration and a rise in pH above 
the setpoint. A glucose feed (50% w/v) was established at that point. Glucose was fed through 
the acid pump of the pH controller, thus maintaining the pH at 6.8. Expression was induced by 
addition of IPTG to a final concentration of 1 mM and the temperature was lowered to 30 °C. 
The cells were harvested after 4 hours by centrifugation for 15 min at 6000 g and 4 °C and 
stored at -20 °C. 
 
Purification by Ni-NTA chromatography, heat precipitation and reversed phase 
chromatography. 70 grams of cells (wet weight) were resuspended in 350 mL lysisbuffer (50 
mM NaH2PO4, pH 8.0; 300 mM NaCl; 1 mM PMSF). Lysozyme was added to 1 mg mL-1 and 
the suspension was incubated on ice for 30 min. Sonication was carried out for 15 min on ice 
using a Branson sonicator (50% duty cycle, 5 units power). RNase A (10 µg mL-1) and DNase I 
(5 µg mL-1) were added, followed by incubation on ice for 15 min. The lysate was centrifuged 
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for 30 min at 10000 g. To the lysate 110 mL of 50% pre-equilibrated Ni-NTA slurry was added 
and mixed by shaking on a rotary shaker at 4 °C for 1 hour. The Ni-NTA agarose beads were 
spun down by centrifugation at 1500 g for 5 min and the supernatant was removed. The beads 
were loaded into a column using wash buffer (50 mM NaH2PO4, pH 8.0; 300 mM NaCl; 1 mM 
PMSF; 10 mM imidazole). The beads were washed with in total 300 mL wash buffer. Then a 30 
mL imidazole gradient was applied from 10 mM to 250 mM, followed by applying 90 mL 
elution buffer (50 mM NaH2PO4, pH 8.0; 300 mM NaCl; 1 mM PMSF; 250 mM imidazole). 
Beta-mercaptoethanol was added to a final concentration of 10 mM. The eluate was then heated 
for 10 min at 70 °C, followed by centrifugation at 6000 g for 15 min. Reversed phase 
chromatography was performed with a RPC-15µm C2/C8 column (HR16/10; Amersham 
Biosciences) operated at room temperature. The composition of the eluents was as follows: 
Eluent A: water + 0.1% TFA; eluent B: 80% MeCN + 0.1% TFA. A 250 mL gradient was 
applied from 0 to 50% eluent B with a flow rate of 2 mL min-1. The sample volume was 5 mL. 
The final yield of full length product was 10 mg L-1 of culture. 
Full-length [(AG)3EG]20 (2): MS (MALDI-TOF): m/z = 16811 Da (calcd. average mass 
for unmodified polypeptide: 16686). 1H-NMR (400 MHz, D2O): δ = 4.34 (m, 93H, Ala/Glu-
Hα), 3.96 (s, 172H, Gly-Hα), 2.26 (m, 44H, Glu-Hγ), 2.10 (m, 44H, Glu-Hβ), 1.40 (d, 210H, 
Ala-Hβ). Truncated polypeptide: Amino acid analysis: (mol percent) Ala, 28.6; Gly, 37.3; Glx, 
12.5; Arg, 1.5; Ser, 1.3; Asx, 1.8; Thr, 2.5; Met, 2.1; Val, 0.3; His, 9.1; Lys, 0.2. MS (MALDI-
TOF): m/z (major peak) = 6237 Da, m/z (additional peaks) = 6109, 6166, 6294, 6365 and 6422 
Da. 
 
4.4.5 Synthesis of maleimide functionalized poly(ethylene glycols) 
Materials. Poly(ethylene glycols) monofunctionalized with an amine group with molecular 
weights of 750, 2000 and 5000 g mol-1 were purchased from Rapp Polymere GmbH (Tübingen, 
Germany). Epsilon-maleimidocaproic acid (Sigma), benzotriazole-1-yl-oxy-tris-
(dimethylamino)-phosphonium hexafluorophosphate (BOP) (Advanced Chemtech), 
diisopropylethylamine (Fluka), 5,5’-dithio-bis-2-nitrobenzoic acid (Sigma) and sodium 2-
mercaptoethanesulfonate (Sigma) were used as received. Thin layer chromatography analyses 
were performed on Merck precoated silica gel 60 F254 plates (layer thickness 0.25 mm) using 
the solvent mixtures indicated. Product purification was performed with a Sephadex LH-20 gel 
filtration resin obtained from Amersham Biosciences. 
Maleimide detection for thin-layer chromatography.[41] Maleimide derivatives were detected 
by spraying the thin layer plates with a 0.1% solution of 5,5’-dithio-bis-2-nitrobenzoic acid in 
1:1 ethanol : 100 mM Tris.HCl buffer (pH 8.2) and then with a 2% solution of sodium 2-
mercaptoethanesulfonate in 80% ethanol until the background was bright yellow. Maleimide 
derivatives appeared as white spots.  
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Maleimide functionalized poly(ethylene glycol)-750 (3a). 391 mg PEG-750-NH2 (0.52 mmol) 
was dried by azeotropic evaporation with benzene. The dried product was dissolved in 5 mL 
DMF together with 110 mg ε-maleimidocaproic acid (0.52 mmol), 230 mg BOP coupling 
reagent (0.52 mmol) and 192 mg diisopropylethylamine (1.60 mmol). After 24 hours stirring at 
room temperature DMF was evaporated and the resulting solid was redissolved in 
dichloromethane. This solution was subsequently extracted with 1N HCl (twice), water, 5% 
NaHCO3 (twice), water and saturated NaCl. After evaporation the product was further purified 
by gel filtration chromatography using methanol/dichloromethane 1 : 1 v/v as eluent. The final 
yield was 217 mg pure product (0.35 mmol, 68%). Rf = 0.60 – 0.75 (methanol/chloroform = 1:4 
v/v, maleimide detection); 1H-NMR (400 MHz, CDCl3): δ = 6.69 (s, 2H,CH=CH), 6.27 (br s, 
1H, NHCO), 3.61 - 3.68 (br m, 68H, O(CH2)2O), 3.55 (t, 2H, CH2CH2NHCO), 3.51 (t, 2H, 
NCH2), 3.44 (m, 2H, CH2NHCO), 3.38 (s, 3H, CH3O), 2.17 (t, 2H, CH2CONH), 1.66 (m, 2H, 
NHCOCH2CH2), 1.60 (m, 2H, CH2CH2N), 1.31 (m, 2H, CH2CH2CH2CH2N); 13C-NMR (75 
MHz, CDCl3): δ = 172.1 (1C, CONH), 163.8 (2C, NCO), 133.5 (2C, C=C), 71.6 (1C, 
CH2CH2NH), 70.2 (30C, O(CH2)2O), 58.7 (1C, CH3O), 38.9 (1C, CH2NH), 37.5 (1C, CH2N), 
36.1 (1C, CH2CONH), 28.1 (1C, CH2CH2N), 26.2 (1C, CH2CH2CH2), 24.9 (1C, 
CH2CH2CONH); MS (MALDI-TOF): Calcd. for n = 15, C43H80N2O19 [M + Na]+: 952.05, found 
m/z = 951.70, Mn (MALDI-TOF) = 1045 g mol-1, Mw/Mn = 1.01. 
Maleimide functionalized poly(ethylene glycol)-2000 (3b). The maleimide functionalization 
and subsequent purification was carried out analogous to the route described for PEG-750. The 
reaction was performed with 800 mg PEG-2000-NH2 (0.4 mmol), 85 mg ε-maleimidocaproic 
acid (0.4 mmol), 177 mg BOP (0.4 mmol) and 155 mg DIPEA (1.2 mmol). The final yield after 
gel filtration chromatography (Sephadex LH-20; methanol/dichloromethane 1:1 v/v as eluent) 
was 784 mg (0.36 mmol, 89%). Rf = 0.50 – 0.65 (methanol/chloroform = 1:5 v/v, maleimide 
detection); 1H-NMR (400 MHz, CDCl3): δ = 6.69 (s, 2H,CH=CH), 6.20 (br s, 1H, NHCO), 3.61 
- 3.68 (br m, 188H, O(CH2)2O), 3.55 (t, 2H, CH2CH2NHCO), 3.51 (t, 2H, NCH2), 3.44 (m, 2H, 
CH2NHCO), 3.38 (s, 3H, CH3O), 2.17 (t, 2H, CH2CONH), 1.66 (m, 2H, NHCOCH2CH2), 1.60 
(m, 2H, CH2CH2N), 1.31 (m, 2H, CH2CH2CH2CH2N); MS (MALDI-TOF): Calcd. for n = 48, 
C109H212N2O52 [M + H]+: 2383.72, found m/z = 2383.127, Mn (MALDI-TOF) = 2325 g mol-1, 
Mw/Mn = 1.02. 
Maleimide functionalized poly(ethylene glycol)-5000 (3c). The maleimide functionalization 
and subsequent purification was carried out analogous to the route described for PEG-750. The 
reaction was performed with 850 mg PEG-5000-NH2 (0.17 mmol), 36 mg ε-maleimidocaproic 
acid (0.17 mmol), 75 mg BOP (0.17 mmol) and 66 mg DIPEA (0.51 mmol). The final yield 
after gel filtration chromatography (Sephadex LH-20; methanol/dichloromethane 1:1 v/v as 
eluent) was 617 mg (0.12 mmol, 70%). Rf = 0.50 – 0.65 (methanol/chloroform = 1:5 v/v, 
maleimide detection); 1H-NMR (400 MHz, CDCl3): δ = 6.69 (s, 2H,CH=CH), 6.20 (br s, 1H, 
NHCO), 3.60 - 3.67 (br m, 460H, O(CH2)2O), 3.55 (t, 2H, CH2CH2NHCO), 3.51 (t, 2H, NCH2), 
3.44 (m, 2H, CH2NHCO), 3.38 (s, 3H, CH3O), 2.17 (t, 2H, CH2CONH), 1.66 (m, 2H, 
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NHCOCH2CH2), 1.60 (m, 2H, CH2CH2N), 1.31 (m, 2H, CH2CH2CH2CH2N); MS (MALDI-
TOF): Mn = 5346 g mol-1, Mw/Mn = 1.01. 
 
4.4.6 Conjugation of poly-[(AG)3EG] and poly(ethylene glycols) 
10 mg polypeptide was dissolved in 5 mL 20 mM NaH2PO4 buffer (pH 8.0) containing 150 mM 
NaCl, 1 mM EDTA and 200 mM dithiotreitol (DTT; Sigma) and incubated for 1 hour at room 
temperature. To remove the excess DTT the polypeptide was precipitated with trichloroacetic 
acid (TCA; Sigma) using a protocol adapted from Maniatis.[36] Precipitation by addition of 0.25 
volumes of ice-cold 100% TCA (w/v) was followed by incubation at -20 °C for 30 min. After 
centrifugation at 13000 rpm for 10 min at 4 °C the pellet was washed with 2.5 mL ice-cold 20% 
TCA followed by a second wash with 2.5 mL 1% TCA for [(AG)3EG]10 and 2.5 mL milli-Q for 
[(AG)3EG]20. After each wash the solution was centrifuged for 5 min at 4 °C. The pellet was 
redissolved in 5 mL 100 mM NaH2PO4 buffer (pH 6.8) containing 150 mM NaCl. For complete 
PEGylation of the cysteine residues an excess of maleimide functionalized PEG was 
immediately added as a 5 mL solution in the same buffer. For [(AG)3EG]10 a 5-fold excess was 
used whereas a 20-fold excess was used for [(AG)3EG]20. For [(AG)3EG]10 a conjugation 
reaction with ε-maleimidocaproic acid (5 equivalents) was carried out. The reaction mixture 
was incubated overnight on a rotating arm. 
Ni-NTA chromatography was used to remove the excess PEG or ε-maleimidocaproic 
acid. The Ni-NTA beads were pre-equilibrated in 100 mM NaH2PO4 buffer (pH 8.0) containing 
150 mM NaCl. The PEG-conjugation solution was added to 10 mL equilibrated 50% Ni-NTA 
suspension and incubated for 1 hour at room temperature. The suspension was centrifuged for 5 
min at 1500 rpm and the supernatant was removed. Wash buffer (10 mL of 100 mM NaH2PO4 
(pH 8.0), 150 mM NaCl) was added and a column was loaded. The agarose beads were washed 
until all the PEG was removed (monitored by measuring absorption profile at 214 nm). 
Subsequently the polypeptide-PEG conjugate was eluted by increasing the imidazole 
concentration to 200 mM. Finally, the product was dialysed against demi-water using a dialysis 
membrane (Spectra Por dialysis tubing, 3.5 kDa molecular weight cut-off) for 2 days and 
lyophilized.  
[(AG)3EG]20-PEG-750 conjugate (4a). 1H-NMR (400 MHz, D2O): The following major 
signals were assigned: δ  = 4.34 (m, 94H, Ala/Glu-Hα), 3.96 (s, 172H, Gly-Hα), 3.71 (s, 136H, 
O(CH2)2O), 3.39 (s, 6H, CH3O), 2.26 (m, 46H, Glu-Hγ), 2.10 (m, 46H, Glu-Hβ), 1.40 (d, 213H, 
Ala-Hβ). MS (MALDI-TOF): m/z = 18679 (calcd. mass for bifunctionalized product: 18907 
Da) and 19807 Da (calcd. mass for trifunctionalized product: 19952 Da). After cyanogen 
bromide cleavage (5a): MALDI-TOF analysis gave no signal. Cleavage was confirmed by 
SDS-PAGE analysis (Figure 4.5). 
[(AG)3EG]10-PEG-750 conjugate (6a). 1H-NMR (400 MHz, D2O): The following major 
signals were assigned: δ  = 4.33 (m, 54H, Ala/Glu-Hα), 3.96 (s, 92H, Gly-Hα), 3.71 (s, 136H, 
Chapter 4 
 -92- 
O(CH2)2O), 3.39 (s, 6H, CH3O), 2.26 (m, 26H, Glu-Hγ), 2.10 (m, 26H, Glu-Hβ), 1.40 (d, 123H, 
Ala-Hβ). (MALDI-TOF): m/z = 13280 (calcd. mass for bifunctionalized product: 13070 Da), 
12317, 14315 Da (calcd. mass for mono- and trifunctionalized product: 12025 and 14115 Da, 
respectively) and 26139 Da (dimeric products). After cyanogen bromide cleavage (7a): MS 
(MALDI-TOF): m/z = 8529 (calcd. mass for bifunctionalized polypeptide (polypeptide part: H-
GTCAG-[(AG)3EG]10-AC-homoserine-OH): 8478 Da) and 10829 Da (incomplete cleavage). 
[(AG)3EG]10-PEG-2000 conjugate (6b). 1H-NMR (400 MHz, H2O/D2O 9:1 v/v): The 
following major signals were assigned: δ  = 4.28 (m, 54H, Ala/Glu-Hα), 3.91 (s, 92H, Gly-Hα), 
3.71 (s, 376H, O(CH2)2O), 3.39 (s, 6H, CH3O), 2.26 (m, 26H, Glu-Hγ), 2.10 (m, 26H, Glu-Hβ),  
1.40 (d, 123H, Ala-Hβ). MS (MALDI-TOF): m/z = 15417 (calcd. mass for bifunctionalized 
product: 15630 Da), 13332 and 17462 Da (calcd. mass for mono- and trifunctionalized product: 
13305 and 17955 Da, respectively). After cyanogen bromide cleavage (7b): MS (MALDI-
TOF): m/z = 10872 Da (calcd. mass for bifunctionalized polypeptide (polypeptide part: H-
GTCAG-[(AG)3EG]10-AC-homoserine-OH): 11038 Da). 
[(AG)3EG]10-PEG-5000 conjugate (6c). 1H-NMR (400 MHz, H2O/D2O 9:1 v/v): The 
following major signals were assigned: δ  = 1.40 (d, 123H, Ala-Hβ), 2.10 (m, 26H, Glu-Hβ), 
2.26 (m, 26H, Glu-Hγ), 3.39 (s, 6H, CH3O), 3.71 (s, 920H, O(CH2)2O), 3.91 (s, 92H, Gly-Hα), 
4.28 (m, 54H, Ala/Glu-Hα). MS (MALDI-TOF): m/z = 21552 (calcd. mass for bi-
functionalized product: 21672 Da), 10926, 16219 and 26323 Da (calcd. mass for non-, mono- 
and trifunctionalized product: 10980, 16326 and 27018 Da, respectively). After cyanogen 
bromide cleavage (7c): MS (MALDI-TOF): m/z = 16890 (calcd. mass for bifunctionalized 
polypeptide (polypeptide part: H-GTCAG-[(AG)3EG]10-AC-homoserine-OH): 17080 Da), 
11589 (calcd. mass for monofunctionalized product: 11734 Da) and 9215 Da (not assigned). 
[(AG)3EG]10-ε-maleimidocaproic acid conjugate (8). 1H-NMR (400 MHz, H2O/D2O 9 : 1 
v/v): The following major signals were assigned: δ = 1.40 (d, 123H, Ala-Hβ), 2.10 (m, 26H, 
Glu-Hβ), 2.26 (m, 26H, Glu-Hγ), 3.91 (s, 92H, Gly-Hα), 4.28 (m, 54H, Ala/Glu-Hα). MS 
(MALDI-TOF): m/z = 11588 (calcd. mass for bifunctionalized product: 11402 Da), 11356 
(calcd. mass for monofunctionalized product: 11191 Da) and 22215 Da (dimeric product). After 
cyanogen bromide cleavage (9): MS (MALDI-TOF): 13600, 20233, 26842 (di-, tri- and 
tetrameric product), 9154 Da. 
 
4.4.7 Synthesis of maleimide functionalized poly(methyl methacrylate) 
PMMA used for conjugation to [(AG)3EG]20 (10b). PMMA was prepared via atom transfer 
radical polymerization. 46.4 mg Cu(I)Cl (0.47 mmol), 127.6 mg 2,2-bipyridyl (0.82 mmol) 
were added to a Schlenk tube and the tube was placed under nitrogen. 67.6 mg tert-
butyloxycarbonyl protected 2-bromoisobutyryloxy(4-amino-butane) (0.39 mmol) (kindly 
provided by Joost Opsteen) and 1.61 g methyl methacrylate (16 mmol) were dissolved in 8 mL 
DMSO-d6 and 1 mL toluene and purged with nitrogen for 5 min. This purged solution was 
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added to the Schlenk tube and the mixture was purged with nitrogen for another 15 min. 
Polymerization was carried out for 5 hours at 20 °C and a conversion of 57% was reached. 
After polymerization a small amount of dichloromethane was added and the solution was 
extracted twice with 2.5% EDTA in water. The dichloromethane layer was dried with Na2SO4 
and filtered. The solvent was removed in vacuo. Yield (10a): 986 mg. 1H-NMR (400 MHz, 
CDCl3): δ = 4.03 (m, 2H, CH2CO2), 3.60 (s, 48H, CH2C(CH3)CO2CH3, 3.16 (t, 2H, CH2NH),  
2.1 – 1.7 (br m, 32H, CH2C(CH3)CO2CH3, 1.45 (s, 9H, (CH3)3CO), 1.13 (s, 6H, (CH3)2CO2), 
1.02 (s, 16H, CH2C(CH3)CO2CH3, 0.85 (s, 29H, CH2C(CH3)CO2CH3). Not assigned: 4H, 
(CH2)2CH2O. GPC: Mn = 3.4 kg mol-1, PDI = 1.22. Subsequently the maleimide functionality 
was introduced according to the following procedure. 386 mg (0.11 mmol) 10a was dissolved in 
dichloromethane. Ethyl acetate/HCl was added, resulting in a white precipitate. 1M NaHCO3 
was added until the pH was 7 – 8. The mixture was extracted twice with dichloromethane. The 
dichloromethane layer was washed with water, dried with MgSO4 and filtered. The solvent was 
removed in vacuo. The deprotected polymer was dissolved in 2 mL DMF. 28.3 mg ε-
maleimidocaproic acid (0.11 mmol), 48.5 mg benzotriazole-1-yl-oxy-tris-(dimethylamino)-
phosphonium hexafluorophosphate (BOP; 0.11 mmol) and diisopropylethylamine (to raise the 
pH to 7 - 8) were added. The coupling was carried out for 2 hours at room temperature. The 
polymer was precipitated by addition of water. The crude product was filtered and washed 
successively with water, 1M HCl, 1M NaHCO3, water and hexane. The polymer was dissolved 
in dichloromethane and dried with MgSO4. After filtration, the solvent was removed in vacuo. 
Yield (10b): 308 mg (75%). 1H-NMR (400 MHz, CDCl3): δ = 6.70 (s, 2H, CH=CH), 4.04 (m, 
2H, CH2CO2), 3.60 (s, 48H, CH2C(CH3)CO2CH3), 3.52 (t, 2H, NCH2), 3.28 (m, 2H, NHCH2), 
2.17 (t, 2H, CH2CONH), 2.1 – 1.7 (br m, 32H, CH2C(CH3)CO2CH3, 1.13 (s, 6H, (CH3)2CO2), 
1.03 (s, 16H, CH2-C(CH3)CO2CH3), 0.85 (s, 29H, CH2-C(CH3)CO2CH3). Not assigned: 2H, 
NHCOCH2CH2; 2H, CH2CH2N; 4H, (CH2)2CH2O. GPC: Mn = 3.6 kg mol-1, PDI = 1.32. 
PMMA used for conjugation to [(AG)3EG]10 (11). Tert-butyloxycarbonyl (Boc) protected 
poly(methyl methacrylate) was kindly provided by Joost Opsteen. 316 mg pMMA-Boc was 
deprotected by stirring in 10 mL ethyl acetate/HCl overnight. The solvent was evaporated and 
the excess HCl was removed by the addition of 20 mL 1 : 1 tert-butanol : dichloromethane. 
After 1 hour the solvent was evaporated. 313 mg of dried product was dissolved in 10 mL 
dichloromethane together with 33 mg ε-maleimidocaproic acid (0.16 mmol), 69 mg BOP 
coupling reagent (0.16 mmol) and 61 mg diisopropylethylamine (0.47 mmol). The reaction was 
allowed to proceed for 24 hours at room temperature. The reaction mixture was successively 
extracted with an equal volume of 1N HCl (twice), water, 5% NaHCO3 (twice), water and a 
saturated NaCl solution. Subsequently the polymer was precipitated in an excess heptane. After 
filtration, the polymer was vacuum-dried. Yield: 254 mg (76 %). 1H-NMR (400 MHz, CDCl3):  
δ = 6.69 (s, 2H, CH=CH), 4.04 (m, 2H, CH2CO2), 3.60 (s, 119H, CH2C(CH3)CO2CH3), 3.52 (t, 
2H, NCH2), 3.28 (m, 2H, NHCH2), 2.17 (t, 2H, CH2CONH), 1.81 (s, 33H, 
CH2C(CH3)CO2CH3), 1.13 (s, 6H, (CH3)2CO2), 1.02 (s, 46H, CH2-C(CH3)CO2CH3), 0.85 (s, 
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79H, CH2-C(CH3)CO2CH3). Not assigned: 2H, NHCOCH2CH2; 2H, CH2CH2N; 4H, 
(CH2)2CH2O. GPC: Mn = 3.9 g mol-1, PDI = 1.19. 
 
4.4.8 Conjugation of poly-[(AG)3EG] and poly(methyl methacrylate) 
The polypeptides [(AG)3EG]10 and [(AG)3EG]20 (5.7 and 8.5 mg, respectively) were dissolved 
to a concentration of 2 mg mL-1 in 20 mM NaH2PO4 buffer (pH 8.0) containing 150 mM NaCl 
and 1 mM EDTA. A 1 M solution of dithiothreitol (DTT) in the same buffer was added to a 
final concentration of 200 mM. After incubation at room temperature for 1 hour, the reduced 
polypeptide was precipitated by the addition of 0.25 volumes of ice-cold 100% (w/v) 
trichloroacetic acid (TCA), followed by incubation at -20 °C for 30 min. After centrifugation at 
13000 rpm for 10 min at 4 °C the pellet was washed with 1 volume of ice-cold 20% TCA 
followed by a second wash with 1 volume of 1% TCA for [(AG)3EG]10 and 1 volume of demi-
water for [(AG)3EG]20. After each wash the solution was centrifuged for 5 min at 4 °C. The 
pellet was redissolved in 1 volume 100 mM NaH2PO4 buffer (pH 6.8) containing 150 mM 
NaCl. To this reduced polypeptide solution a pMMA solution (0.45 - 18 mg mL-1; 
corresponding to 0.5 - 20 equivalents per thiol group) in tetrahydrofuran (THF) was slowly 
added, resulting in a THF : buffer ratio of 3 : 2. This solution was incubated overnight on a 
rotating arm for [(AG)3EG]10 to 3 days for [(AG)3EG]20. For SDS-PAGE analysis, 10 µl 
samples were dried by vacuum evaporation and redissolved in 10 µl 1 × Laemmli buffer and 
loaded on gel according to standard procedures. 
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Abstract 
The assembly behavior of silk-like triblock copolymers consisting of a central β-sheet 
polypeptide block and poly(ethylene glycol) (PEG) end blocks is described. Crystallization of 
the poly-[(AG)3EG] polypeptide block (A = alanine, G = glycine and E = glutamic acid) was 
induced by vapour diffusion of methanol into a solution of the triblock copolymers in 70% 
formic acid. After crystallization the secondary structure of the polypeptide block was 
characterized with infra-red spectroscopy. The predominant absorption bands in the amide I 
and amide II region had frequencies of 1625 cm-1 and 1520 cm-1, respectively. These 
frequencies are typical for an antiparallel β-sheet conformation of the polypeptide block. These 
were the predominant absorption bands for both the polypeptide alone as well as for the PEG-
conjugates. For the polypeptide [(AG)3EG]10 conjugated with various PEG chains  (Mn = 750, 
2000 and 5000 g mol-1) the absorption band around 1655 cm-1 became stronger with increasing 
PEG chain length, indicating that the fraction of the polypeptide chain in the β-sheet 
conformation decreased. 
The microstructure of the block copolymers was analyzed by transmission electron 
microscopy (TEM). It was shown that the block copolymers formed fibrils, whereas this fibrillar 
structure was not present for the polypeptides without conjugated PEG. To obtain information 
about the organization of the block copolymers within the fibrils, the length of the β-sheet and 
PEG block was varied. The fibrils for the block copolymer [(AG)3EG]20-PEG-750 had a width 
of approximately 12 nm. For the block copolymer [(AG)3EG]10-PEG-750 (where the 
polypeptide block has half of the length in comparison to [(AG)3EG]20-PEG-750), no fibrils 
were visible with TEM. Atomic force microscopy (AFM) was carried out on samples applied to 
a mica surface. From this it was clear that crystallization of the block copolymer [(AG)3EG]10-
PEG-750 also resulted in fibril formation. Furthermore, AFM analysis showed that the fibrillar 
height (~ 2 nm) was independent of the polypeptide block length. Variation of the PEG block 
length in conjugates of [(AG)3EG]10 showed that the PEG-750 and PEG-2000 conjugates still 
readily formed fibrils, whereas for PEG-5000 only small fibrillar fragments were present. No 
height differences could be established, however. 
With the present information an assembly model is proposed in which fibril formation 
occurs in the β-sheet stacking direction and the hydrogen-bond direction is perpendicular to 
the length-axis of the fibrils, whereas the PEG-chains prevent side-to-side aggregation of the 
fibrils. Diffraction data are, however, required to provide a direct evidence of this model.  This 
class of polypeptide-polymer hybrids has the potential to allow control over height, width and 
surface functionality of the fibrils, and could therefore be useful as well-defined building blocks 
for the preparation of materials with organization at the nanometer scale. 
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5.1 Introduction 
Peptides and proteins are actively being used as building blocks for the fabrication of higher 
order nanostructures via self-assembly. Knowledge of the relationship between primary amino 
acid sequence and folding behavior, as well as an increasing insight in protein-protein 
interactions make them attractive candidates for the creation of functional nanostructured 
materials. Naturally occurring proteins with an inherent property to self-assemble have been 
used to construct new materials. A variety of such systems have been investigated, such as 
bacterial S-layer proteins[1] and the yeast prion protein Sup35p[2]. S-layer proteins are crystalline 
two-dimensional protein arrays at the cell surface of certain bacteria. Because of the presence of 
defined pores they have been used e.g. for ultrafiltration and as template for the deposition of 
regularly arranged metal nanoparticles.[1] Yeast prion protein fibrils have been used for the 
preparation of conducting nanowires by selective metal deposition.[2] 
Alternatively, new assemblies have been created by “polyvalent design”[3], using 
oligomeric proteins in combination with multivalent ligands. An example is the formation of a 
‘diamond-like’ lattice resulting from the binding of the tetrameric protein concanavalin A and a 
two-headed carbohydrate molecule.[4] In another approach, a two-dimensional network with 
controllable mesh-size could be created by using a tetrameric aldolase conjugated with biotin in 
combination with streptavidin as a rigid linker.[5] 
Besides building blocks of known assembly behavior, “de novo designed” peptide or 
protein building blocks have become increasingly important for the construction of new self-
assembling systems. Especially small peptides forming β-strands and β-hairpins, which can be 
synthesized easily by solid-phase synthesis, have been investigated for their self-assembly 
properties. Simple design principles can be applied, such as amphiphilicity in β-strands by the 
alternation of polar and non-polar residues, charge arrangement in β-strands leading to 
formation of salt-bridges, and introduction of turns and interruption of hydrogen-bonding by the 
use of proline. These factors together determine the orientation of β-strands and the shape of the 
resulting aggregates and offer in addition the opportunity to introduce stimulus-responsiveness. 
A variety of architectures such as ribbons[6, 7], nanotubes[8, 9], monolayers with nanoscale 
order[10-12], gels[13, 14] and membranes[15] have been reported for β-sheet peptides. These systems 
may be used e.g. as scaffolds for tissue engineering or in targeted drug delivery.[16] 
Higher molecular weight designed β-sheet polypeptides have been prepared via protein 
engineering by expression of a combinatorial library of synthetic genes coding for 7-residue 
long amphiphilic β-strands separated by turn sequences.[17] This entire class of well-defined 
polypeptides  assembled into fibrils, formed monolayers at the air-water interface[18] or flat 
sheets on highly oriented pyrolytic graphite (HOPG)[19]. The gelation properties of the high 
molecular weight repetitive β-sheet fibril forming sequence poly-(AEAEAKAK) has been 
reported by Muller and coworkers.[20] Interestingly, they showed that the fibrils were of similar 
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diameter as the low-molecular weight analogues[15], but that the high molecular weight material 
was more elastic. 
Despite the large amount of research that is performed on peptide and protein assembly, 
relatively few reports have described the self-assembly of hybrid block copolymers, i.e. 
copolymers which combine traditional synthetic polymers with peptide sequences. This kind of 
block copolymers have the potential to combine properties of the peptide block, such as 
assembly, recognition or bioactivity with the specific chemical and physical properties of 
synthetic polymers, such as reactivity, solubility and mechanical properties. Most reported 
hybrid block copolymers are composed of a synthetic polymer combined with either a 
homopolypeptide sequence prepared via ring-opening polymerization of an N-
carboxyanhydride[21, 22] or a small peptide prepared via solid-phase synthesis. In particular, the 
latter approach is of interest for self-assembly. Meredith and coworkers reported the formation 
of fibrils of a diblock copolymer consisting of the amyloid-β(10-35) peptide and poly(ethylene 
glycol) (PEG).[23, 24] Side-to-side aggregation of fibrils was hindered by the PEG-coated surface 
of the fibrils. The assembly behavior of hybrid block copolymers consisting of PEG and 
amphiphilic β-strand peptide sequences was investigated by Klok and coworkers.[25, 26] These 
hybrids formed superstructures consisting of alternating PEG layers and peptide domains in an 
antiparallel β-sheet conformation in the solid-state and fibrillar structures after assembly in 
water. Silk-like multi-block copolymers of PEG and the β-sheet forming sequences AGAG (A 
= alanine, G = glycine) and poly(alanine) based on silkworm and spider silk, respectively, were 
reported by Sogah and coworkers.[27, 28] A microphase separated architecture of peptide domains 
(20 – 200 nm) dispersed in a continuous PEG phase was observed for these polymers. 
In this chapter the secondary structure and assembly properties of block copolymers of 
poly-[(AG)3EG] (E = glutamic acid) and PEG is investigated. The preparation of these block 
copolymers was described in Chapter 4. Tirrell and coworkers showed that crystallization of 
poly-[(AG)3EG] from formic acid resulted in the formation of lamellar crystals (Figure 5.1).[29] 
The polar and bulky glutamic acid residues were confined to the lamellar surface.[30, 31] 
Although control over polypeptide folding was demonstrated with this sequence, crystallization 
resulted in extended plate-like structures. Therefore some of the information present in the 
polypeptide design, such as height and width of the β-sheet elements, was lost in the 
aggregation process. 
With the attachment of N- and C-terminal PEG chains, we attempt to restrict 
macroscopic aggregation of the β-sheet polypeptides and allow translation of the β-sheet width 
and height in the assembled structures. This chapter describes the effect of attachment of PEG 
with varying chain length on the secondary structure of the polypeptide block, as determined by 
infra-red (IR) spectroscopy. The microstructure of the various triblock copolymers was 
investigated by transmission electron microscopy (TEM) and atomic force microscopy (AFM). 
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Figure 5.1 Schematic illustration of the basic crystalline entity for poly-[(AG)3EG]. The a-axis 
corresponds to the hydrogen-bond direction. The chain-folded lamellae stack in the b direction. 
From reference [32]. 
 
5.2 Results and discussion 
The conjugates of poly-[(AG)3EG] and poly(ethylene glycol), of which the preparation has been 
described in Chapter 4, are summarized with their compound number in Figure 5.2.  
 
 
 
Figure 5.2 Prepared conjugates of [(AG)3EG]10 and [(AG)3EG]20 with poly(ethyleneglycol) and ε-
maleimidocaproic acid. Uncleaved conjugates still contain the N- and C-terminal non-repetitive 
amino acids (R1 = H-ASMTGGQQMGRDPHHHHHHM, R2 = GVPDPAANKARKEAELAAATAEQ-
OH and R3 = S-CH3). For cyanogen bromide (CNBr) cleaved conjugates these amino acids have 
been removed (R1 = H, R2 and R3 = OH). 
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For [(AG)3EG]20 a conjugate was prepared with PEG-750. The effect of PEG conjugation on 
secondary structure was assessed by IR spectroscopy. Furthermore, the effect of the presence of 
the N- and C-terminal non-repetitive amino acids, on the assembly behaviour of the conjugate 
was investigated by TEM and AFM. Whereas the uncleaved conjugate (4a) still contains 
approximately 20 amino acids (including the 6 × His tag) at both the N terminus and the C 
terminus, these have been removed in case of the cyanogen bromide cleaved conjugate (5a). 
For [(AG)3EG]10, the PEG-chain length was varied from PEG-750 to PEG-5000 and the effect 
on secondary structure and assembly was investigated for the cyanogen bromide cleaved 
variants (7a, 7b and 7c). In addition, as a control, the effect of conjugation of ε-
maleimidocaproic acid (8 and 9) on assembly behaviour was investigated. The effect of the 
polypeptide block length on structure formation was assessed by comparison between 
[(AG)3EG]20-PEG-750 (5a) and [(AG)3EG]10-PEG-750 (7a). 
 
5.2.1 Infra-red and circular dichroism spectroscopy 
The crystallization behaviour of poly-[(AG)3EG] is known to be dependent on crystallization 
conditions.[30] Crystallization from an aqueous lithium bromide solution by dialysis against 
water resulted in a crystal structure analogous to the structure of silk I (the fibroin of Bombyx 
mori in form I)[33]. The antiparallel secondary structure (as in silk II) resulted from 
crystallization from aqueous formic acid. In this chapter poly-[(AG)3EG] and its various PEG-
conjugates (Figure 5.2) were crystallized via the latter method. Crystallization was induced by 
vapour diffusion of methanol into a solution of the polypeptide in 70% formic acid. Formic acid 
serves as a chaotropic agent for the dissolution of the polypeptide. Furthermore, in this solvent 
the glutamic acid side chains will be protonated (pKa of formic acid and the glutamic acid side 
chain are 3.8 and 4.6[34], respectively), which prevents electrostatic repulsion between the turn 
amino acid residues and facilitates folding. 
IR spectroscopy was carried out for the determination of the secondary structure of 
gelated samples of poly-[(AG)3EG]. Furthermore, the effect of conjugation of PEGs of varying 
chain length on the secondary structure of poly-[(AG)3EG] was investigated. The infra-red 
spectra were recorded after drying of the gelated samples. The frequency of the amide I (80% 
C=O stretch vibration) and amide II (60% N-H bend vibration) were used for indication of the 
secondary structure of the polypeptides.[35-37] The effect of methanol-induced gelation of 
[(AG)3EG]20 (without flanking cysteine residues, obtained from its GST fusion as described in 
Chapter 3, Paragraph 2.2) on the secondary structure of this polypeptide was clear after 
comparison of the IR-spectra for freeze-dried polypeptide and gelated polypeptide. The freeze-
dried polypeptide [(AG)3EG]20 showed amide I and II bands at 1656 and 1547 cm-1, 
respectively, which are indicative of a random coil/α-helical conformation (specific assignment 
to one of these conformations could not be made). For gelated [(AG)3EG]20 amide I and II 
bands at 1626 and 1519 cm-1 were observed, which are characteristic for the β-sheet 
conformation (characteristic frequencies for the β-sheet conformation are 1610 – 1640 cm-1 for 
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amide I and 1510 – 1550 cm-1 for amide II). The weak band at 1702 cm-1 and the amide II 
signal below 1630 cm-1 were furthermore indicative for the antiparallel orientation of the β-
strands. 
The effect of conjugation of PEGs with varying chain length on the secondary structure 
of poly-[(AG)3EG] was investigated for the polypeptide [(AG)3EG]10. Figure 5.3a shows the IR-
spectra for gelated conjugates of [(AG)3EG]10 with ε-maleimidocaproic acid, PEG-750, PEG-
2000 and PEG-5000 after cyanogen bromide cleavage (9, 7a, 7b and 7c, respectively). These 
IR-spectra are very similar, showing three bands around 1697, 1654 and 1623 cm-1 in the amide 
I region, as well as a band around 1522 cm-1 in the amide II region. For the conjugate of 
[(AG)3EG]20 with PEG-750 (5a) a similar spectrum was observed (Figure 5.3b). 
 
 
 
Figure 5.3 Infrared spectra of cyanogen bromide cleaved conjugates of (a) [(AG)3EG]10 and (1) ε-
maleimidocaproic acid, (2) PEG-750, (3) PEG-2000 and (4) PEG-5000. (b) [(AG)3EG]20 and PEG-
750. Amide I and II regions are shown. Gelated samples (gelation from 10 mg mL-1 solution in 70% 
formic acid) were dried prior to measurement. 
 
The strong bands at 1623 cm-1 and 1522 cm-1 and the weak band at 1697 cm-1 are again 
indicative for the antiparallel β-sheet conformation. The amide I band around 1654 cm-1 (and 
also the amide II bands around 1550 cm-1) indicates that some fraction of the polypeptide chain 
has adopted a secondary structure different from the antiparallel β-sheet conformation. This 
amide I component has been assigned previously to reverse turns of the β- or γ-type[29], but may 
also (partly) result from a random coil/α-helical conformation. It has also been assigned to the 
silk I structure.[31] This component becomes relatively stronger with longer PEG chains, 
although the main secondary structure is not significantly affected. 
PEG-conjugates which were not treated with cyanogen bromide and therefore still 
contain the N- and C-terminal amino acids flanking the poly-[(AG)3EG] sequence, were also 
subjected to gelation. The IR spectra for these uncleaved PEG-conjugates of [(AG)3EG]10 and 
[(AG)3EG]20 are depicted in Figure 5.4. The spectra are very similar to the cleaved variants 
(Figure 5.3), showing a large β-sheet content. For the PEG-750 and PEG-2000 conjugates the 
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band at 1655 cm-1 was relatively more intense. However, no contribution of the N- and C-
terminal amino acids to specific bands in the final spectrum could be established.  
Overall, we can conclude that the antiparallel β-sheet structure is retained upon 
attachment of PEG and that the spectra do not change significantly for the varying PEG chain 
lengths. The values obtained for amide I and II vibrations of poly-[(AG)3EG] and its conjugates 
were identical to the values reported by Krejchi et al. for [AG)3EG]36.[29] 
 
 
 
Figure 5.4 Infrared spectra of uncleaved (i.e. containing N- and C-terminal amino acids flanking 
poly-[(AG)3EG]) conjugates of (a) [(AG)3EG]10 and (1) PEG-750, (2) PEG-2000 and (3) PEG-
5000. (b) [(AG)3EG]20 and PEG-750. Amide I and II regions are shown. Gelated samples (gelation 
from 10 mg mL-1 solution in 70% formic acid) were dried prior to measurement. 
 
In addition, circular dichroism (CD) spectroscopy was carried out for secondary structure 
determination. The gelated polypeptide [(AG)3EG]20 and its PEG-750 conjugate (both the 
uncleaved and the CNBr cleaved structures) were transferred to the surface of a quartz substrate 
and allowed to dry. Only uncleaved [(AG)3EG]20-PEG-750 conjugate gave a measurable CD-
effect and confirmed the β-sheet conformation with a negative ellipticity at 215 nm and a 
positive ellipticity at 195 nm (Figure 5.5).[38] However, since the preparation of films of gelated 
polypeptide was irreproducible, with the result that absorption was sometimes too high to 
measure CD, secondary structure characterization of the other conjugates was limited to infra-
red spectroscopy. 
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Figure 5.5 Circular dichroism spectrum of uncleaved [(AG)3EG]20-PEG conjugate (T = 20 °C). 50 
µL gelated sample (1  mg mL-1 in methanol) was applied to a quartz surface and allowed to dry. 
 
5.2.2 Transmission electron microscopy analysis 
To study the microstructure of gelated poly-[(AG)3EG] and its conjugates, transmission electron 
microscopy (TEM) analysis was performed. Samples were deposited on carbon-coated grids by 
incubating the grid with the carbon side down on top of a gel. After drying, visualization of the 
microstructure was achieved by platinum shadowing. Initial TEM measurements were 
performed with a gelated sample of [(AG)3EG]20-PEG-750 conjugate, which still contained the 
N- and C-terminal non-repetitive amino acids (4a). Figure 5.6 illustrates that this sample 
exhibited a clear fibrillar microstructure. The fibrils were micrometer long, had a uniform width 
of approximately 12 nm (measured on fibrils lying side-by-side) and were aligned. For 
visualization of single fibrils, the gelated sample was diluted with methanol and applied to the 
TEM grid. It was clear, however, that most the fibrils aggregate into larger bundles (Figure 5.6, 
inset). Comparison of this conjugate with the cyanogen bromide cleaved variant (5a), showed 
that the latter did not have this alignment but instead consisted of a network of fibrils (compare 
Figure 5.7a and b). For [(AG)3EG]20 without conjugated PEG only few (for the uncleaved 
variant) or no fibrils (for the CNBr cleaved variant) were found on the grid surface (Figure 5.7c 
and d). 
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Figure 5.6 TEM micrograph showing the fibrillar microstructure of uncleaved [(AG)3EG]20-PEG-
750 conjugate (4a). The scale bar represents 500 nm. Inset: TEM micrograph of diluted sample (~ 
0.1 mg mL-1) showing fibril bundles of various thicknesses. The scale bar represents 200 nm. 
 
 
 
Figure 5.7 TEM micrographs of crystallized [(AG)3EG]20 polypeptides with and without 
conjugated poly(ethylene glycol)-750. Platinum shadowed samples (1 mg mL-1) of (a) uncleaved 
[(AG)3EG]20-PEG-750 conjugate (4a); (b) CNBr cleaved [(AG)3EG]20-PEG-750 conjugate (5a); 
(c) uncleaved [(AG)3EG]20; (d) CNBr cleaved [(AG)3EG]20. The scale bars represent 200 nm. 
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For [(AG)3EG]10, TEM measurements were performed on conjugates of this polypeptide with 
PEGs of different molecular weight. For the [(AG)3EG]10-PEG-750 conjugates a clear fibrillar 
microstructure was observed only for the uncleaved variant (6a) (Figure 5.8a). The fibrillar 
width was clearly smaller than for the [(AG)3EG]20-PEG-750 conjugate, since it could not be 
measured. The platinum particles used for visualization seemed to be too large relative to the 
fibril width. For the CNBr-cleaved [(AG)3EG]10-PEG-750 conjugate (7a) single fibrils were 
difficult to distinguish, because of dense coverage of the grid (Figure 5.8b). Attempts to 
improve visualization of these fibrils by diluting this sample and by applying negative staining 
(uranyl acetate and phosphotungstic acid) were not successful. 
 
 
 
Figure 5.8 TEM micrographs of crystallized [(AG)3EG]10 polypeptides with conjugated 
poly(ethylene glycols) of 750, 2000 and 5000 g mol-1 (a) uncleaved [(AG)3EG]10 conjugated to 
PEG-750 (6a); the scale bar represents 200 nm. (b) CNBr cleaved [(AG)3EG]10 conjugated to 
PEG-750 (7a); the scale bar represents 200 nm. (c) uncleaved [(AG)3EG]10 conjugated to PEG-
2000 (6b); the scale bars represent 10 µm and 400 nm for the inset. (d) uncleaved [(AG)3EG]10 
conjugated to PEG-5000 (6c); the scale bars represent 10 µm and 200 nm for the inset. 
 
For conjugates of [(AG)3EG]10 with PEG-2000 (6b and 7b) and PEG-5000 (6c and 7c) we were 
not able to visualize any structure for samples crystallized from a 10 mg mL-1 solution. Only for 
the uncleaved samples crystallized from a more dilute, 1 mg mL-1 solution, irregular, µm-sized 
aggregates were visible (Figure 5.8c and d). This morphology is alike the spherulitic texture of 
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a recombinant silk-like protein polymer reported by Anderson and coworkers[39] and is also 
commonly seen in thin films of semi-crystalline polymers.[40] A zoomed-in image of these 
aggregates (inset) showed the presence of a fibrillar morphology. For [(AG)3EG]10 conjugated 
to ε-maleimidocaproic acid (8 and 9) no fibrillar structure or other morphology could be 
observed. It seemed that no material could be transferred to the grid. This is likely to reflect the 
larger extent of physical cross-linking for this conjugate  as a result of the increased interaction 
between the β-sheet polypeptides.  
The presence of PEG end-blocks is apparently a prerequisite for the formation of a 
fibrillar microstructure. Without conjugated PEG, crystallization most likely results in the 
formation of larger aggregated structures, because of the less directed interaction between the β-
sheet polypeptides. The PEG chains contribute a directional force to the β-sheet assembly, 
analogous to the orienting forces in block copolymer phase separation. The observed fibril 
alignment, especially visible for uncleaved [(AG)3EG]20-PEG-750 (4a) could be the combined 
result of the presence of the PEG chains and the N- and C-terminal amino acids. Since these 
flanking peptide elements have a net positive charge under the conditions used for 
crystallization their presence might lead to an additional repulsive force between the 
unorganized domains of the triblock copolymers. This could further limit aggregation of fibrils 
and might facilitate alignment by shear. After attachment of longer PEG-chains (PEG-2000 and 
PEG-5000) to [(AG)3EG]10, no fibrillar microstructure could be detected for the CNBr cleaved 
variants. Since it was clear that the absence of a microstructure could also be the result of the 
fact that the limits of resolution of TEM were reached, atomic force microscopy analysis was 
carried out to obtain more information about the assembly of the various conjugates.  
 
5.2.3 Atomic force microscopy analysis 
The fibrillar microstructure for the various PEG-conjugates of poly-[(AG)3EG] was analyzed 
more extensively using atomic force microscopy (AFM). Initial measurements were performed 
on conjugates of [(AG)3EG]20 with PEG-750 still containing the N- and C-terminal non-
repetitive amino acids (4a). The gelated conjugate (10 mg mL-1) was diluted with methanol (~ 
0.01 - 0.1 mg mL-1) and applied on a freshly cleaved mica surface by spin-coating. Figure 5.9 
depicts representative images obtained for this sample. The fibrillar microstructure of this 
conjugate, as observed by TEM (Figure 5.6) was confirmed by AFM. A similar alignment and 
side-by-side aggregation of fibrils can be seen in Figure 5.9a. Upon further dilution a mixture of 
single and aggregated fibrils could be seen with varying height from approximately 1.5 to 10 
nm (Figure 5.9b). A high resolution phase and height image of a branching point of fibrils is 
depicted in Figure 5.9c and d. The side-by-side aggregation for this block copolymer was 
especially clear from the phase images. 
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Figure 5.9 Representative atomic force microscopy images (tapping mode) of β-sheet polypeptide 
[(AG)3EG]20 conjugated with poly(ethylene glycol)-750 (uncleaved; 4a) showing a fibrillar 
microstructure. Samples were diluted with methanol from a 10 mg mL-1 gelated sample and 
spincoated onto a freshly cleaved mica surface. (a) Phase image of aggregated fibrils (100-fold 
diluted sample). (b) Height image showing single and aggregated fibrils (1000-fold diluted sample) 
(c) High resolution phase image of a branching point of fibrils and (d) its corresponding height 
image and height profiles. 
 
For the [(AG)3EG]10-PEG-750 conjugate, AFM images were recorded for the cyanogen 
bromide cleaved variant (7a), which proved the presence of a fibrillar microstructure (Figure 
5.10a). These fibrils could not be clearly visualized previously using TEM (Figure 5.8b). 
Individual fibrils were also visualized for CNBr cleaved [(AG)3EG]20-PEG-750 (5a) (Figure 
5.10b), but relatively more large aggregates were observed for this sample in comparison to the 
uncleaved variant.  
To obtain information about the molecular organization of the β-sheet conjugates within 
the fibrils, a series of height and width measurements were made for single fibrils of PEG-750 
conjugates of [(AG)3EG]10 and [(AG)3EG]20 (7a and 5a). Within a measurement session, the 
same height values were found for both conjugates, albeit with a broad distribution. Values 
found for [(AG)3EG]10 and [(AG)3EG]20 conjugates were 1.9 ± 0.7 nm and 1.6 ± 0.4 nm, 
respectively. Furthermore, in later measurement sessions lower values were found (typically 0.8 
nm). It can therefore be concluded that no height difference was observed, but that 
quantification of the height proved to be difficult. Possible factors affecting the measured height 
values that have been mentioned in literature are e.g. deformation caused by the tip’s pressure 
and the influence of air humidity.[41] 
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Figure 5.10 AFM height images of cyanogen bromide cleaved PEG-750-conjugates of (a) 
[(AG)3EG]10 (7a) and (b) [(AG)3EG]20 (5a) on mica supports. Height profiles are depicted next to 
the images. 
 
 
 
Figure 5.11 Width-at-half-height measurements of (a) [(AG)3EG]10 and (b) [(AG)3EG]20 fibrils 
measured with an ultrasharp AFM-tip. 
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Although it is well established that the measurement of lateral dimensions of objects by AFM is 
complicated by the finite dimensions of the AFM tip (see Paragraph 5.4.4), width measurements 
were made using a high-resolution AFM tip (carbon, typical radius of 1 nm). These 
measurements showed a similar width for both conjugates. Width-at-half-height values of 11.7 
± 1.7 nm and 12.6 ± 1.8 nm were found for cleaved PEG-750 conjugates of [(AG)3EG]10 and 
[(AG)3EG]20 fibrils, respectively (Figure 5.11).  
The effect of the surface on structure formation was assessed by using instead of mica 
more hydrophobic graphite surfaces (highly oriented pyrolytic graphite, HOPG). For the 
uncleaved [(AG)3EG]20-PEG-750 conjugate (4a) (Figure 5.12a), the interaction between the 
fibrils and the surface was weak, since the fibrils moved over the surface during the AFM 
measurements. For the cleaved [(AG)3EG]10-PEG-750 conjugate (Figure 5.12b and c) the fibrils 
had a twisted appearance, especially visible in the phase image. However, no major effect of the 
surface on the observed structures was observed. 
 
 
 
Figure 5.12 AFM measurement of fibrils on graphite showing height image of (a) uncleaved 
[(AG)3EG]20-PEG-750 conjugate and (b) cleaved [(AG)3EG]10-PEG-750 conjugate. (c) Phase 
image of cleaved [(AG)3EG]10-PEG-750 conjugate showing branching and an apparent twisted 
shape of the fibrils. 
 
AFM analysis of cyanogen bromide cleaved [(AG)3EG]10-PEG-2000 (7b) and [(AG)3EG]10-
PEG-5000 (7c) showed fibrillar microstructures for both conjugates (Figure 5.13a and b), in 
contrast to TEM measurements. Whereas for [(AG)3EG]10-PEG-2000 (7b), micrometer-long 
fibrils were observed, the fibrillar structure seemed to be less defined for [(AG)3EG]10-PEG-
5000 (7c). Furthermore, no fibrils were observed for [(AG)3EG]10-ε-maleimidocaproic acid (9) 
(Figure 5.13c), again confirming  that the formation of fibrils is a result of the presence of PEG. 
For the determination of fibrillar heights of the PEG-conjugates more diluted samples 
were applied to the mica surface. Long fibrils were still present for [(AG)3EG]10-PEG-2000 
(7b), but only short fibril fragments were observed for [(AG)3EG]10-PEG-5000 (7c). 
Presumably, conjugation of longer PEG-chains hinders the formation of long fibrils. A 
relatively broad distribution in the measured heights was obtained with values of 2.2 ± 0.3 and 
2.4 ± 0.9 nm for the PEG-2000 and PEG-5000 conjugates, respectively. This is in the same 
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range as measured for the PEG-750 conjugates. The width-at-half height values for both 
conjugates were 26.5 ± 1.2 nm, higher than for the PEG-750 conjugates. However, direct 
comparison of these results is not possible, since these measurements were not performed with 
the same tip.  
The difference in TEM and AFM observations for the PEG-2000 and PEG-5000 
conjugates can not be explained easily. As was already observed for the PEG-750 conjugate, 
clear visualization of the fibrillar structure was only obtained for the non-cleaved sample, where 
fibrils were aligned. Since the samples were applied to the surface for TEM and AFM analysis 
(carbon and mica, respectively) after crystallization (and presumably fibril formation) in a 
similar procedure, no major differences would be expected. It seems more likely that the 
resolution of TEM analysis was the limiting factor as a result of the grain size of the platinum 
particles used for shadowing. 
 
 
 
Figure 5.13 AFM analysis of microstructures of [(AG)3EG]10 conjugated with (a) PEG-2000, (b) 
PEG-5000 and (c) ε-maleimidocaproic acid. Height profiles are shown for (d) PEG-2000 and (e) 
PEG-5000 conjugates. All samples were cleaved with cyanogen bromide. Crystallized samples were 
diluted with methanol and dropcasted on mica (concentrations in the range 0.01 – 0.1 mg mL-1). 
 
5.2.4 Proposed model for fibril formation 
Based on the combined results from AFM and TEM measurements it can be stated that the 
formation of a fibrillar microstructure for these conjugates was shown to depend on the 
presence of PEG end-blocks. With the chosen crystallization method, the PEG blocks are 
expected to stay dissolved, since methanol is a good solvent for this polymer.[42] A possible 
arrangement of the triblock copolymers within the fibrils is depicted for PEG-conjugates of 
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[(AG)3EG]10 in Figure 5.14. Fibril formation occurs in the β-sheet stacking direction resulting 
in an assembly in which the hydrophobic β-sheet surfaces are shielded from methanol, whereas 
the PEG-chains are in contact with the solvent. Based on this model the expected values for the 
width of the [(AG)3EG]10 and [(AG)3EG]20 polypeptide blocks are 4.3 and 8.9 nm, 
respectively.[29] The radius of gyration of the PEG-chains can be estimated to be 0.8, 1.5 and 2.6 
nm for PEG-750, PEG-2000 and PEG-5000, respectively.[42] The total fibril width for the 
[(AG)3EG]10-PEG-750 and [(AG)3EG]20-PEG-750 conjugates can then be estimated to be ~ 7.5 
and 12.1 nm, respectively, when it is assumed that the PEG-chains can adopt a random coil 
structure. The fibrillar width or more accurately expressed, a repeating distance of ~ 12 nm 
could be measured for the [(AG)3EG]20-PEG-750 conjugate with TEM. These measurements 
together with the TEM data showing the smaller fibrillar width of [(AG)3EG]10-PEG-750 are 
supportive for the suggested assembly model. 
 
 
 
Figure 5.14 Proposed model for the organization of triblock copolymers of a central [(AG)3EG]10 
peptide block and PEG end blocks within fibrils. The model comprises folded β-sheets stacked 
along the z-axis, leading to fibril formation (perpendicular to the plane of the page). Antiparallel β-
strands are formed (x = hydrogen bonding direction, y = chain axis direction) with glutamic acid 
residues at the fibril surface. PEG chains hinder further lateral aggregation by preventing further 
hydrogen-bonding along the x-axis. Depending on the molecular weight of the PEG-chain used 
(with radius of gyration from ~ 8Å for PEG-750 to 26 Å for PEG-5000), widths of ~ 75 to 147 Å are 
expected. 
 
AFM analysis showed similar height values of ~ 2 nm for all conjugates of [(AG)3EG]10 and 
[(AG)3EG]20, which are in reasonable agreement with the calculated height of 2.8 nm[29], 
particularly when one takes into account that AFM measurements do not give absolute height 
values as a result of possible deformation caused by the tip’s pressure and the influence of air 
humidity.[41] For an alternative assembly arrangement, in which cylindrical instead of 
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rectangular fibrils are formed, as reported for PEG-conjugates of small β-sheet peptides by a 
number of research groups[24, 25], changing the PEG-chain length is expected to be reflected in 
the height values as measured by AFM. In our case we seem to be able to exclude such an 
arrangement, since no difference in height could be established for the varying PEG-conjugates. 
However, the length of the PEG-chains seems to have some effect on fibril formation. 
With a calculated width of the [(AG)3EG]10 polypeptide block of ~ 4.3 nm, it is clear that 
especially with PEG-5000 (radius of gyration of ~ 2.6 nm), the size of the PEG-chain is larger 
than the polypeptide structure. Although the model in Figure 5.14 suggests that the PEG-chains 
are only responsible for lining up the β-sheet polypeptides and prevent further aggregation in 
the hydrogen-bonding direction, it seems likely that blocking of aggregation also occurs in the 
β-sheet stacking direction. Fibril formation by β-sheet stacking will become more difficult with 
increasing PEG-content, resulting in shorter or less stable fibrils. 
Although for poly-[(AG)3EG] the confinement of glutamic acid residues at the lamellar 
surface was supported particularly by solid-state NMR spectroscopy data[43], for the PEG-
conjugates the decoration of the fibrillar surface with glutamic acid residues still has to be 
proven. The most straightforward way to test the model for fibril formation (Figure 5.14) is the 
preparation of polypeptides with an increasing number of consecutive alanylglycine repeats. 
The effect of this on fibril height can then be estimated by AFM. For example, fibril formed by 
PEG-conjugates of poly-[(AG)5EG] should have a calculated height of approximately 4.2 nm.  
In addition, the fibrillar width measured by TEM should increase with increasing 
number of -(AG)3EG- repeats. Diffraction experiments can furthermore give more information 
on the regular arrangement of the β-sheet polypeptide in the fibrils as well as possible 
crystallinity of the PEG-blocks after drying. X-ray diffraction measurements were carried out 
for [(AG)3EG]20 and its PEG-conjugate. However, no diffraction pattern was obtained, which 
could be the result of the use of insufficient material and/or lack of alignment within the 
sample. Electron diffraction on a selected area containing aligned fibrils will be the most 
suitable method for an unambiguous assignment of the direction of β-sheet hydrogen bonding 
relative to the fibril axis. 
 
5.3 Conclusions 
Methanol-induced crystallization of conjugates of poly-[(AG)3EG] and PEG resulted in folding 
of the polypeptide chains in an antiparallel β-sheet conformation, as was observed by infra-red 
spectroscopy. Conjugation of PEG did not have a significant effect on the polypeptide backbone 
conformation, since the values for the amide I and II vibrations were similar as for the 
polypeptide alone.[29]  Furthermore, it was shown that the attachment of PEG end blocks to a 
central poly-[(AG)3EG] β-sheet block prevents the macroscopic aggregation of the β-sheet 
blocks into needle-shaped lamellar crystals. Instead, crystallization resulted in well-defined 
fibrils. Microscopy data suggest an organization in which fibrils are formed in the β-sheet 
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stacking direction. The absolute control over the amino acid sequence might offer the 
possibility of introducing specific amino acid residues at the turns of the β-sheets, creating a 
regular array of functional moieties at the fibril surface. Patterning of the surface with different 
amino acid combinations might provide a method for positioning different chemical 
functionalities at the nanometer scale. 
 
5.4 Experimental section 
5.4.1 Crystallization experiments  
Crystallization was induced by vapour diffusion of methanol (p.a. Merck) into a solution of 1 or 
10 mg mL-1 of polypeptide or conjugate in 70% formic acid (Merck). This was achieved by 
placing an eppendorf tube with polypeptide or conjugate solution (100 µL) in a Duran bottle 
filled with 20 mL methanol. The bottle was closed and incubation was carried out for 2 days. 
 
5.4.2 Fourier transform infrared and circular dichroism spectroscopy  
Transmission-FTIR spectra were measured with a Thermo Mattson Genesis IR-300 
spectrometer using a deuterated triglycine sulphate detector (resolution, 4 cm-1; number of 
scans, 64). Samples were allowed to dry on the surface of the ATR-crystal prior to 
measurement. Circular dichroism spectroscopy was performed on a Jasco J-810 
spectropolarimeter (band width: 1nm, response: 1 sec., sensitivity: standard, λ range: 260-180 
nm, data pitch: 0.5 nm, scanning speed: 100 nm min.-1, accumulation: 5). 
 
5.4.3 Transmission electron microscopy studies  
All samples were prepared on copper specimen grids covered with a carbon support film 
(CF200-Cu; Electron Microscopy Sciences, Washington, USA). The grids were placed with the 
carbon film down on top of a 5 µl droplet of protein suspension (1 mg mL-1) in methanol or on a 
gel (10 mg mL-1) for 30 seconds. The grids were allowed to dry and were subsequently 
shadowed with platinum at an elevation angle of 45 degrees. Images were recorded using a 
JEOL JEM 1010 electron microscope (60 kV) equipped with a CCD camera. 
 
5.4.4 Atomic force microscopy studies  
Polypeptide or conjugate suspensions diluted with methanol to concentrations of 10 - 100 µg 
mL-1 were spincoated onto freshly cleaved mica surface. For Figure 5.12 and 5.13 dropcasting 
was used for applying the protein suspensions to graphite and mica, respectively. The 
morphologies of the samples were analyzed by means of tapping mode AFM using a 
Nanoscope IIIa instrument operating in air at room temperature. Height and phase images were 
recorded with microfabricated silicon cantilevers (length 100 mm and width 35 mm) having a 
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spring constant between 5.5 and 22.5 N m-1, using scan rates of 1 – 2 lines s-1 and a resolution 
of 512 × 512 pixels. 
It is well established that the width measured by AFM is a convolution of the actual size 
of the objects and that of the AFM tip. Obviously, the distortion is especially large for objects 
with a similar or smaller size as the AFM tip (with a typical radius of 10 nm). For rectangular 
objects (Figure 5.15a) the true width W* can be calculated from the observed width W with the 
equation W* = W – 2X, where X = {H(2R - H)}1/2.[44] Alternatively, the true width W* can be 
calculated from the measured width at half height W1/2 with the equation W* = W1/2 – 2X, 
where X = (RH – ¼H2)1/2. For spherical objects (Figure 5.15b) the observed width W is equal to 
4(Rr)1/2. R is the radius of curvature of the AFM tip and r is the radius of the measured 
object.[45] Therefore, the true radius of the sphere (r) can be calculated from the observed width 
W with the equation r = W2/(16R). Alternatively, the true radius can be calculated from the 
measured width at half height W1/2 with the equation r = (R2 + ¼W1/22)1/2 – R.[41] 
 
 
 
Figure 5.15 Widths measured by atomic force microscopy are a convolution of AFM tip size and 
the shape of the object. A schematic representation for (a) spherical and (b) rectangular objects is 
depicted. 
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Abstract 
The interaction between cell-surface carbohydrate ligands and protein receptors is important in 
many biological recognition events. Multivalent glycopolymers that mimic carbohydrate 
ligands can be potent inhibitors of carbohydrate-binding receptors. They are therefore 
considered as attractive drug candidates for certain disease states such as bacterial infections 
and chronic inflammation. Chemical syntheses of glycopolymers result in heterogeneous 
products with a limited control over the positioning of the saccharide epitopes. The protein 
engineering method can therefore be useful in the generation of monodisperse polypeptide 
scaffolds which can be functionalized with saccharide moieties at defined positions. Through 
the use of a polypeptide backbone with an α-helical conformation, it will be possible to place 
reactive handles at various spatial intervals along the axis of the helix and at defined sides of 
the helix. A design of such an α-helical polypeptide scaffold is described as well as attempts to 
produce this artificial polypeptide recombinantly in E. coli. 
For the design of an α-helical polypeptide scaffold amino acid residues were chosen 
with a high intrinsic propensity for the α-helical structure as well as amino acids with reactive 
handles for functionalization. An initial design with the repetitive amino acid sequence 
[(MAKA)2MAA]n (M = methionine, A = alanine and K = lysine) was made. In an α-helical 
conformation the methionine and lysine residues are located at opposing sides of the helical 
axis. The lysine residues can be directly used for the conjugation with saccharide residues, 
whereas replacement of methionine with the non-proteinogenic analogue 2-amino-5-hexynoic 
acid via the auxotroph methodology provides a handle for the highly efficient and 
chemoselective [3 + 2]-cycloaddition with azide-functionalized saccharides. 
Circular dichroism spectroscopy was carried out on small [(MAKA)2MAA]n 
polypeptides, with n = 1, 2 and 3 to determine whether the polypeptides adopted an α-helical 
conformation. Indeed, it was demonstrated that the sequence is prone to adopt this 
conformation. Although the percentage α-helix was low, it increased with increasing 
polypeptide length and pH, being 32% for [(MAKA)2MAA]3 at pH 12. The predicted higher α-
helical content of longer polypeptide scaffolds encouraged us to investigate the recombinant 
production of longer [(MAKA)2MAA]n polypeptides in E. coli. Unfortunately, bacterial 
expression of repetitive polymers of this sequence was unsuccessful. Although immunoblot 
analysis of expression of T7-tagged [(MAKA)2MAA]n (n = 6 and 12) suggested polypeptide 
expression, Ni-NTA purification was unsuccessful. Expression as a fusion with NusA, which is 
highly expressed in E. coli, was attempted. Unfortunately, after fusion of the repetitive 
[(MAKA)2MAA]n gene, no expression could be observed. 
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6.1 Introduction 
The creation of materials with structural control at the nanometer level has received increasing 
attention in the last decades. With modern lithography construction methods well-defined two-
dimensional structures in the order of 50 - 100 nm can nowadays efficiently be generated.[1, 2] 
Besides this ‘top-down’ procedure, a complementary approach is the build-up of materials from 
the ‘bottom-up’ through molecular self-assembly. Molecular self-assembly is characterized by 
the spontaneous and specific association of molecules as a result of multiple non-covalent 
interactions. The design of new nano-structured materials has been carried out, inspired by the 
design principles found in nature using a variety of building blocks, such as small molecules, 
lipids, DNA, proteins and peptides. Envisioned applications are, e.g. smaller computational 
devices, smart drug delivery systems and new tissue engineering scaffolds.[3, 4] 
Peptides and proteins are particularly attractive building blocks for the construction of 
new materials, since much is known about their folding behaviour and their interactions. In the 
field of materials design via protein and peptide assembly we can distinguish between two types 
of hydrogen-bonded structures, namely the α-helix and the β-sheet. Whereas in β-sheets 
hydrogen-bonding occurs between different β-strands, hydrogen-bonding in α-helices occurs 
internally. Because of this capacity to form intermolecular hydrogen bonds the field of materials 
science is more advanced for β-sheet-based and amyloid-like structures, since it enables the 
formation of all kinds of regular structures, like tapes, ribbons, tubes, fibrils and monolayers 
(see previous chapters).   
The study of assemblies based on the α-helix lags behind. Research in this field mainly 
focuses on the well-studied folding motif, the coiled coil. It was first described in 1953 by 
Pauling, Corey[5] and Crick[6] and is a common motif identified in a large variety of proteins 
such as keratins, myosin, DNA transcription factors and smaller peptides such as hormones and 
venoms.[7] A coiled coil is a bundle of α-helices that are wound into a left-handed superhelix. 
The coiled coil is characterized by the amino acid heptad repeating units designated as 
‘abcdefg’ with hydrophobic residues at position ‘a’ and ‘d’, and polar residues at the other 
positions. This arrangement of amino acid residues results in amphipathic α-helices with 
opposing polar and nonpolar faces oriented along the helix axis. This drives the association by 
excluding the hydrophobic surface from the aqueous environment and leads to the formation of 
coiled coils in general consisting of two to four helices with either parallel or antiparallel 
orientation. 
The self-assembly properties of the coiled coil motif have been used to prepare new 
fibrous materials. For example, mixing of two peptides designed to form “sticky ended” 
heterodimeric coiled coils resulted in micrometer-long fibres which are tens of nanometers thick 
(Figure 6.1a and b).[8, 9] The thickness of these fibres is larger than would be expected for a 
dimeric coiled coil (~ 2 nm), indicating that lateral assembly takes place. 
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Figure 6.1 (a) The sequences of two peptides forming sticky ended coiled coil dimers, where A 
complements D and B complements C, resulting in fibre formation.[8] (b) Transmission electron 
micrograph of coiled coil self-assembling fibres.[10] 
 
This concept has been worked out extensively using e.g. T-shaped or dendritic peptides, 
resulting in branched fibres and fibre networks.[11-15] Furthermore, hybrid diblock copolymers of 
coiled coil peptides and poly(ethylene glycol) have been prepared and their self-assembly in 
solution and in the solid state has been investigated.[16-18] 
Alternatively, coiled coils have been used for the preparation of hydrogels, which are 
interesting materials for their application in drug delivery and tissue engineering. Triblock 
copolymers consisting of a central polyelectrolyte domain with the repetitive sequence -
(AG)3PEG- and terminal coiled coil domains, were prepared via bacterial protein expression. 
Reversible gelation of this artificial polypeptide could be carried out by switching between the 
aggregated and dissociated state of the coiled coil domains via change in pH or temperature.[19, 
20] In a hybrid system, which exhibited a similar stimulus responsive gelation behaviour, coiled 
coil domains were bound via their His-tag to an iminodiacetate functionalized polyacrylamide 
polymer.[21] 
Besides coiled coil proteins, an example of another α-helical protein which has been 
prepared via protein engineering is poly(γ-benzyl α,L-glutamate) (PBLG).[22, 23] Monodisperse 
poly(α-L-glutamic acid) was prepared via bacterial expression and subsequently chemically 
modified to yield PBLG. Polydisperse PBLG prepared by N-carboxyanhydride (NCA) 
polymerization was known to form nematic liquid crystalline phases, characterized by 
orientational, but not positional molecular order.[24] However, solutions of the recombinantly 
produced polymer exhibited smectic liquid crystalline order. The equal chain length of this 
polymer resulted in ordering in layers, which is not possible with the polydisperse polymers.   
The sequence control of the protein engineering methodology was used for the 
preparation of artificial, helical glycopolymers with controlled placement of saccharide 
moieties.[25] Alanine-rich, repetitive protein polymers were prepared with glutamic acid residues 
placed at defined positions along the helical backbone.[26] The carboxylic acid group of the 
glutamic acid residues was then modified with the sugar β-D-galactosylamine. The multivalent 
presentation of galactose was shown to result in an increased binding to the galactose-binding 
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sites of the cholera toxin in comparison to monovalent galactose. This methodology allows a 
detailed investigation of saccharide number, saccharide spacing and polymer conformation on 
the binding properties of glycopolymers.[25, 26] 
These artificial glycopolymers could also be of interest as anti-inflammatory drugs.[27-29] 
The inflammatory response after injury, infection, or disease involves the recruitment of 
leukocytes from the bloodstream to damaged tissues or lymphoid organs.[30-32] Important 
mediators in this process are the “selectins”, which are transmembrane proteins present at the 
cell surface of leukocytes, endothelial cells and platelets. L-selectin, for example, is 
constitutively expressed on leukocytes and binds to cell adhesion molecules on activated 
endothelial cells. This is the first step of leukocyte migration into inflamed tissue.[33] Inhibition 
of L-selectin-mediated leukocyte recruitment is considered as a promising approach in the 
development of anti-inflammatory drugs for the treatment of chronic and acute inflammation 
diseases, where aggressive leukocyte migration is detrimental.[30, 34] The design of inhibitors can 
be inspired on the natural ligands for L-selectin. Several ligands that bind L-selectin have been 
identified, including glycosylated, extended polypeptides. One of these ligands, GlyCAM-1, is a 
heavily O-glycosylated protein that presents sulfated derivatives of the tetrasaccharide sialyl 
Lewis x (sLex).[35, 36] Inhibitors of L-selectin have therefore been designed that present multiple 
copies of the sulfated saccharide epitopes. Multivalent selectin inhibitors have demonstrated 
enhanced binding relative to their monomeric derivatives in cellular and cell free binding 
inhibition essays.[28] 
The design of the appropriate scaffold used for the display of saccharide units is 
important. Multivalent saccharide displays have been mimicked by the conjugation of 
saccharides to bovine serum albumin, to short synthetic polypeptides or to lipids.[37, 38] Other 
approaches are the use of small molecule templates that allow the attachment of a few 
carbohydrates[39-41] and spherical carbohydrate displays in the form of dendrimers (highly 
branched oligomers)[42] or liposomes[43]. However, the most popular method for generating 
multivalent ligands is through the free radical polymerization of modified acrylamides, resulting 
in linear carbohydrate displays.[44-47] Lack of control over polymer chain length is a 
disadvantage of this method. An improvement has been the use of ring-opening metathesis 
polymerization (ROMP).[48-51] ROMP can be carried out in polar solvents and protection of the 
carbohydrate residues is not required. The synthesized polymers have narrower polydispersities 
and can be end-capped with reporter groups for detection.[50] Although these investigations have 
given insights in specificity and avidity of multivalent interactions, a more quantitative 
understanding is complicated by the heterogeneity of the polymers and the lack of control over 
saccharide spacing. 
The protein engineering method can therefore be useful in the generation of 
monodisperse polypeptide scaffolds which can be functionalized with saccharide moieties at 
defined positions. Through the use of a polypeptide backbone with an α-helical conformation, it 
will be possible to place reactive handles at various spatial intervals along the axis of the helix 
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and at defined sides of the helix. In this chapter, a design of such an α-helical polypeptide 
scaffold is described as well as attempts to produce this artificial polypeptide recombinantly in 
E. coli. 
 
6.2 Results and discussion 
6.2.1 Helical peptide design 
For the design of an α-helical polypeptide scaffold amino acid residues had to be chosen with a 
high intrinsic propensity for the α-helical structure as well as amino acids with reactive handles 
for functionalization. Alanine (A) residues were used in positions where a reactive handle was 
not needed, since this amino acid is a good helix-former.[52, 53] Two amino acid residues, lysine 
(K) and methionine (M), were chosen for functionalization of the helix. Both of them have high 
helix-forming propensities. The primary amine-group of lysine can be readily used for a range 
of chemical modification reactions.[54] Methionine residues can be replaced by non-
proteinogenic analogues via the protein engineering approach.[55-58] Some of the methionine 
analogues that have been incorporated in proteins through the use of methionine auxotroph host 
strains are depicted in Figure 6.2a. One of the non-natural amino acids that can replace 
methionine in good efficiency is 2-amino-5-hexynoic acid. Its alkyne functionality can be used 
for a highly efficient and chemoselective reaction with azide-functionalized molecules via [3 + 
2]-cycloaddition (Figure 6.2b).[59, 60] 
 
 
 
Figure 6.2 (a) Some amino acid analogues that can replace methionine during in vivo protein 
synthesis. [55-58] (b) After incorporation of 2-amino-5-hexynoic acid into the polypeptide the alkyne 
functionality can be used for the highly efficient and chemoselective reaction with azide-
functionalized sugars via [3 + 2]-cycloaddition.[59, 60] 
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A design was made with the aim to incorporate lysine and methionine residues at opposing 
sides of the helical axis. Several amino acid sequences were tested with different orders and 
ratios of alanine, methionine and lysine by fitting them in perfect α-helix geometry using the 
“Macromodel” program. One of them, having the repetitive amino acid sequence  
[(MAKA)2MAA]n, fitted well with the criterium of aligned methionine and lysine residues 
which are located at opposing sides of the helical axis (Figure 6.3). With this initial design one 
alkyne functionality can, in principal, be incorporated at every helical turn (i.e. with spacings of 
~ 5.4 Å). At the other side of the helical axis lysine residues occupy approximately 2 of the 3 
turns. 
 
 
 
Figure 6.3 Model of the [(MAKA)2MAA]n  polypeptide (n =3). (a) side view (b) view along the helix 
axis. Methylene hydrogens have been omitted for clarity. 
 
Besides replacing the methionine residues with its 2-amino-5-hexynoic acid analogue, this 
residue can be used for immobilization of the polypeptide scaffold on a gold surface. Although 
its thioether group does not bind to gold as strongly as the more frequently used thiol group, this 
should be compensated by the presence of multiple interactions.[61, 62] This kind of 
immobilization could be used in surface plasmon resonance studies (SPR, Biacore).[63] With 
sugar moieties conjugated via the lysine residues, the resulting glycopolymer can be directly 
coated on the gold surface of the biosensor chip, without the requirement of performing 
immobilization chemistry. The interaction between the artificial glycopolymer and sugar-
binding proteins (lectins) can then be studied.[64] 
Based on these considerations the repetitive -(MAKA)2MAA- sequence was chosen as 
our model peptide for the construction of α-helical scaffolds. [(MAKA)2MAA]n oligopeptides  
were prepared via solid phase peptide synthesis and their secondary structure was investigated 
by circular dichroism spectroscopy (Paragraph 6.2.2). Furthermore, the feasibility of 
recombinant production of this sequence in E. coli was investigated (Paragraph 6.2.3). 
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6.2.2 Secondary structure determination of [(MAKA)2MAA]n polypeptides 
To determine whether the designed [(MAKA)2MAA]n polypeptide scaffold adopted an α-
helical structure, polypeptides consisting of one, two and three repeats (n = 1, 2 and 3) of this 
sequence were prepared by solid phase peptide synthesis. MALDI-TOF analysis of the 
synthesized polypeptides showed in addition to full-length polypeptide, some signal 
corresponding to polypeptides having an alanine or lysine deletion. The crude polypeptide 
product after cleavage from the resin was used for an initial indication of the secondary 
structure of this sequence. Circular dichroism (CD) spectroscopy was used for the 
determination of the conformation of [(MAKA)2MAA]n in solution. Figure 6.4a shows the 
effect of polypeptide chain length (n = 1, 2 and 3) on the secondary structure. The spectra were 
recorded at pH 12, which ensured a deprotonated state of the amine groups of the lysine 
residues. For n = 1 a spectrum typical of a random coil, with a minimum at 197 nm was 
observed. However, with increasing polypeptide chain length (n = 2 and 3) the CD spectra with 
two minima located at 222 nm and around 208 nm, became typical for the α-helical structure.[65] 
 
 
 
Figure 6.4 CD spectra of (a) [(MAKA)2MAA]n polypeptide for n = 1, 2 and 3 at pH 12 and (b) 
[(MAKA)2MAA]3 at varying pH. Spectra were recorded at 25 ºC at polypeptide concentrations of 
0.1 mg mL-1. 
 
The increased optical activity with increasing polypeptide chain length could be expected based 
on theoretical calculations; the mean residue ellipticity at 222 nm, [θ]222, was shown to vary 
linearly with the inverse of the number of amino acids.[66, 67] The helical content for the peptides 
can be estimated from the mean residue ellipticity at 222 nm with the equation,                 
%Helix = [θ]222 /{-61000(1 – 2.5/n)}, where n is the number of amino acids.[68] The use of this 
equation results in a helical content of 3, 18 and 32% for peptides containing one, two and three 
repeats of the -(MAKA)2MAA- sequence, respectively. The dependence of the secondary 
structure on pH for [(MAKA)2MAA]3 is depicted in Figure 6.4b. With a decreasing pH, the 
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random coil character increased at the cost of the α-helical secondary structure, as would be 
expected when the lysine residues become protonated. These results clearly indicate that the 
designed sequence is prone to adopt an α-helical conformation. The low helical contents can be 
expected for these relatively short polypeptides, since the stabilizing interactions do not 
compensate the entropic cost associated with the folding of the polypeptide chain. Furthermore, 
since the synthesized polypeptides are not protected with uncharged groups (e.g. by N-terminal 
acetylation and C-terminal amidation), electrostatic repulsion between the charged ends and the 
helix macrodipole takes place. This results in helix destabilization.[69] 
However, the helical content is expected to increase with increasing peptide length.[68, 70] 
Using the algorithm “Agadir” which predicts the helical behaviour of monomeric peptides, the 
effect of polypeptide length on α-helix percentage was calculated.[71, 72] For [(MAKA)2MAA]n 
polypeptides, where n = 3, 6 and 12, an average helix content of respectively 34, 74 and 87% 
was calculated. The helix content at the residue level for these polypeptides is depicted in 
Figure 6.5. This indicated that higher plateau values are reached for longer polypeptides and a 
value of up to 100% is reached for n = 12. The predicted higher α-helical content of longer 
polypeptide scaffolds encouraged us to investigate the recombinant production of longer 
[(MAKA)2MAA]n polypeptides in E. coli. 
 
 
 
 
Figure 6.5 Prediction of α-helix content at the residue level for polypeptides with the repetitive 
sequence [(MAKA)2MAA]n of varying length (n = 3, 6, 12). The prediction algorithm     
“Agadir”[71, 72] was used with the following settings: free N- and C-termini, T = 298 K, pH 7.0, 
[NaCl] = 0.1 M. 
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6.2.3 E. coli expression of [(MAKA)2MAA]n polypeptides 
To determine whether bacterial expression would be a suitable method for production of protein 
polymers consisting of repeats of the α-helical -(MAKA)2MAA- sequence, synthetic genes 
coding for this sequence were constructed. The cloning strategy used was analogous as 
described for poly-[(AG)3EG] (Chapter 3, paragraph 3.1) and is described in the experimental 
section. Artificial genes were built up encoding 6 and 12 repeats of the -(MAKA)2MAA- 
sequence. The target polypeptide sequence is depicted in Figure 6.6. It contains a T7- and a 6 × 
His-tag for immunoblot analysis and purification, respectively. Furthermore, the acid-labile 
aspartyl-prolyl bond allows removal of the tags to result in a polypeptide consisting 
predominantly of the (MAKA)2MAA sequence.[73] 
 
 
 
Figure 6.6 Target sequence of [(MAKA)2MAKA]n polypeptide. The acid-labile aspartyl-prolyl 
peptide bond allows removal of the N-terminal T7 and 6 × His tag. 
 
The expression of the polypeptides in E. coli BL21(DE3)pLysS was followed by SDS-PAGE. 
Coomassie staining did not reveal the presence of overexpressed bands. Immunoblot analysis 
with T7-tag antibodies showed the presence of multiple bands for both 6 and 12 repeats of the -
(MAKA)2MAA- sequence after induction with IPTG (Figure 6.7). Whereas for 
[(MAKA)2MAA]6, the lowest band could correspond to the desired polypeptide with an 
expected molecular weight of 9.5 kDa, an additional band at 14 kDa was visible. Furthermore, 
signal was observed at high molecular weight, in the form of product which did not migrate into 
the ‘separating gel’. Also for [(MAKA)2MAA]12, bands were observed at 14 kDa and at high 
molecular weight. The expected molecular weight of this polypeptide is 15.9 kDa. Purification 
of the expressed polypeptides was attempted using Ni-NTA chromatography under denaturing 
conditions. Unfortunately, dot blot analysis with T7-tag antibodies showed that only signal was 
present in the flow-through (8 M urea, pH 8.0) and the wash fraction (8 M urea, pH 6.3), but not 
in the elution fractions (8 M urea, pH 5.9 and 4.5) (data not shown). A possible explanation is 
that, due to its cationic nature, the polypeptide only weakly binds the Ni-NTA beads. However, 
also in an alternative purification procedure using agarose beads functionalized with T7-tag 
monoclonal antibodies, no binding seemed to occur. 
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Figure 6.7 T7-tag immunoblot analysis of expression of polypeptides with the sequence 
[(MAKA)2MAA]n for (a) n = 6 and (b) n = 12. Expression was carried out in E. coli 
BL21(DE3)pLysS cells at 37  °C. Expression was induced by the addition of IPTG to a final 
concentration of 0.4 mM. 
 
In an alternative approach, it was attempted to express the [(MAKA)2MAA]n sequence as a 
fusion protein. The protein NusA (N utilization substance A; 66 kDa) was chosen a fusion 
partner, since it can be highly expressed in E. coli in the soluble form.[74] Although relatively 
large in comparison to the desired polypeptide, it was a good way to determine the effect of the 
[(MAKA)2MAA]n sequence on the expression level. In addition, experiments with the synthetic 
[(MAKA)2MAA]3 peptide suggested that this peptide could be toxic to E. coli cells when added 
to the culture medium (data not shown). Similar amphipathic helical peptides have been shown 
to have antimicrobial activity ascribed to their ability to form pores in the lipid bilayer.[75-77] 
Fusion with a large protein might prevent this. Furthermore, the host strain Rosetta(DE3)pLysS 
was used which contains a plasmid carrying among others the methionyl tRNA gene. 
Insufficient tRNA is known to result in translation problems, which could play a role in the 
expression of [(MAKA)2MAA]n because of the relatively high methionine content of this 
sequence. The production of additional methionyl tRNA might be a solution for expression 
problems.[78] 
The fusion protein consisted of an N-terminal NusA protein, followed by a 6 × His-tag 
and the target polypeptide (Figure 6.8a). Figure 6.8b shows the SDS-PAGE analysis of the 
expression and Ni-NTA purification of NusA and its fusion with [(MAKA)2MAA]n (n = 6 and 
12). Whereas for NusA alone (66 kDa) clear expression was observed, no overexpressed bands 
could be observed for both fusions (69 and 75 kDa). Using Ni-NTA chromatography, 
substantially purified NusA protein was obtained, whereas for the [(MAKA)2MAA] fusion 
proteins only weak bands were observed around the expected molecular weight. These were 
however not shifted upwards relative to NusA alone, which would be expected to be visible at 
least for [(MAKA)2MAA]12. Thus, fusion of the [(MAKA)2MAA] sequence to the highly 
expressed NusA protein resulted in loss of overexpression. No further experiments have been 
 Chapter 6 
 -130- 
performed to determine whether low level expression of these fusion proteins had occurred. The 
possibility that the fusion proteins were produced in an insoluble form and did not migrate into 
the gel should be verified as well. 
 
 
 
Figure 6.8 (a) Target NusA fusion proteins. (b) SDS-PAGE analysis of expression and native Ni-
NTA purification of NusA and its fusions with the repetitive polypeptides [(MAKA)2MAA]6 and 
(MAKA)2MAA]12 (lys = soluble lysate, ft = column flow-through, w1/w2 = column wash and el = 
elution). 
 
6.3 Conclusions 
The short polypeptides with the sequence [(MAKA)2MAA]n (n = 1, 2 and 3), which were 
prepared by solid phase peptide synthesis, were shown to be prone to adopt an α-helical 
conformation. The α-helical content was shown to increase with increasing peptide length and 
pH. Although an α-helical content of 32% was still low for [(MAKA)2MAA]3, it was expected 
to increase significantly for longer polypeptides. 
However, the recombinant production of longer polypeptides in E. coli was 
unsuccessful. Although immunoblot analysis seemed to suggest the expression of the T7-tagged 
[(MAKA)2MAA]n polypeptide (n = 6 and 12), no binding to Ni-NTA agarose beads was 
observed. Fusion of the repetitive genes to the 3’-end of the highly expressed NusA gene, 
resulted in loss of overexpression. Although methionine-rich repetitive proteins have been 
expressed in E. coli[79], expression and purification of this specific sequence has not been 
successful. 
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6.4 Experimental section 
6.4.1 Materials 
The synthetic oligonucleotides were obtained from Isogen. The vectors pBluescriptII® SK(-) 
and pET-3b and E. coli strain XL1-Blue were obtained from Stratagene. The vector pET-43.1b 
and the E. coli strains BL21(DE3)pLysS and Rosetta(DE3)pLysS were from Novagen. 
Restriction endonucleases (Gibco/New England Biolabs), T4 polynucleotide kinase (Gibco), T4 
DNA ligase (Promega), calf intestine phosphatase (New England Biolabs) were used as 
recommended by the manufacturers. Plasmid midiprep kits and Qiaquick® gel extraction kits 
were from Qiagen. Isopropyl-β-D-thiogalactopyranoside (IPTG) and phenylmethanesulphonyl 
fluoride (PMSF) were purchased from Sigma. Ni-NTA agarose beads were obtained from 
Qiagen. The T7-tag Lumiblot™ Kit was from Novagen. Sinapinic acid was from Sigma. 
 
6.4.2 General methods 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analysis. SDS-
PAGE was performed using 15% resolving gels according to standard procedures.[80] Typically, 
cell pellets obtained from 0.5 mL cell culture were resuspended in (OD600 × 100) µl and heated 
for 5 min at 95 °C. 10 µL of this sample was loaded on gel. For immunoblot analysis transfer to 
a nitrocellulose membrane was carried out, followed by T7-tag immunoblot analysis using the 
‘T7-tag® Lumiblot™ Kit’, according to the manufacturer’s instructions. 
MALDI-TOF mass spectrometry. Spectra were measured on a Bruker Biflex III spectrometer. 
Freeze-dried products were dissolved in 1:1 (v/v) water:acetonitrile with 0.1% trifluoroacetic 
acid to a final concentration of 10 mg mL-1 and mixed in a 1:1 ratio with a solution of 20 mg 
mL-1 of sinapinic acid in the same solvent and spotted on a MALDI-plate. 
 
6.4.3 Synthetic [(MAKA)2MAA]n peptides 
The synthetic peptides with the sequence [(MAKA)2MAA]n (n = 1, 2 and 3) were synthesized 
by Hans Adams by solid phase peptide synthesis on a trityl resin using an Fmoc strategy. 
MS (MALDI-TOF) H-[(MAKA)2MAA]n-OH:  
n = 1: C45H84N13O12S3 [M + H]+: calc. mass 1094.5 Da, found m/z = 1093.8 Da, [M + Na]+: 
calc. mass 1116.5 Da, found m/z = 1115.8 Da. In addition to full-length product, peptides with 
the following deletions were found: Alanine deletion [M + H]+: calc. mass 1023.5 Da, found 
m/z = 1022.8 Da. Lysine deletion [M + H]+: calc. mass 966.5 Da, found m/z = 965.7 Da.  
n = 2: C90H166N26O23S6 [M + H]+: calc. mass 2170.1 Da, found m/z = 2169.3 Additional signals: 
m/z = 2098.3 (- alanine) and 2060.3 Da (not assigned).  
n = 3: C135H245N39O34S9 [M + H]+ calc. mass 3245.6 Da, found m/z = 3245.6 Da. Additional 
weak signals: m/z = 3117.3 (- lysine) and 2991.6 Da (not assigned). 
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6.4.4 Circular dichroism spectroscopy 
Circular dichroism spectroscopy was performed on a Jasco J-810 spectropolarimeter (band 
width: 1nm, response: 1 s, sensitivity: standard, λ range: 260 - 180 nm, data pitch: 1 nm, 
scanning speed: 100 nm min-1, accumulation: 1) in a 1 mm quartz cuvette. Measurements were 
carried out at a concentration of 0.1 mg mL-1. Dissolution of the peptides in demi-water (milli-
Q) resulted in a pH of 3.5. The pH was adjusted to pH 10 and 12, respectively, by the addition 
of a NaOH solution. The peptides were dissolved in 20 mM NaH2PO4 buffer, pH 7.7 for 
measurement at this pH. Measurements were performed at 25 ºC. The mean residue ellipticity, 
[θ] in deg cm2 dmol-1, was calculated from 
 
[θ] = (θ × MW) / (10 × l × c × n)     (1) 
 
where θ is the ellipticity measured in mdeg, MW is the molecular weight in g mol-1, l is the 
optical path length of the cell in cm, c is the concentration of the sample in mg mL-1 and n is the 
number of amino acid residues. 
 
6.4.5 Construction of expression vectors with genes coding for [(MAKA)2MAA]n 
The double-stranded oligonucleotide 1 coding for 2 repeats of the sequence (n = 2) is depicted 
below. Annealing was carried out as described in Chapter 3, Paragraph 4.3. 
 
 
 
A cloning vector was constructed for insertion of this oligonucleotide. Thereto, EcoRI/BamHI 
digested pBluescriptII® SK(-) was ligated with the double-stranded oligonucleotide 2, depicted 
below, resulting in the vector pSK-RT. 
 
 
 
This vector was digested with BspMI and dephosphorylated with calf intestine phosphatase. 
The linearized vector was ligated with oligonucleotide 1 and the sequence of this construct, 
designated as pSK-RT-MAKA2, was confirmed. For further multimerization, this vector was 
digested with BspMI. The 66 bp oligonucleotide was isolated from agarose gel and 
multimerized by T4 DNA ligase. After 1.5 hours of ligation, BspMI digested and 
dephosphorylated pSK-RT was added and ligation was continued overnight. Via this procedure 
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cloning vectors were obtained carrying 6 and 12 repeats of the -(MAKA)2MAA- sequence 
(designated as pSK-RT-MAKA6 and pSK-RT-MAKA12). These vectors were digested with 
BamHI, followed by ligation of the genes with the BamHI digested and dephosphorylated 
expression vector pET-3b or pET-43.1b. 
 
6.4.6 Expression and purification of T7-tagged [(MAKA)2MAA]n polypeptides 
The expression vectors pET-3b-RT-MAKA6 and pET-3b-RT-MAKA12 (coding for 6 and 12 
repeats of the -(MAKA)2MAA- sequence, respectively) were transformed into the E. coli  strain 
BL21(DE3)pLysS. A typical starter culture of 50 mL 2 × YT medium, containing 200 µg mL-1 
ampicillin and 30 µg mL-1 chloramphenicol, was inoculated with a single colony from a fresh 
agar plate and incubated overnight at 37 °C with shaking (300 rpm). After centrifugation at 
3000 g for 15 min at 4 °C, the pellet was resuspended in 5 mL 2 × YT medium. This was used 
for inoculation of 500 mL 2 × YT medium (200 µg mL-1 ampicillin and 30 µg mL-1 
chloramphenicol) to give an OD600 of 0.1. Incubation was carried out at 37 °C with shaking 
(300 rpm) and expression was induced with IPTG (0.4 mM), when an OD600 of ~ 0.8 was 
reached. The cells were harvested 4 hours after induction by centrifugation at 3000 g for 15 min 
at 4 °C and the pellet was stored at -80 °C.  
The pellets were resuspended in lysis buffer (8 M urea, 100 mM NaH2PO4, 10 mM 
Tris.HCl, pH 8.0) at 5 mL per gram wet weight. The cells were stirred for 30 min at room 
temperature. The lysate was centrifuged at 10000 g for 30 min at room temperature and the 
supernatant was loaded on a 1 mL Ni-NTA column. The column was washed subsequently with 
10 mL wash buffer (8 M urea, 100 mM NaH2PO4, 10 mM Tris.HCl, pH 6.3). Elution was 
carried out using subsequently 5 mL elution buffer, pH 5.9 and 5 mL elution buffer, pH 4.5 (8 
M urea, 100 mM NaH2PO4, 10 mM Tris.HCl). 
 
6.4.7 Expression and purification of NusA fusion proteins 
The plasmids pET-43.1b, pET-43.1b-RT-MAKA6 and pET-43.1b-RT-MAKA12 were used for 
transformation of E. coli strain Rosetta(DE3)pLysS. A single colony was used to inoculate 50 
mL 2 × YT medium containing 200 µg mL-1 ampicillin, 30 µg mL-1 chloramphenicol and 1% 
glucose. After growth overnight at 30 °C, the cells were centrifuged at 4000 rpm for 15 min at 4 
ºC. The pellet was resuspended in 5 mL 2 × YT and used to inoculate 50 mL 2 × YT medium 
(200 µg mL-1 ampicillin and 30 µg mL-1 chloramphenicol) to give an OD600 of 0.1. This culture 
was grown at 37 °C (230 rpm) and expression was induced with IPTG (0.4 mM), when an 
OD600 of ~ 0.8 was reached. Every hour a 1 mL sample was taken and centrifuged at 8000 rpm 
for 5 min. The pellet was stored at -20 °C for analysis by SDS-PAGE. The cells were harvested 
4 hours after induction by centrifugation at 3000 g for 15 min at 4 °C and the pellet was stored 
at -80 °C.  
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Pellets were resuspended in 5 mL lysisbuffer (50 mM NaH2PO4 (pH8.0), 300 mM NaCl, 
1 mM PMSF, 10 mM imidazole) and sonicated on ice for 1 min (250 W Branson sonicator, 
50% duty cycle). The lysate was centrifuged at 10000 g for 30 min. at 4 °C. The soluble 
fraction was used for native Ni-NTA purification at 4 °C. This was carried out using disposable 
columns (BioRad) filled with 100 µL equilibrated Ni-NTA agarose beads. The lysate was 
loaded on the column and allowed to empty by gravity. The beads were then subsequently 
washed with 1 mL lysisbuffer and 1mL washbuffer (50 mM NaH2PO4 (pH8.0), 300 mM NaCl, 
1 mM PMSF, 20 mM imidazole). Elution was carried out by the addition of 300 µL elution 
buffer (50 mM NaH2PO4 (pH8.0), 300 mM NaCl, 1 mM PMSF, 200 mM imidazole). 
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Summary 
The synthesis of macromolecules of well-defined length, composition and end-group 
functionality is of utmost importance in polymer chemistry. Although substantial progress has 
been made in this area, the biological synthesis of macromolecules, such as proteins and DNA, 
is unsurpassed. For proteins, the amino acid sequence determines polypeptide folding and 
assembly into supramolecular structures. The level of complexity in the assembly of proteins 
has not been equaled by synthetic systems, such as block copolymers. Protein-like self-
assembly has therefore become a popular strategy for the preparation of materials with ordening 
at the nanometer scale. 
This thesis describes the recombinant production of artificial, periodic polypeptides that 
form regular β-sheet structures. These polypeptides have the repetitive amino acid sequence 
[(AG)3EG]n (A = alanine, G = glycine and E = glutamic acid). The repeating alanylglycine 
(AG) sequence is also found in silk of the domesticated silk worm Bombyx mori and is part of 
the crystalline β-sheet domains, which are responsible for the strength of the silk fiber. By the 
presence of bulky, polar glutamic acid residues (E) at regular distances the β-strand structure is 
disturbed. Crystallization of these artificial polypeptides results in a regular folding with 
polypeptide chains folding back on themselves at the position of the glutamic acid residues. 
This results in an antiparallel β-sheet structure with alanylglycine repeats in the extended β-
strands and glutamic acid residues in the turns (Figure 1). 
 
 
 
Figure 1. The formation of an antiparallel β-sheet structure by a polypeptide with the repetitive 
amino acid sequence [(AG)3EG]n in the solid phase. The alanylglycine (AG) repeats form 
antiparallel β-strands. The glutamic acid residues are located at the turns. 
 
Although folding of these polypeptides is controlled, crystallization results in large aggregates. 
The structure information in the polypeptide sequence, such as height and width of the β-sheet 
structures is lost in the aggregation process. To avoid this “hybrid” block copolymers were 
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synthesized, in which the aggregating β-sheet polypeptide block is flanked on both sides by a 
non-aggregating poly(ethylene glycol) (PEG) block. This thesis describes subsequently the 
recombinant production of repetitive β-sheet polypeptides (Chapter 3), the synthesis of hybrid 
block copolymers (Chapter 4), and the physical characterization of these block copolymers 
(Chapter 5). These chapters are preceded by a literature overview of synthetic methods for the 
preparation of hybrid block copolymers and their potential applications (Chapter 2). Moreover, 
Chapter 6 describes efforts made for the recombinant production of repetitive α-helical 
polypeptides, which could be useful for the preparation of well-defined glycopolymers. 
The construction of artificial genes coding for polypeptides with the repetitive sequence 
[(AG)3EG]n is described in Chapter 3. The expression of these polypeptides in E. coli was 
carried out via a number of strategies. Polypeptides consisting of 10 to 50 repeats of the -
(AG)3EG- sequence were effectively produced as fusion proteins with glutathione-S-transferase 
(GST, 26 kDa). The expression of the fusion protein GST-[(AG)3EG]20 resulted in a yield of 
approximately 80 mg per liter of culture. After proteolytic cleavage of the fusion-protein with 
thrombin, the polypeptide [(AG)3EG]20 was separated from GST by reversed phase 
chromatography, resulting in a yield of approximately 20 mg [(AG)3EG]20 per liter of culture. 
In an alternative approach [(AG)3EG]n (n = 10, 20, 30) was produced with the T7 bacteriophage 
expression system (pET). The polypeptide [(AG)3EG]20 was produced without the presence of a 
fusion partner. Besides complete polypeptide truncated polypeptide was formed, which could 
be removed with reversed phase chromatography. The yield was also approximately 20 mg per 
liter of culture. The advantage of this method was that no proteolytic cleavage was necessary 
and that removal of the N and C termini could be carried out directly by cyanogen bromide 
cleavage. 
Also the expression of a polypeptide with the repetitive sequence [(AG)3KG]n is 
described. The expression of this polypeptide was carried out with the aim to use the lysine 
residues for functionalization with e.g. mesogenic groups to obtain liquid crystalline materials. 
However, the production was complicated by the sensitivity of this sequence to proteolysis. The 
polypeptide [(AG)3KG]24 was purified directly after expression by Ni-NTA chromatography. 
Polypeptides with the complete repetitive part were separated from the truncated polypeptides 
by gel filtration chromatography and a yield of approximately 2 mg per liter of culture was 
obtained. 
The synthesis and chemical characterization of block copolymers consisting of the 
polypeptide block [(AG)3EG]n flanked on both sides by a PEG block is described in Chapter 4. 
The polypeptides [(AG)3EG]10 and [(AG)3EG]20 were expressed in E. coli. Besides complete 
polypeptide also truncated polypeptides were formed (from N terminus to approximately 6 -
(AG)3EG- repeats). The polypeptide [(AG)3EG]10 was produced in erlenmeyer cultures and 
purified with Ni-NTA chromatography. The complete polypeptide was separated from the 
truncated product using gel filtration chromatography. The yield was approximately 6 mg per 
liter of culture. The polypeptide [(AG)3EG]20 was produced with high cell density fermentation 
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(HCDF) and purified with subsequently Ni-NTA chromatography, heat precipitation and 
reversed phase chromatography. The yield was approximately 10 mg polypeptide per liter of 
culture. HCDF was unfortunately not successful in the production of larger quantities of 
polypeptide, since the amount of expressed polypeptide per cell was clearly lower (5 – 50 
times) in HCDF than in erlenmeyer cultures. 
The cysteine residues on both sides of the polypeptides [(AG)3EG]10 and [(AG)3EG]20 
were used for the coupling of maleimide functionalized PEG (Figure 2). The polypeptide 
[(AG)3EG]20 was coupled to PEG-750 (Mn = 750 g mol-1). For the polypeptide [(AG)3EG]10 
conjugation was carried out to PEGs with various lengths (Mn = 750, 2000 and 5000 g mol-1). 
The coupling was carried out subsequently by (1) reduction of the cysteine residues with 
dithiothreitol (DTT), (2) removal of DTT by precipitation of the polypeptide with 
trichloroacetic acid, (3) coupling of an excess maleimide functionalized PEG, (4) purification of 
the block copolymer with Ni-NTA chromatography and (5) removal of the non-repetitive ends 
of the polypeptide by cyanogen bromide cleavage. Mass spectrometry showed that the main 
product was polypeptide functionalized with two PEG chains. 
 
 
Figure 2. Block copolymer consisting of the β-sheet polypeptide poly-[(AG)3EG] flanked by PEG 
end blocks. Cysteine residues on both sides of the polypeptide block were used for conjugation of 
maleimide functionalized PEG (n = 17, 47, and 115). 
 
Chapter 5 describes the physical characterization of the block copolymers described in Chapter 
4. After crystallization the secondary structure of the polypeptide block was characterized with 
infra-red spectroscopy. Thereto the frequencies in the amide I (predominantly C=O stretch 
vibration) and the amide II (predominantly NH-bend vibration) area were used. The 
predominant absorption bands had frequencies of ~ 1625 cm-1 for amide I and ~ 1520 cm-1 for 
amide II. These frequencies are typical for an antiparallel β-sheet conformation of the 
polypeptide block. These were the predominant absorption bands for both the polypeptide alone 
as well as for the PEG-conjugates. With longer PEG-chains the absorption band around 1655 
cm-1 became relatively stronger, indicating that the fraction of the polypeptide chain in the β-
sheet conformation decreased. 
The microstructure of the block copolymers was analyzed by transmission electron 
microscopy (TEM). It was shown that the block copolymers formed fibrils, whereas this 
fibrillar structure was not present for the polypeptides without conjugated PEG. The fibrils for 
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the block copolymer [(AG)3EG]20-PEG-750 had a width of approximately 12 nm (Figure 3). 
For the block copolymer [(AG)3EG]10-PEG-750 (where the polypeptide block has half of the 
length) no fibrils were visible with TEM. Atomic force microscopy (AFM) was carried out on 
samples applied to a mica surface. From this it was clear that crystallization of the block 
copolymer [(AG)3EG]10-PEG-750 also resulted in fibril formation. The height of the fibrils was 
approximately 2 nm for both [(AG)3EG]10-PEG-750 as well as [(AG)3EG]20-PEG-750. For the 
polypeptide [(AG)3EG]10 conjugated to PEG-2000 a clear fibrillar structure was present, 
whereas for the conjugate with PEG-5000 the fibrils were less defined and only short fibril 
fragments were present. 
 
 
 
Figure 3. Electron microscopy images of the crystallized block copolymer [(AG)3EG]20-PEG-750. 
The scale bar represents 200 nm. 
 
A possible ordening of the block copolymers within the fibrils was proposed based on TEM and 
AFM results. The model consists of a stack of β-sheets along the length-axis of the fibrils. The 
hydrogen-bond direction is perpendicular to the length-axis of the fibrils. The PEG-chains 
prevent a side-to-side aggregation of the fibrils. Diffraction data are, however, required for a 
direct evidence of this model.  
Chapter 6 describes the design of an α-helical polypeptide for the preparation of well-
defined glycopolymers. The interaction between cell-surface carbohydrate ligands and protein 
receptors is important in many biological recognition events. Multivalent glycopolymers that 
mimic carbohydrate ligands can be potent inhibitors of carbohydrate-binding receptors. They 
are therefore considered as attractive drug candidates for certain disease states such as chronic 
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and acute inflammations. Chemical syntheses of glycopolymers result in heterogeneous 
products with a limited control over the positioning of the saccharide epitopes. The recombinant 
production method can therefore be useful in the generation of monodisperse polypeptides 
which can be functionalized with saccharide moieties at defined positions. Through the use of a 
polypeptide backbone with an α-helical conformation, it will be possible to place reactive 
handles at various spatial intervals along the axis of the helix and at defined sides of the helix. 
A design of such an α-helical polypeptide is described as well as attempts to produce this 
artificial polypeptide recombinantly in E. coli. 
For the design of an α-helical polypeptide amino acid residues were chosen with a high 
propensity for the α-helical conformation as well as amino acids with reactive handles for 
functionalization. An initial design with the repetitive amino acid sequence [(MAKA)2MAA]n 
(M = methionine, A = alanine and K = lysine) was made. In an α-helical conformation the 
methionine and lysine residues are located at opposing sides of the helical axis. The lysine 
residues can be directly used for the conjugation with saccharide residues, whereas replacement 
of methionine with the non-proteinogenic analogue 2-amino-5-hexynoic acid via the auxotroph 
methodology provides a handle for the highly efficient and chemoselective [3 + 2]-
cycloaddition with azide-functionalized saccharides. 
Circular dichroism spectroscopy was carried out on small [(MAKA)2MAA]n 
polypeptides, with n = 1, 2 and 3 to determine whether the polypeptides adopted an α-helical 
conformation. Indeed, it was demonstrated that the sequence is prone to adopt this 
conformation. Although the percentage α-helix was low, it increased with increasing 
polypeptide length and pH, being 32% for [(MAKA)2MAA]3 at pH 12. The predicted higher α-
helical content of longer polypeptides encouraged us to investigate the recombinant production 
of longer [(MAKA)2MAA]n polypeptides in E. coli. Unfortunately, bacterial expression of 
repetitive polymers of this sequence was unsuccessful. Although immunoblot analysis of 
expression of [(MAKA)2MAA]n (n = 6 and 12) with an N-terminal T7-tag suggested 
polypeptide expression, Ni-NTA purification was unsuccessful. Expression as a fusion with 
NusA, a protein that can be highly expressed in E. coli, was attempted. Unfortunately, after 
fusion of the repetitive [(MAKA)2MAA]n gene, no expression could be observed. 
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Samenvatting 
In de polymeerchemie is de synthese van macromoleculen met een goed gedefinieerde lengte, 
compositie en eindgroepfunctionaliteit uiterst belangrijk. Hoewel grote vooruitgang op dit 
gebied is geboekt, is de biologische synthese van macromoleculen, zoals eiwitten en DNA, 
onovertroffen. Voor eiwitten bepaalt de aminozuurvolgorde de vouwing van de 
polypeptideketen en de assemblage van eiwitten tot supramoleculaire structuren. De mate van 
complexiteit in de assemblage van eiwitten is niet geëvenaard door synthetische systemen, zoals 
blok copolymeren. Eiwit-gebaseerde assemblage is daarom een belangrijke strategie in de 
synthese van materialen met structuur op de nanometer schaal. 
Dit proefschrift beschrijft de recombinante productie van kunstmatige, periodieke 
polypeptiden die regelmatige β-plaat structuren vormen. Deze polypeptiden hebben de 
repetitieve aminozuurvolgorde [(AG)3EG]n (A = alanine, G = glycine en E = glutaminezuur). 
De zich herhalende alanylglycine (AG) sequentie komt ook voor in zijde van de 
gedomesticeerde zijderups Bombyx mori en maakt daar onderdeel uit van de kristallijne β-plaat 
domeinen, die verantwoordelijk zijn voor de sterkte van de zijdevezel. Door nu op regelmatige 
afstand grote, polaire glutaminezuur residuen (E) in te bouwen wordt de β-streng structuur 
verstoord. Kristallisatie van deze kunstmatige polypeptiden resulteert in een regelmatige 
vouwing waarbij de polypeptideketen op zichzelf terugvouwt ter plaatse van de glutaminezuur 
residuen. Hierdoor ontstaat een antiparallele β-plaat structuur met alanylglycine herhalingen in 
de uitgestrekte β-strengen en glutaminezuur residuen in de bochten (Figuur 1). 
 
 
 
Figuur 1. De vorming van een antiparallelle β-plaat structuur door een polypeptide met de 
repetitieve aminozuurvolgorde [(AG)3EG]n in de vaste fase. The alanylglycine (AG) herhalingen 
vormen antiparallelle β-strengen. De glutaminezuur residuen zijn gelocaliseerd in de bochten. 
 
Hoewel voor deze polypeptiden de vouwing gecontroleerd is, leidt kristallisatie tot grote 
aggregaten. De structuurinformatie in de polypeptide sequentie, zoals de hoogte en de breedte 
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van de β-plaat structuren gaat verloren in het aggregatieproces. Om dit te voorkomen werden 
“hybride” blok-copolymeren gesynthetiseerd, waarbij het aggregerende β-plaat polypeptide 
blok aan beide zijden wordt geflankeerd door een niet-aggregerend poly(ethyleenglycol) (PEG) 
blok. In dit proefschrift wordt achtereenvolgens de recombinante productie van repetitieve β-
plaat polypeptiden (Hoofdstuk 3), de synthese van de hybride blok-copolymeren (Hoofdstuk 4), 
en de fysische karakterisatie van deze blok-copolymeren beschreven (Hoofdstuk 5). Deze 
hoofdstukken worden voorafgegaan door een literatuuroverzicht van synthetische methodes  
voor het maken van hybride blok-copolymeren en hun mogelijke toepassingen (Hoofdstuk 2). 
Daarnaast beschrijft hoofdstuk 6 het ontwerp en de synthese van repetitieve α-helix 
polypeptiden, die gebruikt kunnen worden voor het maken van goed gedefinieerde 
glycopolymeren. 
In hoofdstuk 3 wordt de constructie van kunstmatige genen coderend voor een 
polypeptide met de repetitieve sequentie [(AG)3EG]n beschreven. De expressie van dit 
polypeptide in E. coli werd uitgevoerd via een aantal strategieën. Polypeptides met 10 tot 50 
herhalingen van de -(AG)3EG- sequentie konden effectief worden geproduceerd als fusie-eiwit 
met glutathion-S-transferase (GST, 26 kDa). De expressie van het fusie-eiwit GST-[(AG)3EG]20 
resulteerde na GST-affiniteitschromatografie in een opbrengst van ca. 80 mg per liter culture. 
Na proteolytische klieving van het fusie-eiwit met thrombine werd het polypeptide [(AG)3EG]20 
gescheiden van GST d.m.v. omgekeerde fase chromatografie, resulterend in een opbrengst van 
ca. 20 mg [(AG)3EG]20 per liter culture. Als alternatief werd [(AG)3EG]n (n = 10, 20, 30) 
geproduceerd met het T7 bacteriofaag expressiesysteem (pET). Het polypeptide [(AG)3EG]20 
werd geproduceerd zonder de aanwezigheid van een grote fusiepartner. Hierbij werd naast 
compleet polypeptide verkort produkt gevormd, dat verwijderd kon worden met omgekeerde 
fase chromatografie. De opbrengst was ook ca. 20 mg per liter culture. Het voordeel van deze 
methode was dat geen proteolytische klieving nodig was en dat het verwijderen van de 
aminozuren aan de N- en C-uiteinden direct met cyanogeen bromide klieving uitgevoerd kon 
worden. 
Ook de expressie van een polypeptide met de repetitieve sequentie [(AG)3KG]n is 
beschreven. De expressie van dit polypeptide was uitgevoerd met het doel om de lysine 
residuen te gebruiken voor de functionalisatie met bijv. mesogene groepen om vloeibaar-
kristallijne materialen te verkrijgen. De productie werd bemoeilijkt door de gevoeligheid van 
deze sequentie voor proteolyse. Het polypeptide [(AG)3KG]24 werd na expressie direct 
gezuiverd met Ni-NTA chromatografie. Polypeptide met het complete repetitieve deel werd 
gescheiden van de verkorte producten d.m.v. gelfiltratie chromatografie en een opbrengst van 
ca. 2 mg per liter culture werd verkregen. 
In hoofdstuk 4 wordt de synthese en chemische karakterisatie beschreven van blok-
copolymeren waarin het polypeptide blok [(AG)3EG]n aan beide zijden wordt geflankeerd door 
een PEG blok. De polypeptiden [(AG)3EG]10 en [(AG)3EG]20 werden tot expressie gebracht in 
E. coli. Gedurende de expressie werd naast het complete polypeptide ook verkorte polypeptiden 
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gevormd (van N-terminus tot ongeveer 6 -(AG)3EG- herhalingen). Het polypeptide 
[(AG)3EG]10 werd geproduceerd in erlenmeyer cultures en gezuiverd door middel van Ni-NTA 
chromatografie. Het complete polypeptide werd gescheiden van de verkorte produkten middels 
gelfiltratie chromatografie. Een opbrengst van 6 mg per liter culture werd verkregen. Het 
polypeptide [(AG)3EG]20 werd geproduceerd met behulp van hoge celdichtheid fermentatie 
(HCDF) en gezuiverd met achtereenvolgens Ni-NTA chromatografie, hitte precipitatie en 
omgekeerde fase chromatografie. De opbrengst was 10 mg polypeptide per liter culture. HCDF 
was helaas niet succesvol in de productie van grotere hoeveelheden polypeptide, aangezien de 
hoeveelheid tot expressie gebracht polypeptide per cel duidelijk lager was (5 – 50 maal) in 
HCDF dan in erlenmeyer cultures.  
De cysteine residuen aan beide zijden van de polypeptiden [(AG)3EG]10 en [(AG)3EG]20 
werden gebruikt voor de koppeling van maleimide gefunctionaliseerd PEG (Figuur 2). Het 
polypeptide [(AG)3EG]20 werd gekoppeld met PEG-750 (Mn = 750 g mol-1). Voor het 
polypeptide [(AG)3EG]10 werd conjugatie uitgevoerd met PEGs van verschillende lengtes (Mn = 
750, 2000 en 5000 g mol-1). De koppeling werd uitgevoerd door achtereenvolgens (1) reductie 
van de cysteine residuen met dithiothreitol (DTT), (2) verwijdering van DTT d.m.v. precipitatie 
van het polypeptide met trichloorazijnzuur, (3) koppeling met een overmaat maleimide 
gefunctionaliseerd PEG, (4) zuivering van het blok-copolymeer m.b.v. Ni-NTA chromatografie 
en (5) verwijdering van de niet-repetitieve uiteinden van het polypeptide d.m.v. klieving met 
cyanogeen bromide. Massa spectrometrie liet zien dat het hoofdproduct overeenkwam met 
polypeptide gefunctionaliseerd met twee PEG ketens. 
 
 
Figuur 2. Blok-copolymeer bestaande uit het β-plaat polypeptide poly-[(AG)3EG] geflankeerd door 
poly(ethyleenglycol) (PEG) eindblokken. De cysteine residuen aan weerszijden van het polypeptide 
blok werden gebruikt voor conjugatie van maleimide gefunctionaliseerd PEG (n = 17, 47 en 115). 
 
Hoofdstuk 5 beschrijft de fysische karakterisatie van de in hoofdstuk 4 beschreven blok-
copolymeren. Na kristallisatie werd de secundaire structuur van het polypeptide blok 
gekarakteriseerd met behulp van infra-rood spectroscopie. Hiervoor werden de frequenties in 
het amide I (vnl. C=O strekvibratie) en het amide II (vnl. NH-buigvibratie) gebied gebruikt. De 
overheersende absorptiebanden hadden frequenties van ~ 1625 cm-1 voor amide I en ~ 1520  
cm-1 voor amide II. Deze frequenties zijn typisch voor een antiparallelle β-plaat conformatie 
van het polypeptide blok. Dit waren de overheersende absorptiebanden zowel voor het 
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polypeptide alleen als voor de PEG-conjugaten. Voor langere PEG-ketens werd de 
absorptieband rond 1655 cm-1 relatief sterker, wat erop duidt dat de fractie van de 
polypeptideketen in de β-plaat conformatie afneemt. 
De microstructuur van de blok-copolymeren werd geanalyseerd met 
electronenmicroscopie (TEM). Hierbij werd aangetoond dat de blok-copolymeren fibrillen 
vormden, maar dat deze fibrillaire structuur niet aanwezig was voor de polypeptiden zonder 
geconjugeerd PEG. De fibrillen voor het blok-copolymeer [(AG)3EG]20-PEG-750 hadden 
afmetingen van ongeveer 12 nm (Figuur 3). Voor het blok-copolymeer [(AG)3EG]10-PEG-750 
(waarbij het polypeptide blok de helft van de lengte heeft) waren de fibrillen niet zichtbaar met 
electronenmicroscopie. Atoomkracht microscopie (AFM) werd uitgevoerd op monsters 
aangebracht op een mica oppervlak. Hieruit bleek dat ook kristallisatie van het blok-copolymeer 
[(AG)3EG]10-PEG-750 leidde tot de vorming van fibrillen. De hoogte van de fibrillen was 
ongeveer 2 nm voor zowel [(AG)3EG]10-PEG-750 als [(AG)3EG]20-PEG-750. Voor het 
polypeptide [(AG)3EG]10 geconjugeerd met PEG-2000 was er nog steeds een duidelijke 
fibrillaire structuur aanwezig, terwijl voor het conjugaat met PEG-5000 de fibrillen minder 
goed gedefinieerd waren en slecht korte fragmenten te zien waren. 
 
 
 
Figuur 3. Electronenmicroscopie opname van het gekristalliseerde blok-copolymeer [(AG)3EG]20-
PEG-750. De schaalstreep komt overeen met 200 nm. 
 
Gebaseerd op de TEM en AFM resultaten is een mogelijke ordening van de blok-copolymeren 
in de fibrillen voorgesteld. Het model bestaat uit een stapeling van β-platen in de lengte-as van 
de fibrillen. Hierbij staat de richting van waterstofbruggen loodrecht op de lengte-as van de 
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fibrillen. De PEG-ketens voorkomen daarbij een zijdelingse aggregatie van de fibrillen. Voor 
een direct bewijs van dit model zijn diffractie gegevens echter noodzakelijk. 
Hoofdstuk 6 beschrijft het ontwerp van een α-helicaal polypeptide welke gebruikt kan 
worden voor het maken van goed gedefinieerde glycopolymeren. De interactie tussen suiker 
liganden op het celoppervlak en eiwit receptoren is belangrijk in veel biologische 
herkenningsprocessen. Multivalente glycopolymeren welke suiker liganden nabootsen kunnen 
sterke inhibitoren zijn van suiker-bindende receptoren. Ze worden daarom beschouwd als 
interessante kandidaten om als medicijn ingezet te worden in ziektes, zoals chronische en acute 
ontstekingen. De chemische synthese van glycopolymeren resulteert in heterogene producten 
met een beperkte controle over de plaatsing van de suiker epitopen. Recombinante productie 
methoden kunnen daarom nuttig zijn om monodisperse polypeptides te maken die 
gefunctionaliseerd kunnen worden met suikereenheden op gedefinieerde posities. Door het 
gebruik van een polypeptide met een α-helicale conformatie is het mogelijk om reactieve 
groepen op verschillende afstanden van elkaar langs de helix-as te positioneren. Het ontwerp 
van zo’n α-helix polypeptide en pogingen om dit kunstmatige polypeptide recombinant te 
produceren in E. coli zijn beschreven. 
Voor het ontwerp van een α-helicaal polypeptide werden aminozuur residuen gekozen 
die een sterke neiging hebben om een α-helix conformatie aan te nemen en die reactieve 
groepen hebben voor functionalisatie. Een eerste ontwerp is gemaakt met de repetitieve 
aminozuurvolgorde [(MAKA)2ΜΑΑ]n (M = methionine, A = alanine en K = lysine). In een α-
helix conformatie zijn de methionine en lysine residuen aan tegenovergestelde zijden van de 
helix as geplaatst. De lysine residuen kunnen direct gebruikt worden voor de conjugatie met 
suiker residuen. De methionine residuen kunnen middels het gebruik van methionine auxotrofe 
E. coli stammen vervangen worden door de niet-natuurlijke aminozuur analoog 2-amino-5-
hexynzuur. Daarmee wordt een functionele groep aangebracht die gebruikt kan worden voor de 
zeer efficiënte en chemoselectieve [3 + 2]-cycloadditie met azide-gefunctionaliseerde 
suikergroepen.  
Circulair dichroisme spectroscopie werd uitgevoerd aan kleine [(MAKA)2ΜΑΑ]n 
polypeptiden met n = 1, 2 en 3 om te bepalen of de polypeptides een α-helix conformatie 
aannemen. Er werd aangetoond dat de aminozuurvolgorde geneigd is tot het aannemen van deze 
conformatie. Hoewel het α-helix percentage laag was, nam het toe met langere polypeptide 
lengte en hogere pH. Voor [(MAKA)2MAA]3 was het α-helix percentage 32% bij pH 12. Het 
voorspelde hogere α-helix percentage voor langere polypeptiden was bemoedigend om de 
recombinante productie van deze polypeptiden in E. coli te onderzoeken. Helaas was de 
bacteriële expressie van deze repetitieve polypeptidende niet succesvol. Hoewel immunoblot 
analyse een succesvolle expressie van [(MAKA)2MAA]n (n = 6 en 12) met een N-terminale T7-
tag suggereerde, was de zuivering met Ni-NTA chromatografie niet succesvol. Expressie als 
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fusie met NusA, een eiwit dat zeer goed tot expressie komt in E. coli, werd uitgeprobeerd. 
Bacteriële expressie van deze fusie-eiwitten werd echter niet aangetoond. 
 -151- 
Dankwoord 
 
Op deze laatste pagina’s wil ik de ruimte nemen om de mensen te bedanken zonder wiens hulp 
en steun dit proefschrift nooit tot stand gekomen was. Allereerst wil ik mijn promotor, prof. Jan 
van Hest, bedanken voor het geven van de mogelijkheid om dit onderzoek uit te voeren. Je hebt 
me de vrijheid gegeven om het onderzoek op mijn eigen manier aan te pakken. Zeker toen het 
onderzoek aanvankelijk moeizaam verliep, heb ik veel steun gehad aan je enthousiaste en 
motiverende ideeën en je geduld. Ik heb veel van je geleerd, zowel op het professionele als op 
het persoonlijke vlak. 
Ik wil ook mijn copromotor, prof. Henk Stunnenberg, bedanken. Niet alleen heb je me 
de mogelijkheid gegeven om (langer dan oorspronkelijk gepland) in je lab te werken, maar ik 
heb ook veel steun gehad aan je hulp bij allerlei praktische zaken (zoals het uitvoeren van 
eiwitzuiveringen) en je kritische commentaren. 
Gelukkig was ik met het feit dat ik in het begin van mijn AiO-schap het kantoortje heb 
mogen delen met Colin, Paul en Torill. De sfeer in dit kantoortje heb ik als zeer bijzonder 
ervaren. Colin wil ik daarnaast speciaal bedanken voor de tijd die hij voor me heeft vrijgemaakt 
om me te helpen met het opzetten van het DNA-werk. Verder wil ik Anita bedanken wiens 
praktische hulp onmisbaar was o.a. bij het op een degelijke manier uitvoeren van kloneringen 
en eiwitzuiveringen. Daarnaast wil ik Josephine en Maria bedanken voor al hun hulp. 
Theo Sonke en Wilco Peeters van DSM Research wil ik bedanken voor het feit dat ze me 
de mogelijkheid hebben gegeven om fermentaties uit te voeren in het lab in Geleen. Jens Thies 
van DSM Research ben ik erkentelijk voor zijn aanzet tot het maken van zijde-analoge hybride 
blok copolymeren en het verschaffen van plasmiden. 
Het belang van degelijke chemische analyses is gedurende mijn promotieonderzoek 
steeds duidelijker geworden. Mijn dank gaat daarbij uit naar Rien van der Gaag 
(aminozuuranalyse en HPLC) en Ad Swolfs (NMR), die uitgebreid de tijd hebben genomen om 
mij te helpen. Ook belangrijk voor mijn proefschrift waren de microscopie analyses. Huub 
Geurts wil ik danken voor zijn begeleiding bij het uitvoeren van de electronenmicroscopie 
metingen. Matthijs Otten en Peter Schön wil ik bedanken voor het uitvoeren van de 
atoomkracht microscopie metingen en de enthousiaste samenwerking die we gehad hebben.  
Verder wil ik natuurlijk iedereen van de Bio-organische Chemie groep bedanken. Hans 
Adams ben ik niet alleen erkentelijk voor de peptiden die hij voor me gesynthetiseerd heeft, 
maar ook voor al zijn praktische hulp, zoals de uitvoering van eiwithydrolyses en de tijd die hij 
voor me genomen heeft om mijn chemische vragen te beantwoorden. Ook Dennis Löwik en 
Joris Meijer wil ik bedanken voor al hun hulp. Lee Ayres, Henri Spijker en Joost Opsteen wil ik 
bedanken voor o.a. hun hulp bij het uitvoeren van polymerisaties en de GPC-karakterisaties. 
Peter van Dijk wil ik daarnaast bedanken voor zijn hulp bij het verkrijgen van 
Dankwoord 
 -152- 
fermentoronderdelen. De secretaresses Maria Versteeg en Désirée van der Weij ben ik 
erkentelijk voor hun hulp bij alle administratieve zaken. 
Gedurende mijn promotieonderzoek heb ik het geluk gehad om drie studenten geheel of 
gedeeltelijk te mogen begeleiden. Als eerste Joost Clerx, die gedurende zijn bijvakstage de 
aanzet heeft gegeven voor het ontwerp van α-helix polypeptiden die in het laatste hoofdstuk 
van dit proefschrift zijn beschreven. Door de ervaring die je al had opgedaan in je hoofdvak had 
je een hoge mate van zelfstandigheid en het was daarom ook leerzaam om met je samen te 
werken. Ik hoop dat de opgedane technieken je geholpen hebben bij het doen van je eigen 
promotieonderzoek. Tjaart-Jan Huizing, polymeerchemie student aan de Hogeschool van 
Arnhem en Nijmegen, wil ik bedanken voor het uitvoeren van gecontroleerde polymerisaties 
van methyl methacrylaat en de moeilijke experimenten die hij ondernomen heeft om deze 
relatief eenvoudig te synthetiseren polymeren te koppelen aan de wat minder voorradige β-plaat 
polypeptiden. Rosalie Teeuwen, ik wil je bedanken voor de inzet die je getoond hebt bij je 
pogingen om de α-helix polypeptiden recombinant te produceren, iets was geenszins eenvoudig 
bleek te zijn. Ik hoop dat de ervaringen die je daarbij hebt opgedaan, nuttig zijn geweest voor de 
uitvoering van je eigen promotieonderzoek. 
Coen, Torill en Xavier, jullie aanwezigheid in het lab en daarbuiten heeft ervoor 
gezorgd, dat ik een geweldig leuke en interessante tijd heb gehad. Zowel de vele spontane 
avondjes eten en drinken als onze actieve vakanties waren een goede afleiding van het labwerk. 
Goede herinneringen heb ik dan ook aan de rustige avondjes praten, de wat meer fanatieke 
avondjes “Kolonisten”, het langlaufen naar de top van de Synnfjell (en de ongecontroleerde 
afdaling ervan), de koude, maar ontspannen sleetochtjes in Røros, het door de modder kruipen 
in de grotten van de Ardennen en het paardrijden aan de Franse kust. 
Belangrijk was ook de ontspanning op sportief gebied. Ik wil daarom ook iedereen van 
het voetbalteam Uni vv1 en in het bijzonder trainer Wil de Haard bedanken voor deze leuke 
tijd. Tot slot wil ik mijn vrienden en familie bedanken voor hun steun, vertrouwen en geduld.
 -153- 
List of publications 
 
J. M. Smeenk, T. J. Huizing, H. G. Stunnenberg, J. C. M. van Hest “Well-defined polymer 
architectures for controlled assembly: Beta-sheet containing hybrid block copolymers” Polym. 
Prep. 226, U360 (2003). 
 
J. M. Smeenk, L. Ayres, H. G. Stunnenberg, J. C. M. van Hest “Polymer protein hybrids” 
Macromol. Symp. 225, 1 (2005). 
 
J. M. Smeenk, D. Lowik, J. C. M. van Hest “Peptide-containing block copolymers: Synthesis 
and potential applications of bio-mimetic materials” Curr. Org. Chem. 9, 1115 (2005). 
 
J. M. Smeenk, M. B. J. Otten, J. Thies, D. A. Tirrell, H. G. Stunnenberg, J. C. M. van Hest 
“Controlled assembly of macromolecular beta-sheet fibrils” Angew. Chem. Int. Edit. 44, 1968 
(2005). 
 
J. M. Smeenk, P. Schön, M. B. J. Otten, S. Speller, H. G. Stunnenberg, J. C. M. van Hest “Fibril 
formation by triblock copolymers of silk-like beta-sheet polypeptides and poly(ethylene 
glycol)” Macromolecules 39, 2989 (2006). 
 -154- 
Curriculum Vitae 
Jurgen Smeenk werd geboren op 4 april 1976 te Winterswijk. Na het behalen van het VWO 
diploma aan de R.K. Scholengemeenschap Marianum in Groenlo, begon hij in 1994 met de 
studie Bioprocestechnologie aan de Wageningen Universiteit. Met de specialisatie “Toegepaste 
biokatalyse” werd afstudeerwerk verricht in de vakgroep Proceskunde (prof. K. van ’t Riet) met 
als titel “Integratie van oligosacharidenverwijdering d.m.v. adsorptie aan actief kool en 
enzymatische oligosacharidensynthese”. Daarna werd in de vakgroep Biotechnologie (prof. P. 
Adlercreutz, Universiteit van Lund, Zweden) een afstudeervak gedaan met als titel “Porcine 
liver esterase in organic solvents”, waarin het gebruik van enzymen in niet-waterig milieu werd 
bestudeerd. In maart 2000 behaalde hij het doctoraal examen. Van maart 2000 tot mei 2004 was 
hij aangesteld als AiO in de vakgroep Organische Chemie van de Radboud Universiteit 
Nijmegen. Onder leiding van Prof. J.C.M. van Hest en Prof. H.G. Stunnenberg (Moleculaire 
Biologie) werd gewerkt aan het in dit proefschrift beschreven onderzoek. Daarna werkte hij als 
Post-doc in het polymeerchemie laboratorium van Prof. O. Nuyken aan de Technische 
Universiteit München. 
 
